A Study on Cegana Vatham (Cervical Spondylosis) by Elakkia, K
A STUDY ON 
CEGANA VATHAM 
(Cervical spondylosis) 
 
Dissertation Submitted To 
THE TAMIL NADU Dr. M.G.R. Medical University 
Chennai – 32 
 
For the Partial fulfillment for the Award of Degree of 
DOCTOR OF MEDICINE (SIDDHA) 
(Branch – III, SIRAPPU MARUTHUVAM) 
 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
Government Siddha Medical College 
Palayamkottai – 627 002. 
OCTOBER - 2018 
PALAYAMKOTTAI, TIRUNELVELI-627002, 
TAMILNADU, INDIA. 
 
Phone: 0462-2572736 / 2572737/ Fax:0462-2582010 
Email: gsmc.palayamkottai@gmail.com 
 
BONAFIDE CERTIFICATE 
 
           This is to certify that the dissertation entitled  “A STUDY ON CEGANA 
VATHAM is a bonafide work done by  Dr. K. ELAKKIYA,                                      
(Reg No: 321513002) GOVERNMENT  SIDDHA  MEDICAL  COLLEGE, 
PALAYAMKOTTAI in partial fulfillment of the University rules and regulations 
for award of  M.D (SIDDHA), BRANCH - III SIRAPPU MARUTHUVAM  
under my guidance and  supervision during the academic year  2015-2018 
OCTOBER. 
 
Name and Signature of the Guide: 
 
 
 
Name and Signature of the Head of Department: 
 
 
 
 
 
Name and Signature of the Principal : 
GOVERNMENT  SIDDHA  MEDICAL  COLLEGE 
PALAYAMKOTTAI, TIRUNELVELI-627002, 
TAMILNADU, INDIA. 
 
Phone: 0462-2572736 / 2572737/ Fax:0462-2582010 
Email: gsmc.palayamkottai@gmail.com 
 
 
DECLARATION BY THE CANDIDATE 
 
 
  I hereby declare that this dissertation entitled “A STUDY ON                         
CEGANA VATHAM”  is a bonafide and genuine research work carried out by 
me under the guidance of  Prof. Dr. A. S. POONGODI KANTHIMATHI., 
M.D(s)., HOD, PG - Department of Sirappu Maruthuvam, Govt. Siddha Medical 
College, Palayamkottai and the dissertation has formed the basis for the award  of 
any Degree, Diploma, Fellowship or other similar title. 
 
 
Date :  
Place:        Signature of Candidate 
            Dr. K. Elakkiya 
 

 

 



 
 

ACKNOWLEDGEMENT 
 
 The author is extremely grateful to Lord Almighty who empowered the author 
with His blessings and grace to complete this dissertation work successfully. 
 I take this opportunity to express my gratitude to the Vice Chancellor, The 
Tamilnadu Dr.M.G.R. Medical University, Chennai and The Director. Directorate of  
Indian  Medicine and Homeopathy, Chennai who flagged my dissertation with cheer. 
 My grateful thanks to  Prof. Dr. R. Neelavathy, M.D.(s), Ph.D., Principal, 
Government Siddha Medical College, Palayamkottai and Prof. Dr. S .Victoria M.D (s) 
Vice - Principal, Government Siddha Medical College, Palayamkottai for permitting me 
to make use of facilities available in this institution to bring out the dissertation,                           
a successful one. 
 The author is grateful to Dr.A.S.Poongodi Kanthimathi.,M.D(S)., Professor, 
HOD, Department of Sirappu Maruthuvam, (P.G III),Government Siddha Medical 
College, Palayamkottai for her valuable guidance regarding these studies. 
  I would like to show my gratitude to Dr.M. Ahamed Mohaideen, M.D(s)., 
Associate Professor, Department of Sirappu Maruthuvam (P.G III) for his kind guidance 
and good co-operation  to make the easy way to complete the dissertation. 
 I would like to show my gratitude to Lecturer (Grade II) Dr.S.Sujatha M.D(s)., 
Department of Sirappu Maruthuvam  for her kind guidance and good co-operation to 
make the easy way to complete the dissertation. 
 I would like to show my gratitude to Lecturer (Grade II) Dr.G.Ganesan M.D(s)., 
Department of Sirappu Maruthuvam, for his kind guidance and good co-operation. 
 I would thank to Lecturer (Grade II) Dr.R. Vanamamalai M.D (s), Department 
of Sirappu Maruthuvam for his kind guidance and good co-operation. 
 The author is thankful to Mrs.Nagaprema M.Sc., Head of the Department 
Biochemistry, Government Siddha Medical College, Palayamkottai for all technical 
assistants of clinical laboratory for their help in evaluating the trial drugs. 
  The author is so grateful to Dr. Mr. .Kalaivanan M.Sc.,M.Phil.,Ph.D  Lecturer, 
Department of Pharmacology, Government Siddha Medical College, Palayamkottai in 
carrying out the Pharmacological analysis of the trial drugs, needs special mention and 
appreciation. 
  I express my thanks to Dr.S.Sudha, M.Sc., M.Ed., Ph.D., Associate Professor, 
Department of Medicinal Botany, Government Siddha Medical College, Palayamkottai 
for the guidelines in identification of herbal drugs. 
 I sincerely thank the great Siddhars who show me the right pathway in Siddha 
system. My heartful thanks to my colleagues and friends for assisting and helping in many 
ways.   
 Finally, I am very thankful to the computer centre, Maharaja DTP services 
Tiruchendur road, Palayamkottai for his kind  co-operation in bringing out this 
dissertation work in an excellent format. 
 S.NO CONTENTS PAGE NO 
1 INTRODUCTION 1 
2 AIM AND OBJECTIVES 3 
3 REVIEW OF LITERATURE   
        Siddha Aspect 4 
        Modern Aspect  33 
4. MATERIALS AND METHODS 45 
5. OBSERVATION AND RESULTS 48 
6. DISCUSSION 79 
7. SUMMARY 82 
8. CONCLUSION 83 
 ANNEXURES  
 I. Preparation and Properties  89 
 II. Bio-Chemical Analysis 114 
 III.  Pharmacological Analysis  116 
 IV.  Acute toxicity study 130 
 V. Sub Acute toxicity study 136 
 VI. Histopathology studies 177 
 VII. Assessment Forms 181 
10 BIBLIOGRAPHY 199 
 
1 
 
INTRODUCTION 
            Man is a wonderful creature blessed by God. Imagination and laughter are milestone 
on the way that distinguishes man from other animals of mere living, no man was ever proud, 
but the good life had always been his aim. 
  To desire among goods the greatest good which is the most desirable, thus to be 
trusted to the self, to prefer among beautiful things, the grandeur beauty, thus to weigh 
objective things most truly, to worship that only which reflects infinite value, for this sound 
mind, one needs sounds body.  Health stated which not only keeps the body sound but also 
the mind. 
  Today’s modern industrialization imbalance the ecosystem which paves way for many 
disease. To uproot the disease there should be a system of medicine which goes hand in hand 
with nature. The Siddha system of medicine is an “Indigenous system of Medicine”. The 
unique nature of this system is its continuation of service to humanity from time immemorial.  
Siddha system of medicine is ancient one, it is believed to be originated from Agasthiyar to 
Siddhars, from Siddhars this system of medicine gifted to mankind. The siddha system has 
been involved by the hard work and hearted contribution of Tamil sages turned Medical 
scientists called “Siddhars”. 
  The ultimate aim of siddhars is to attain eternal bliss. For attaining eternal bliss 
human body is considered to be a media. This media must be protected from degeneration 
ageing and disease. So the siddhars followed specific type of life style and food style which 
was also included in this system. 
  The advantage and unique features of siddha system is the removal of the root cause 
of the disease and provide perfect remedy for mind and soul. Siddhars have enumerate ways 
to that are to be followed to maintain the body without being affected by any disease and to 
maintain sound mind which are called panacea. 
 
gx<hLjxgt<< << << <!
! “gx<hk<jk!B{<miz<!gibl<!npqbiK!
! ! gx<hk<kqeiOz!gi{zil<!jgjzjb!
! gx<hk<kq!eiOz!gi{zil<!Osikqjb!
! ! gx<hk<kq!eiOz!gijzBl<!gm<cOm”!
. kqVlf<kqvl<< << << <!
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           In recent times, pain in the neck is frequently reported from the public as 80% of them 
are engaged with a profession which makes chronic flexion to the cervical vertebra ( Eg: 
cooks, beedi workers,  agriculture labors etc., 
           The clinical feature of Ceganavatham is described by Siddhar  Yugi in his 
classification of Vatha disease.  Most of the clinical features of this disease are closely 
resemble that of cervical spondylosis in modern clinical entity. 
           The incidence of this disease is observed during the study at Government Siddha 
Medical College, Palayamkottai.  The author’s choice of drug for the clinical study were, 
Vathathirku leghiyam - Kottaipakalavu ( 6.022gm) twice a day internally. 
-Athmaratchamirtham 
Pancharka thylam – Externally 
-Agathiyar mani ennum vaithiya sinthamani venba-4000 
 Those drugs were prepared by the author and were tried in 40 cases of Cegana vatham 
of varied aetiology and the clinical study was undertaken in the post graduate and in the out 
patient department of sirappu maruthuvam and the follow up study of all the cases was done 
in the post graduate out patient department. 
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AIM AND OBJECTIVES 
AIM :  
  Phase II Clinical observation criteria based study of CEGANA 
VATHAM (Cervical Spondylosis)  and the drug Choice  VATHATHIRKU 
LEGHIYAM (Internal) and PANCHARKA THYLAM (External).  
 
OBJECTIVES: 
 Primary objective: 
 To evaluate the therapeutic efficacy of VATHATHIRKU LEGHIYAM 
(Internal) and PANCHARKA THYLAM (External) in reducing the pain in 
CeganaVatham. 
 
Secondary objective: 
•  To study the Siddha basic principles like envagaithervugal including 
neerkkuri and neikkuri .  
• To evaluate the safety profile of the trial medicine 
• To Evaluate the pharmacological study of trial medicine  
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REVIEW OF LITERATURE 
                                                     CEGANA VATHAM 
DEFINITION: 
  The literature of  “ Yugi Vaidhiya Chinthamani 800” , classified the vatha disease  in 
to 84 types. Cegana vatham is one of the vatha disease. Cegana vatham is a disease that 
associates with involvement of upper back, which is parallel to cervical spine. 
The symptoms include pain present in the neck, pain radiating to the upper limbs, feeling 
heaviness of the body, giddiness , mental depression, burning sensation of eye and 
constipation. 
 
AETIOLOGY: 
  In various siddha literatures, common aetiological factors of vatha disease are 
described, these aetiological factors are also applicable for the cegana vatham.  
 
IN YUGI VAITHIYA CHINTHAMANI 
“kioee<x!gsh<OhiM!KuIh<Hjxh<H!
!!!!!! sikglib<!lqR<SgqZl<!sjlk<k!u{<{l<!
!Noee<x!uixqeK!Hsqk<k!ziZl<!
!!!!! Ngibx<!OxzK!Gck<kziZl<!
!hioee<x!hgZxg<g!lqviuqpqh<H!
!!!!! hm<ceqOb!lqgUXkz<!hiv!olb<kz<!
!Okoee<x!olipqbiI!Olx<sqf<jk!bikz<!
!!!!! sQg<gqvlib<!uiklK!oseqg<Gf<kiOe#!
!!
“hgvOu!uiklK!Ogihqk<kh<Ohi!
!!!!!! h{<hig!oh{<Ohig!lKkie<!osb<bqz<!
!!fgvOu!ouGK~v!upq!fmg<gbqz<!
!!! ftqvie!gix<XOl!heqOlx<!hm<miz<!
!!lqgvOu!gib<gt<!geqgqpr<G!ke<je!
!!!!!! lqguVf<kq!lQxqOb!kbqIkie<!ogi{<miz<!
!!LgvOu!LKogZl<jh!LXg<gq!ofif<K!
!!!!!! Lpr<giZl<!gj{g<giZl<!gMh<H!d{<miOl#!
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 Consumption of bitter taste, astringents, pungent food items excessively, 
 Eating previously cooked foot, 
 Drinking contaminated water, 
 Altered sleep rhytm, 
 Excessive starvation, 
 Lifting heavy objects, 
 Excessive lust,  
 Long distance walking, 
 Living in cold environment, 
 Excess eating of tubers, fruits, curd. etc., 
Kanma  vinai is also one of the aetiology of vatham, including cegana vatham. 
 
IN AGASTHIYAR GUNAVAGADAM 
!! “uquvlmi!nskq!se<eq!&jt!OfiU!
!!!!!!!!!!!uqvquie!&jtbK!lqVKuigq!
!!!!!!nueqkeqz<!kqmligh<!OhiukiZl<!
!!!!!!!!!!!nh<hOe!&k<kqv!G{<cg<gib<!uqbikqbiZl<!
!!!!!!kuLequI!kQIg<gig<jg!Olg!Ovigl<!
!!!!!!!! ke<jlBt<t!Lk<k{<M!ogicuqbikq!
!!!!!nulqzih<!hvqs!fvl<hPk<kr<!g{<miz<!
!!!!!!!!!! n[Glmi!uikOfib<!NGl<hiOv# 
!
 Disease of Spinal cord and Vertebral column, 
 Disease of muscles, 
 Menorrhagia, 
 Mercury and Lead poison. 
 
IN AGASTHIYAR KANMA KANDAM 
“F~oze<x!uikl<!uf<k!ujgkiOeK!
!! ! F{<jlbib<g<!ge<lk<kqe<!ujgjbg<!OgT!
!!!!!gizqOz!Okie<xqbK!gMh<hOkK!
!!!!!!!!!!!jggizqz<!Lmg<gqbK!uQg<gOlK!
!!!!!!OgizqOz!hMgqe<x!uqVm<slie!
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!
!!!!!!! Gpf<jk!lvf<ke<je!oum<mz<!Olz<Okiz<sQuz<!
!!!!!!!fizqOz!sQuosf<K!giz<Lxqk<kz<!
!!!!!!!!!!!fz<zogil<H!kjpLxqk<kz<!fzqk<kz<!giO{/#!
!
 Cutting trees, bark, tender leaves, 
 Breaking Animal’s legs, 
 Breach of Trust 
 Abusing elders, and Priests, 
 Damaging charitable properties, 
 Discreditable to mother, father and teacher, 
 Disrespectful attitude with god, 
 Refusing food for destitute and hermits, 
 Involvement in theft and murder. 
 
ALTERATION IN UDAL VANMAI 
           An significant cause of Cegana Vatham is alteration in Udal Vanmai ( Body strength). 
It is described as Kaala Vanmai, Eyarkai Vanmai and Seyarkai Vanmai. Generally in Kaala 
Vanmai the old age persons are affected. In Seyarkai Vanmai, the conditions like wrong 
postures, sedentary life style and incomplete foods causes Cegana Vatham. 
 
PATHOLOGY 
         The alteration in ideality of life style, occupation, and food habits causes the 
derangements of micro elements in the body ( Panchapoothangal). Comparing to other factor, 
food habits play the direct role. 
        When these micro elements in the body altered, three humours namely Vatham, Pitham, 
Kabam get deranged. This on other hand , leads to derangement of seven Udal thathukkal and 
produces symptoms. 
        The main aetiological agent of cegana vatham is diet that produce excessive Vayu and 
on other hand, it cause vitiation of Aahayam, Earth, Water, and Fire. Depending upon the 
type of agent that affecting , the corresponding Uyir thathu is affected. Vali and Aahayam 
constitute Vatham. Earth constitute Kabam and fire constitutes Pitham. So when the micro 
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elements are affected, Uyir thathukkal get affected, which in turn affects Udal thathukkal, 
that give rise to clinical features of Cegana Vatham. 
        In Uyir Thathu, when Vatham is affected ; 
 The derangement of Vyanan causes pain in cervical and dorsal spine, pain along 
upper limbs, scorpion bite like pain and heaviness of the body. 
 The derangement of Abanan causes constipation and 
 The derangement of devathathan cause mental depression.  
       In Uyir Thathu, when Pitham is affected ; 
 The derangement of Sathaga Pitham causes giddiness. 
      In Uyir Thathu when Kabam is affected ; 
 The derangement of Tharpagam causes burning sensation of eyes. 
  Along with this derangement of Uyir Thathus, Udal Thathukkal namely Saaram, 
Seneer, Oon, Kozhuppu, Enbu, are also affected. 
 
CLINICAL FEATURES 
       In Yugi Vaidhiya Chinthamani and Pararasasekaram the sings & symptoms of Cegana 
Vatham is described. 
In Yugi Vaidhiya Chinthamani ; 
!!!!!!!!!!!!#!OgTOl!gPk<kqe<!gQpjvg<G!OlZr<!
ogcbie!gvlqv{<M!lqgOu!ofif<K!
!!!!!!!!!!!!!!uiTOl!svQvolz<zil<!gek<kqVg<Gl<!
!!!!!!!!!!!!!!!!!!!!!uizqhIg<G!ler<g{<[!lbg<gliGl<!
!!!!!!!!!!!!!!WTOl!bqv{<M!g{<[!olvqs<sziGl<!
Olx<xlib<!szr<kiE!lqXgqg<!gi[l<!
!!!!!!!!!!!!!!OkTOl!ogim<ceK!Ohix<gMg<Gl<!
sgeui!kk<kqeqmf<!kQIg<gf<!kiOe!#!
In Pararasasekaram ; 
#!g{<mOkiI!osge!uikr<!gPk<kqe<!gQpjvg<G!OlZl<!
l{<mzr<!gvlqv{<M!lqgofif<K!gek<kqVg<Gl<!
l{<cOb!kqlqIk<Kg<!Gk<Kl<!uzq!lqGk<KjtU{<miGl<!
u{<mlI!GpzqeiOt!lkqbqeiZe<EuiOb#/!
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THE CLINICAL FEATURES INCLUDES ; 
 Pain in the cervical region 
 Pain radiating to shoulder and upper limb 
 Heaviness of body  
 Mental depression 
 Giddiness 
 Burning sensation of Eye 
 Constipation 
 Tingling sensation and numbness of upper limbs. 
 
DIAGNOSIS OF CEGANA VATHAM 
                    The following siddha diagnostic methods are used to diagnose the disease. 
1. PORIYAL ARITHAL ( Sensory organs) 
 Patient’s  porigal must be examined by physician’s porigal.  
IYMPORIGAL Physiological function 
1. Mei For feeling touch sensation 
2. Vaai For knowing taste 
3. Kan For vision 
4. Mooku For knowing the smell 
5. Sevi For hearing 
 
2.  PULANAAL ARITHAL ( Five senses ) 
          Patient’s pulangal must be examined by physician’s pulangal. 
 
IYMPULANGAL Physiological function 
Ooru Touch ( perception of sensation ) 
Osai Sound ( perception of sound ) 
Suvai Taste ( perception of  taste ) 
Oli Vision ( Perception of vision ) 
Naatram Smell ( Perception of smell ) 
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3. VINAATHAL ( INTERROGATION )  
                The physician should interrogate about , patient’s name, age, occupation, socio-
economical status, diets, history of allergy, history of present and past illness, family and 
personal history. If the patient’s is in the stage of inability to speak, physician should 
interrogate the details with the person, who is taking care of him. 
 
4. THINAIGAL 
The land are classified into five types according to the geographical distribution. 
 Kurunji      -  Kabha and Liver disease are common. 
 Mullai        - Vatha and Pitha disease are common. 
 Marutham  - Safest place to maintain good health. 
 Neithal       - Vadha disease and Liver enlargement are common. 
 Paalai         - All the three humours may be affected. 
          Most of the patients came from Maruthanilam. Patients were also reported from 
Neithal and Kurunji nilangal. 
5. PARUVA KAALAM : 
               One year is divided into six season or kaalam. Each kaalam constitutes two month. 
They are 
S.No. Paruvakalangal Kuttram 
1. Kaarkaalam       –      Aavani and Purattasi 
(August 16 – October 15)*!
Vatham ↑ ↑ 
Pitham  ↑ 
2. Koothirkaalam     -      Ayppasi and kaarthigai 
(October 16 – December 15)* 
Vatham (-) 
Pitham  ↑ ↑ 
3. Munpanikaalam     -     Maargali and Thai 
(December 16 – February 15*!
Pitham  (-) 
4. Pinpanikaalam        -    Maasi and Panguni 
(February 16 – April 15* 
Kabam  ↑ 
5. Elavenilkaalam       -     Aani and Aadi 
(April 16 – June 15)*!
Kabam ↑↑ 
6. Muduvenilkaalam  -    Aani and Aadi 
(June 16  - August 15* 
Vatham  ↑ 
Kabam (-) 
↑ Thannilai valarchi 
↑↑ Vetrunilai valarchi 
(-) Thannilai adaithal 
According to alteration of thannilai valarchi and vetrunilai valarchi, disease can be diagnosed. 
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6. UYIR THAATHUKKAL 
                  Uyir thaathukkal means “Life force” Vatham, Pitham, Kabam, which are the 
humours responsible for the creation, preservation, and desdruction of human body and 
health. When they are in the state of equilibrium in the ratio (1:1/2:1/4) in which they exit our 
body remains in a healthy state, but in case of any disturbance in this ratio leads to diseased 
conditions. 
 
 VATHAM 
                   Vatham represents the elements Air & Space. 
                   It is responsible for all movements of mind, and body. Motor and sensory 
activities are governed by vatham. 
S.No. Vatham Physiological function Features in Ceganavatham 
1 Pranan 
Inspiration and expiration 
responsible for sneezing coughing 
and belching 
Not affected 
2 Abanan Act with downward movement Affected constipation present. 
3 Viyanan 
Helps in various movements of body, 
responsible for sensation 
Affected  Restricted neck 
movements radiating pain in 
shoulder and arm with 
tingling sensation. 
4 Udhanan 
Regulates the higher functions of 
brain.  Responsible for physiological 
reactions like hiccough and vomiting 
Not affected 
5 Samanan Regulates all other vayus 
Affected Due to others types 
of vatham 
6 Nagan 
Responsible for intelligence helps in 
opening and closing of eyes 
Affected in aged pateints.  
Acuity of vision is 
deminished. 
7 Koorman 
Responsible for lacrimation.  Helps 
in visualization of all things of 
world. 
Affected in aged pateints.  
Acuity of vision is 
deminished. 
8 Kirukaran Increase salivation in oral cavity and Affected ( Lack of 
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mucosa secretion in nasal cavity, 
Increase appetite and helps in 
concentration. 
concentration) 
9 Thevathathan 
Responsible for laziness. Rotation of 
eyeballs. 
Affected (Sleeplessness 
present due to pain). 
10 Thananjeyan Responsible for tinnitus oedema.  
 
PITHAM 
           Pitham is formed by the elements Fire in our body and is responsible for the 
preservation of health. 
S.No. Pitham Physiological function Features in Ceganavatham 
1. Anar pitham 
Digests all the ingested 
particles. 
Affected (Indigesion  
present) 
2. Ranjaga pitham Increases the blood and gives 
blood colour 
Affected (Anaemia present) 
3. Saathaga pitham 
Makes the work to complete 
what mind thinks to do 
Affected neck pain and 
restricted movement 
4. Prasaga pitham Gives colours to skin Not affected 
5. Aalosaga pitham Responsible for clear vision Affected in old age peoples. 
 
KABAM 
              Kabam is formed by elements for strength, joint movements. 
S.No. Kabam Physiological function Features in Ceganavatham 
1. Avalambagam Controls other 4 types of kabam Affected (santhigam affected) 
2. Klethagam Moistens the food Not affected 
3. Pothagam Helps to know the taste Not affected 
4. Tharpagam Gives cooling effect to the eyes 
Affected ( burning sensation 
of eye presen)t 
5. Santhigam Gives lubrication to joints Affected (pain in cervical 
region) 
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7. EN VAGAI THERVU : 
 
                En vagai thervu is the unique & special method described in siddha system to 
diagnose the disease. 
                           “fich<hiqsl<!fifqxl<!olipquqpq!
lzl<!&k<kqvlqju!lVk<Ku!viBkl<”!
. Ofib<fimz<!Ofib<!Lkz<fimz<!hGkq!< < < < << < < < << < < < < –!I!
i) NAADI (Pulse) 
               By examining the naadi, the condition of humours and the fracture are understood, 
which is helpful for correct treatment. 
              In vatha disease, following stages of naadi are seen 
Vatha naadi : 
!!!!!!!!“uikolEl<!ficbK!Okie<xqz<!
!!!!!!!!!!!!!!sQklf<koliM!ubqX!ohiVlz<!kqvm<squiB!
!!!!!!!!!sQkLXr<!gqvi{q!lOgikvl<!fQvijl!
!!!!!!!!!!!!!!kqvt<uiB!$jzuzq!gMh<Hk<!kqjv!#/!
.skgfic/!
Vatha Pitha naadi : 
!!!!!!!!#!ohiVtie!uikk<kqz<!hqk<kR<!OsIf<K!
!!!!!!!!!gVuie!Okglk<kqZjts<sz<!Osil<hz<!
!!!!!!!!!jggiz<!kxqh<H!#!
.skgfic/!
Vatha Kapha naadi : 
!!!!!!!!“hir<gie!uikk<kqz<!Osk<Kl!fic!
!!!!!!!!!hvqsqk<kiz<!kqlqIOlU!Ljts<sziGl<!#/!
.skgfic/!
Pitha Vatha naadi : 
!!!!!!!!#hqk<kk<kqz<!uikligqz<!hqmvqBr<!giZr<!jgBr<!
!!!!!!!!!!!!!Gk<kK!OhiOzbiGr<!GXgq!olb<hkXl<!hqe<Oe!#/!
.ngk<kqbI!fic/!
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Pitha Kapha naadi : 
!!!!!!!!#hqk<kk<kqz<!Osk<Klligqz<!uib<GtXlqg<g!
!!!!!!!!///////////////////////////!
!!!!!!!!hqk<kL!olMk<Kg<!ogim<ch<!hqmvqbqz<!OfiukiOli!#!
.ngk<kqbI!fic/!
Kabha Vatha naadi : 
!!!!!!!!#uim<cMR<!Osk<Klk<kqz<!uf<kqMl<!uikligqz<!
!!!!!!!!!fim<cb!giz<gt<Ohiz!fvl<ohz<zil<!uzqk<K!fqx<Gl<!#/!
!.ngk<kqbI!fic/!
In all cegana vatham patients, Thondha naadi was noted. 
ii) Sparisam: 
                 By sparisam,, temperature, smoothness or roughness, sweet, dryness, hard patches, 
swelling, tenderness, abnormal growth, nourishment of skin can be felt. 
                 In cegana vatham, there was tenderness in cervical regions for all patients. 
iii) Naa: 
              By nothing the tongue, the colour, dryness, coated, surface, excess, salivation, 
redness, ulceration, pallor, yellowish discolourations, malignant growth, movement of 
tongue, and sensation predominant taste is noted. 
            In cegana vatham , generally no characterized changes is seen in tongue but 4 cases 
shows pale colour of tongue due to anemia. 
iv) Niram: 
            Colour changes like blackish, yellow, pallor or bluish discolouration is noted. Here 
there is no specific abnormality in niram. 
v) Mozhi: 
           Slurring, clarity of speech, talk induced by hallucination, undue argument are noted. 
Here there is no specific abnormality in mozhi. 
vi) Vizhi: 
          Eye is inspected for any abnormal colour, pallor, lacrimation, sub conjectival pallor, 
accumulation of secretion at angles of eye, bleeding and visual disturbance. 
          In cegana vatham generally no characterized changes seen, but in 4 cases conjunctival 
pallor is seen. 
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vii) Malam: 
         Consistency, quantity, colour, odour, frequency, is noted. Constipation was noted in 22 
cegana vatham patients. All other patients showed normal malam. 
viii) Moothiram: 
        Examination of urine is classified into two types. 
a) NEERKURI: 
                 In neerkuri quantity, colour, odour, froth, frequency, retention, deposits, presence 
of abnormal consistency are noted. It is expressed in following lines, 
sqXfQiqe<!ohiKg<G{l<Q < < <Q < < <Q < < <!
! “uf<k!fQIg<giqwjm!l{l<!FjvwR<soze<!
! jxf<kqbZtuju!bjxGK!LjxOb” 
. Ofib<fimz<!Ofib<!Lkz<fimz<!hGkq!< < < < << < < < << < < < < –!I!
b) NEIKURI 
The predominantly affected humour is assessed by neikuri. 
Exposed to bright sunlight, a drop of gingelly oil is allowed to fall on the surface of 
urine kept in kidney tray. 
Observation: 
                         “nvoue!fQ{<ce0Ok!uikl<”!
!!!!!!!!!!!!!Npq!Ohix<hvuqe<!n0Ok!hqk<kl<”!
!!!!!!!!!!!!!Lk<okik<K!fqx<gqe<!olipquoke<!ghOl”!
. Ofib<fimz<!Ofib<!Lkz<fimz<!hGkq< < < < << < < < << < < < < .I!
If the drop of oil on the surface of oil 
i) Spreads like a snake - Vatha disease 
ii) spreads like a ring    -  Pitha disease 
iii) Appears like pearl    - Kapha disease 
In cegana vatham urine is in straw or hay colour. 
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8. SEVEN PHYSICAL CONSTITUENTS OF BODY 
S.No. Seven physical 
constituents 
Physiological function Features in 
Ceganavatham 
1. Saaram Strengthens the body and mind Affected 
2. Senneer Preserves brightness, boldness, 
power& knowledge 
Affected 
3. Oon Gives structure and shape to 
the body. 
Early stage  - Not affected 
Later stage  - Affected 
4. Kozhuppu Responsible for movement 
lubricants the joint 
Affected 
5. Enbu Responsible to joint 
movements 
Affected 
6. Moolai Present inside the bones and 
gives strength to the bones 
Not affected 
7. Sukkilam (or) 
suronitham 
 Not affected 
 
9. GNANENTHIRIYAM: 
S.No. Gnanendhiriyam Physiological function 
1. Mei Feels the sensation of touch 
2. Naa Analyses taste 
3. Kan For vision 
4. Mooku For smell 
5. Sevi For hearing 
 
10. KANMENTHIRIYANGAL ( Motor organs ) 
              Examination of patient’s motor organs. 
S.NO Motor organs Physiological function 
1 Kai Work done by hands 
1. Kaal For walking 
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2. Vaai For speech 
3. Eruvaai For defaecation 
4. Karuvaai For reproduction 
5. Karuvaai For reproduction 
 
  In cegana vatham mei is affected which leads to pain and numbness. 
 
DIFFERENTIAL DIAGNOSIS  
                   These are certain other vatha disease which resembles the clinical signs and 
symptoms of cegana vatham. cegana vatham must be differentiated from such disease. They 
are 
1. Kumba vatham 
2. Kandakiraga vatham 
3. Paanikamba vatham 
 
1.KUMBA VATHAM: 
! “fuqzOu!Okit<lQKr<!gvk<kqe<!lQK!
! ! fzqf<K!olk<kuigqOb!fsU{<miGl<!
! guqzOu!ge<eoliM!fbef<!kiEr<!
! ! gMk<KOl!uqXuqXh<H!oliqUr<!gi[l<!
! KuqzOu!Kch<hiGR<!sqvS!ke<eqx<!
! ! Spx<xqOb!fihqg<gQp<!uzqB!L{<mil<!
! nuqzOu!bcfig<gq!zpe<X!gi[!
! ! lzVOl!uVGl<h!uikf<!kiOe”!
. B,gq!juk<<<<kqb!sqf<kil{q<<< !
The clinical features are!
1. Pain in shoulder and upper limbs, 
2. Burning sensation in the chest and eyes, 
3. Twitching over the region of scalp, 
4. Lower abdominal pain 
 5. Glossitis 
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3/!KANDAKIRAGA VATHAM 
! “ujgbit!Gvzkjeh<!hx<xq!ofif<K!
! liIOhiM!hqmiqkeqz<!uzqB{<migq!
! Fgvie!siQvolz<zil<!ofif<k!pzix<xq!
! F{g<glib<!SuislK!Hxh<hmilz<!
! Ljgbie!fiuiOz!&s<S!lixq!
! Lgk<kqOz!uqbi<uigq!uqziOfi!U{<mil<!
! hjgbie!ue<ek<jkh<!hVogim<miK!
! hiqb!g{<m!gqvigk<kqe<!h{<H!kiOe”/!
. B,gq!juk<kqb!sqf<kil{q!< << << < –!911!
The clinical features are, 
1. Pain in the throat, chest and occipital region 
2. Breathing through mouth, backache, sweating on face. 
 
3. PAANIKAMBA VATHAM: 
! “liIg<glib<!uib<Ulib<!olb<fqjxf<K!
! ! ubqXkeqx<!hsqbqzi!K~[lx<X!
! fiIg<glib<!Rizk<K!fmg<jgbx<X!
! ! fMg<glib<!jgbqv{<Mf<!kqVlqV{<mil<!
! DIg<gli!Bxg<glqz<zi!K{i<s<sq!bx<X!
! ! dkxqOb!siQv!olr<G!Lzi<f<K!gi[f<!
! hiIg<glib<!uib<uqm<M!nzi<k<kziGl<!
! ! hi{qg<gl<h!uikk<kqe<!hir<GkiOe”!
. B,gq!juk<kqb!sqf<kil{q< << << < !
!The clinical features are 
1. Anorexia 
2. Tingling sensation and numbness of upper limbs 
3. Tremors found in upper limbs 
4. Sleeplessness 
5. Dryness all over the body 
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NOI NEEKAM (TREATMENT) 
             The main aim of the treatment is to cure both physical illness and mental illness. 
Treatment is not only for complete healing but also for the rejuvenation. 
It is essential to know the nature of the patient, aetiology, severity and time of occurrence of 
the disease. 
  In siddha system the line of treatment consists of the following: 
1. Neekam (Treatment) 
2. Niraivu (Restoration of wellbeing) 
3. Kaappu (Prevention) 
NEEKAM 
  The aim of treatment is based on the following, 
a) To bring the three dhosas to equilibrium state. 
b) To treat the patients by internal and external medicines. 
c) To stabilize seven udal thathukkal and three uyir thathukkal. 
d) Diet and advises 
e) Sirappu maruthuvam – Thokkanam and yoga 
f) Kanma nivarthi 
 
1. BRING THE THREE DHOSAS IN EQUILIBRIUM: 
          Since the siddha system is based on mukkutra theory, the treatment is aimed to bring 
down the three dhosas to its equilibrium state and thereby restoring the physiological 
conditions of various thathus. 
           Vitiation of vatha is the prime factor for “Cegana vatham”. 
           Kalichal maruthuvam (Purgation) is the best method to correct the vitiated vatham. 
The following verses reveals the importance of kalichal maruthuvam. 
           In the first day of treatment 15ml vellai ennai is administrated with hot water at early 
morning as a kalichal medicine. 
 
2. DRUGS: 
                  Next day onwards the trial drugs were given. 
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i) INTERNAL MEDICINE: 
DRUG -“VATHATHIRKU LEGHIYAM” DOSE - KOTTAIPAKALAVU  
(6.022gm) Twice a day 
ii) EXTERNAL MEDICINE:“PANCHARKA THYLAM” was applied locally                   
over the affected area. 
 
3. DIET AND ADVISES: 
  I) PATHIYAM (DIET REGIMENS): 
                According to nature of illness and the drug administrated during the course of 
treatment the patients were advised to follow certain special and specific dietary methods 
called “PATHIYAM”. Therayar explains the importance of pathiyam as below,  
!!!!!!!!!!!!“hk<kqbk<kqeiOz!hze<!d{<miGl<!lVf<K!
!!!!!!!!!!!!!!!!!!!hk<kqbr<gt<!Ohieiz<!hze<!OhiGl<!
!!!!!!!!!!!!!hk<kqbOl!oux<xq!kVl<!h{<ckIg<G!Nkzqeiz<!
!!!!!!!!!!!!!!!!!!!hk<kqbOl!dk<kqobe<X!hiI”!
.!Okve<!ou{<hi!
Substance used for neutralizing three humours are: 
                            “ye<xqb!uikhqk<k!ghlqju!Bbvi!u{<{l<!
!!!!!!!!!!!!!!!!!!fe<xK!gxq!gotz<zil<!fiTOl!sjlh<hvib<OkiI!
!!!!!!!!!!!!!kqe<xqM!lqtU!lR<st<!sQvg!LbIf<k!gibl<!
!!!!!!!!!!!!!!!!!!oue<xq!ogit<!Sg<OgiOmzl<!ouf<kqbl<!dt<tq!OsIOk#!
.!h/G/sq!
 
                To maintain three vital humours in equilibrium one should take food cooked with 
• Pepper           - Piper nigrum 
• Turmeric        - Curcuma longa 
• Cumin seeds  - Cuminum cyminum 
• Asafoetida     - Ferula asafetida 
• Dry ginger     - Zingiber officinale 
• Cardamom    - Elettaria cardamom 
• Fenugreek     - Trigonella foenum 
• Garlic            - Allium sativa 
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OsIg<gg<!%cb!d{Ugt<!)< < << < << < < Diet to be included): 
gib<gt<!< << << < (Vegetables) 
• gk<kvqh<hqR<S!
• LVr<jgh<hqR<S!
• nujvh<hqR<S!
gQjvgt<Q <Q <Q <!)Greens) 
• ohie<eir<g{<{q!
• &g<gqvm<jm!
• K~KOujt!
• Lmg<gXk<kie<!
• nXgQjv!
• gvqsijz!
hpr<gt<< << << <!)Fruits) 
• liKjt!
• Nh<hqt<!
• hh<hitq!
• NvR<S!
• OhvQs<js!
• nk<kq!
• fiuz<!
njsul<!(Non-vegetarian diet) 
• out<tim<Mg<gxq!
• gijm!!
• sqX-xiz<!lQe<!
SIRAPPU MARUTHUVAM  FOR  CEGANA VATHAM 
1.THOKKANAM 
2. YOGA ASANAS 
THOKKANAM  
 Thokkanam is the siddha way of touch therapy.  it is the physical manipulation of the 
body usually done with or without oil application.  It is very effective for neurological and 
musculoskeletal problems.  It also promotes mental and physical fitness.  According to 
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siddha, disease in the body occur due imbalance of three humours that is vatham, pitham and 
kapham which in turn are governed by five fundamental elements – Akayam (Space, vayu 
(air), Theyu (fire), Appu (water and Mann (Earth.  Thokkanam is one of the 32 types of 
external medicines mentioned in siddha literature.  In this technique, the physician uses his 
hands on the body of the patient in 9 different unique ways with or without using medicated 
oil with acurative or palliative point of view.  The 9 different techniques in thokkanam which 
makes siddha medicine unique in all aspects.  They are 
1. Thattal or patting technique 
2. Irukkal or tightening 
3. Pidithal or holding 
4. Murukkal or twisting 
5. Kattal or tying 
6. Azhuthal or pressing 
7. Izhuthal or pulling 
8. Mallathuthal or supinating 
Benefits of Thokkanam 
 Helps to cure vatha disease even without internal medicines. 
 Chronic disease like spondylosis, lumbago, disc prolapse, hemiplegia, neurological 
conditions etc are managed well through thokkanam. 
 Improve circulation 
 Treats obesity 
 Helps in pain relief 
 Removes indigestion, constipation and flatulence 
 Induce sleep 
 Helps maintain normal blood pressure 
 Restores vatham, pitham and kapham in normal ratio 
 Regulates vatha humour. 
 Delays the aging process 
 Helps to rejuvenate the body. 
 Helps to increase the quantity of oxygen in the cells. 
 Helps to prevent wrinkles and maintain the complexion of the skin. 
 Tones the muscles 
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 Helps to keep the joint flexible 
 Improves the complexion of the skin 
 Improves energy and mental alertness. 
Massage (okig<g{l<*< << << < !
  Thokkanam  is a systemic manipulation of the body parts by the by physician (or) 
physiotherapist. 
! uikl<!Lkzqb!Lg<Gx<x! hq{qgt<!d{<mig<Gl<! uzqjb! ouXr<jgbiOzi! )n*!
jkzl<!kmuqObi!hqch<hK/!
! okig<g{k<kq!eizqvk<kf<!Okiz<D!{qjugm<G!
! lqg<G!sUg<gqbR<s!lQv[l<ohi!–!olb<g<gkqg!
! Hm<cBxg<gl<!H{i<s<sq!bqju!gkqg<Gl<!
! hm<m!njzs<szXl<!hiI”!
. Okve<<<<!
Of these 2 of the methods are very much beneficial in treating cervical spondylosis. 
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THOKKANAM (THADAVU MURAI) 
!
!
!
!
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hqck<kz<< << << <! !
! “hqck<kzq!br<Gl<!jlkqbq!Ef<kGl<!hqf<kiOk!–!w{<o{!
! BMk<kK!osb<bqx<!xsutq!B,Em!Zf<kiOk!
! Oux<xK!osb<bqER<!$sqjg!hiiqjs!uqm<OmiMl<!.!Hzq!
! Ohix<xK!uiBU!lx<XK!Olezqh<!ohim<OmiMl<”!
! okig<g{l<! osb<bg<%cb! 6! fqjzgtqZl<! osb<bzil</! ! jkzl<! kmuqObi?!
kmuilOzi!hqck<Kuqm!uik!Ofib<gTg<G!sqxh<hig!ohiVf<Kl</!
! It is made on the upper fibers of trapezius muscle and the underlying bone. 
!
-Pk<kz<!)< << << < Pulling) 
 -Pk<kz<!gqmk<k!zqVk<k!zqv{<cx<G!OlviOl!–!we<hqz<!
! LPk<kK!u{<[gr<!gielf<!kg<gkq!sQviOl!
! dVUk!oze<hK!lqk<Okipq!OzOfvl<!H,xigq!–!lel<!
! ouVUX!&e!uqjegjt!olb<bM!Ouxigq!
! utg<GX!ol{<o{b<!OzbqK!osb<uK!uz<zi{<jl!–!dmx<!
! gtg<gRI!Ohig<gs<!STg<oge!uiukqk<!okiz<zi{<jl”!
! -jk! jkzk<jk! H,sqOb! osb<bOu{<Ml</! ! wZl<Hgt<! fe<xib<k<!
okiqBlqmr<gtqZl<?!kjzbqZl<!dVUl<OhiK!lf<klig!osb<bOu{<Ml</!
! -keiz<!fvl<hqz<!Dxq!uXk<Kgqe<x!uiBg<gt<?!hqch<Hgt<?!STg<Ggt<!G{liGl</!
! Done for sternocleidomastoid muscles. 
 The treatment normally starts with applying the medicated oil on the affected area.  It 
directly acts on lymphatic, muscular, nervous and vascular system. 
 Strengthens muscle and skin 
 Relaxes whole body 
 Regulates nerve function 
 Improve blood circulation 
 Improve sleep 
Through massage, the medicated oil applied permeates through the skin and reaches the 
tissues under them.  It releives pain and tension by stimulation the sensory and motor nerves. 
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Benefits 
 It reduces the production of some hormones such as cortisol and nor epinephrine 
which are responsible for stress. 
 Brings fresh oxygen to the affected tissues. 
 Swelling and thickening of tissues are reduced. 
kmuz<!sqgqs<js< << << < !
hR<s!Lcs<Sk<!kmuz< < << < << < < <!
 gV{ikq!Lcs<S!)Atlanto –occipital joint)!
 svLcs<S!)C7 – Cervical vertebra)!
 Ke<ez<!Lcs<S!)T12 – Throacic vertebra)!
 hkq?!hS?!his!Lcs<S!)Lumbo sacral joint)!
 Gl<hg!Lcs<S!)Sacro –coccygeal joint)!
Ngqb!-mr<gjtk<!kmu!Ou{<Ml</!
uqSk<kq!ui<l!K~{<mz<< < < << < < << < < <!
2/ hqmiq!ui<ll<!
3/ Lcs<S!ui<ll<!
-f<k!uqSk<kq! ui<l! Ht<tqgjt!K~{<c!uqSk<kq!Nkivk<jk! kmUkz<!&zl<! uiB?!
H,k!GjxhiMgt<!sQvig<gh<hMgqxK/!
 
YOGA 
   Yoga is one of India’s wonderful gifts to mankind. 
  The word “yoga” is derived from Sanskrit origin “Yuj” which means to bind, to join, 
(or) to apply. 
  Traditionally philosophers had interpreted this to read “Yoking of all powers of the 
body, the mind and soul to God”. 
  Another frequently used definition of “Yoga” is that of union of the individual sprit 
with the universal, since that is its highest aim. 
  The parallel classical western concept of “Mens sana in corporesano”- a healthy body 
in a healthy mind has always been recognized and is finding increasing emphasis today. 
It has eight clearly defined aspects and in its purest form is a complete system capable of 
answering all human needs.  
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Matsyasana 
 
Paschimottaasana 
 
Matsyendrasana 
 
Makarasana 
 
Dhanurasana 
 
Yogamudra 
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ASANAS 
            Prior to everything, asana is spoken of as the first part of hatha yoga. 
            Having done asana, one attains steadiness of body and mind freed from disease and 
lightness of the limbs. 
-Hatha yoga pradipika (1:17) 
           Asana means a state of being in which one remains physically and mentally steady, 
calm, quiet and comfortable. 
           In the yoga sutras of patanjali there is a concise definition of yogasanas. “Sthiram 
Sukham Asanam”, meaning that position which is comfortable and steady. Asanas are 
specific body position which opens the energy channels and psychic centre. They are tools to 
higher awareness and provide the stable foundation for our exploration of the body, breath, 
mind, and beyond. 
           Our siddhars were well aware of the importance of the spine in relation to disease. 
Hence they explained many asanas and postures which were designed to make the spine more 
flexible to prevent spinal mis-alignment, and some may even correct minor spinal mis-
alignment. The author had explained about few asanas for ceganavatham patient as a 
preventive cure.   
 
Vertical stretching asanas: 
• Parvatasana (Mountain pose) 
Anterior stretching asanas: 
• Backward bending postures 
ASANAS COMPLEMENTARY ASANAS 
  
Bhujangasana (Snake pose) Yoga mudra 
Chakrasana (Wheel pose) Pada hastasana 
Matsyasana (Fish pose) Paschimottasana 
Shalabhasana (Lotus pose) Utthanapadasana 
Ustrasana (Camel pose) Pada hastasana 
Dhanurasana (Bow curve pose) Paschimottasana 
             Backward bending asanas increase the activity of Jatharagni, which helps to burn and 
eliminate dross from the physical and subtle bodies. They open up the front vertex of the 
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chakras. (Chakras are energy centre’s along the spine to the top of the head). In terms of the 
distribution of prana, samana, viyana vayu are stimulated by these types of asanas. 
 
Lateral stretching asanas: 
• Konasana (Angle pose) 
 
Spinal twisting asanas: 
• Bhu Namanasana (Spinal twist prostration pose) 
• Ardha matsyendrasana (Half spinal twist) 
  The twist imposed on the spine and the whole trunk exercises the muscle, make the 
spinal coloumn more flexible and stimulates the spinal nerves.  
 
Relaxation asanas: 
  They are especially recommended for any back/spinal problem. 
• Advasana (Reversed corpse pose) 
• Makarasana (Crocodile pose) 
 
Procedures of few asanas: 
1. Yoga Mudra (Reintegration posture): 
Starting position 
             Sit in Padmasana 
Method of practice 
             Bring the hands to the backside of the trunk and hold the wrist of the right hand by 
the left hand. 
             Bending the trunk slowly forward and try to touch the ground with the forehead. If it 
is not possible try to hold the forehead as nearer to the ground as possible. 
Benefits 
             It allows the spinal column more flexible. 
 
2. Paschimottaasana: 
Starting position 
             Sit on the floor with the legs outstretched, feet together and hands on the knees. 
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Method of practice 
             Raising the hands slowly sideward, upward without bending the elbows and hold 
them above the head. 
             Bringing the hands slowly downwards, forward without bending the elbow and try to 
catch the toes with fingers. If it is not possible try to hold the knees. 
             Bending the body forward and try to touch the knees with the forehead without any 
strain anywhere in the body. 
 
Benefits 
             It gives more flexibility to the vertebral column. 
             It stimulates circulation to the nerves and muscles of spine. 
 
3. Bhujangasana (Snake pose): 
Method of practice 
1. Lie on the floor with facing downward. keep the legs straight and together place 
the hands close to the body with palms facing downward. 
2. Raising the head, neck and shoulder slowly one by one. 
3. Raising the chest as much as possible in such a way that the lower abdomen 
should keep on in touching with the floor. 
Benefits 
            It strengthens the neck and back muscles 
            It gives more flexibility to  the vertebral column. 
 
4. Dhanurasana (The bow curve pose) 
 Starting position 
           Same in Bhujangasana 
Method of practice 
           Folding the right leg slowly at the knee and holding the angle with the right hand. 
Folding the left leg slowly at the knees and holding the ankle with the left hand. Raising the 
head, chest, and thigh as high as possible by gradual application of force on the head and 
legs. Raising the body slowly and making a perfect back arch on the vertebral column as 
much as possible. 
 Benefits:  Relaxes the spinal column 
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5. Matsyasana (Fish pose): 
Starting position 
            Sit in Padmasana 
Method of practice 
           Carefully bend backward, supporting the body with the arms and elbows. Lift the chest 
slightly, take the head back and lower the crown of the head to the floor. Hold the big toes 
and rest the elbows on the floors. Adjust the position of the head so that the maximum arch of 
the back is attained. 
Benefits 
            It recirculates stagnant blood in the back, alleviating backache and cervical 
spondylosis.  
 
6. Gomukhasana (Cow face pose): 
Posture 
           Try to clasp the fingers of both hands behind shoulder blades, sitting with both legs 
bent in a manner where knees are overlapping. 
Benefits 
            Induce relaxation 
            Relieves the stiffness of shoulder and neck. 
 
7. Makarasana (Crocodile posture): 
Method of practice 
• This is a lying posture and taking rest. 
• Lie flat on the stomach 
• Raise the head and shoulders and rest the chin in the palms of the hands with the 
elbows on the floor. 
• Keep the elbows together for a more pronounced arch to the spine, separate the 
elbows slightly to relieve excess pressure on the neck.  
Benefits 
           Stop cervical bone disorders and to helps one avoid using neck brace. 
           Release compression of spine nerves. 
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8. Ardha Matsyendrasana (Half spinal twist): 
Posture 
           Sit with right leg bent at the knee and bring heel under left thigh. Interlock the left heel 
with right knee. 
            Inhale and grasp left big toe with right hand fingers, give twist to the whole trunk with 
exhalation. 
Benefits 
            It reduces the tendency of adjoining vertebrae to develop osteopytes. When practiced 
with cae, it has proved beneficial for mild cases of slipped disc. 
 
How asanas relief the pain in cegana vatham? 
I). Effect on Spinal muscle 
           Asanas dampens the inflow of sensory impulse to the brain, which causes less 
stimulation to the emotional brain (Cortex, Hypothalamus, Anterior pituitary and their 
connectives with Adrenal glands). Therefore, there are less visceral disturbance to disturb 
attention and concentration. The reduction of sensory input creates a reciprocal chain, 
relaxing the muscle, inhibition of synapses at the relaxed neuromuscular junction in turn 
reduce the sensory input further. Thus asanas made musculature of spine as relaxed as 
possible. 
 II). Effects on tendon and ligaments 
            The accentuated curve of the spine makes it supple and mobile. The action on the 
ligaments and tendons of the spine has important effect on the nervous activity. 
III). Effects on nervous system 
            Acts on the spine by stretching it, generates reflex actions in the vegetative functions 
and tones the chain of ganglion situated on both sides of the spine. 
KANMANIVARTHI: 
            Kanmam means the deeds which are bad, committed by an individual in this previous 
birth. So he must expiate it to get better relief before the treatment. 
NIRAIVU: 
            By promoting the awareness about the dietary, seasonal, emotional influence on the 
disease assurance from disease recovery was given. Lifestyle modification was also advised 
to them. 
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KAAPU: 
            Knowing the cause there by removing it and thus preventing the disease is main aim 
of siddha system of medicine. 
            Siddha system emphasizes the purification of thought and activities as mentioned in 
the siddha text “Theraiyar Piniyanuga Vithi” which emphasizes virtueness to be followed 
even in the daily life activities. 
 
  
33 
 
MODERN ASPECT 
THE ANATOMY 
Vertebral coloum 
Our body skeletal system is divided into axial and appendicular skeleton sections. 
Cranium, vertebral column, ribs and sternum constitutes the axial skeleton. 
The vertebral column forms back bone of the body. It is made up of 33 pieces of 
vertebrae and intervening intervertebral disc. Length is about 60-70 cm. The vertebral column 
which lodges and protect the spinal cord, its meanings in a canal within it is called as 
vertebral canal.. It  supports the body weight and transmits it to the ground through the lower 
limbs. 
 The segments can be divided into  
cervical   - 07 
Thoracic   - 12 
Lumbar   - 05 
Sacral    - 05 
Coccygeal   - 04 
The general features of the vertebrae: 
 The Vertebrae can be divided into two parts. Vertebral body (ventral part ), Vertebral 
arch (dorsal part). 
  Vertebral bodies is cylindrical and large in size. The vertebral arch has two pedicles, 
seven processes and two laminae. The laminae are vertical plate like structures fuses together 
to form spinnus process. The articular  processes are four in number, bearing the articular 
facts and articulate with the adjacent vertebrae. Transverse processes project laterally from 
the junction of pedicle and laminae. In thoracic region they articulate with ribs. 
Intervertebral discs: 
         Intervertebral disc are fibro cartilaginous in nature. The central part is avascular. They 
are thicker in lumbar region. 
The intervertebral disc acts as 
 As a shock absorber. 
 As a spacer: It maintains its height which allows the segmental nerve roots to exits 
each spinal level without compression. 
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 As a hydraulic cylinder: Annular fibres serve a containment function to prevent the 
nucleus from bulging or herniating. 
 As a motion unit: The elasticity of the disc allows motion coupling. So that the spinal 
segment can flex, rotate and bend all side. 
Cervical vertebrae: 
  The cervical segment of vertebral column contains 7 vertebrae. 
 The first second and the seventh are atypical and the third to sixth are typical. 
 They are smaller and delicate than the thoracic and lumbar vertebrae. 
 All the cervical vertebrae have a foramen in the transverse process known as foramen 
transversarium.  
Features of Typical cervical vertebrae: 
Body: 
  It is small and oval. Its superior surface is can care transversely with upward 
projecting lips on each side and its inferior surface is saddle shaped. 
Vertebral foramen: 
  It is larger than the body and triangular. 
Vertebral Arch: 
1)       Spine: 
              It is short and bifid. 
II) Laminae: 
             These are long and narrow being thinner above than below. 
III) Pedicles: 
            These are short and directed downwards from the middle of posterolateral  
parts of the body. 
IV) Articular facets: 
The superior and inferior articular processes project laterlly at the junction of 
the pedicle and the lamina. 
V) Transverse process: 
The transverse process lies laterally from the junction of pedicle and laminae 
to end in posterior tubercle. 
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The Atypical Cervical vertebrae: 
1. Atlas: 
  It is the first cervical vertebrae it support the heads. It has no body and spine.  It has 
anterior and posterior arch, right and left lateral mass and transverse processes. 
The Posterior aspect bears an oval facet which articulate with dens. its anterior arch bears an 
anterior tubercle in the anterior aspect. The posterior surface of the posterior arch has a 
median posterior tubercle. The two lateral masses bear an elongated superior articular facet 
for atlanto – occipital joint and an inferior articular facet for atlanto – axial joint. 
2. Axis: 
  The axis has a tooth – like process projecting from the body is known as the dens or 
odontoid process. It has circular facet anteriorly articulating with atlas. There are two 
articular facet on either side of the dens on the upper surface  of the body. The laminae are 
thick. The spine is large and bifid terminating in two rough tubercle. The transverse process 
is small and represent the true posterior tubercles only. 
3. The seventh cervical vertebrae: 
  It is also known as the vertebral prominence. The transverse process does not posses 
anterior tubercle. The foramen transversarium is small or absent. It transmits accessory 
vertebral vein only. The spine is long and non-bifid. 
 
Joints of the Neck: 
1. Atlanto – occipital joint: 
It is a synovial joint of the condyloid variety. 
Movements: 
 Flexion, Extension, lateral bending. 
2. Atlanto – axial Joint: 
 It comprises three joints. 
(i) A Pair of lateral atlanto – axial joints. 
(ii) Median atlanto – axial joint. 
Movement: 
 Rotatory movements around a vertical axis occur in this joint. 
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3. The unco vertebral Joint: (LUSCHKA’S JOINT) 
 Luschka’s Joints are not true synovial Joint. Which develop as a result of degenerative 
changes in the edges of the disc in early adult. Luschka’s Joints are important because 
                                     (a) They are important site of osteophyte formation. 
   (b) The ostrophytes may compress the cervical nerves. 
Blood supply of the Vertebral column: 
 The vertebrae and  longitudinal muscles attached to them are supplied by segmental 
arteries. The arteries give multiple small branches to the vertebral bodies. The extensor 
muscles of the neck are supplied by the occipital the deep cervical and the transverse cervical 
arteries. 
Venous drainage: 
 The internal vertebral venous plexus lies within the vertebral canal, but outside the 
spinal dura. It received tributaries from  
 (i) The Vertebrae through the basilo vertebral veins. 
 (ii) The meninges and the spinal cord. 
 
Palpable parts of cervical vertebrae: 
i. The transverse process of C1 through the anterior border of sterno cleidomastoid  
immediately below the tip of the mastoid process. 
ii. The spine of C2 is in the nape of the neck 5cm below the external occipital 
protuberance. 
iii. The spine of C7 Where the collor bone crosses the posterior medium line of the neck. 
Movements of the Vertebral column: 
 The greater thickness of the disc in the cervical region compared with thoracic region 
is associated with the greater individual range of movements occurring in those regions. 
 Flexion, Extension, lateral flexion and rotation are possible in vertebral column. 
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MUSCLE AND NERVE SUPPLY INVOLVED IN MOVEMENTS: 
Movements Muscles Nerve Supply 
Flexion 
Sternocleidomastoid Accessory ventral rami of cervical 
spinal nerves C2, C3, C4 
Longus Capitis Cervical Ventral rami C1-C3 
Longus coli Cervical ventral rami C2-C6 
Rectus Capitis anterior C1 Ventral Ramus 
Extension 
Trapezius Accessory Nerve 
Erector spinae Dorsal rami 
Rectus capitis posterior 
major and minor 
Dorsal Rami C1 
Oblique capitis superior C1 – Dorsal ramus 
Lateral 
flexion and 
rotation 
Scalene Cervical ventral rami C3-C8 
Sternocleidomastoid Acessory, ventral rami of cervical 
spinal nerves C2,C3,C4. 
Rectus Capitis C1 – ventral ramus 
Splenius Cervical dorsal ramus. 
Longus coli Cervical ventral rami C3-C8 
Levator scapulae Cervical ventral rami C3,C4,C5 
Longismus obliques capitis 
superior and inferior 
C1 Dorsal ramus 
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CERVICAL SPONDYLOSIS 
 
DEFINITION 
 Cervical spondylosis is a disorder characterised by degenerative changes in 
intervertebral disc, with subsequent changes in the bones and soft tissues.  Spondylosis is 
usually asymptomatic. Symptoms are usually manifested of encroachment of local neural 
elements such as cervical nerve roots, spinal cord, vertebral artery (or) sympathetic nerves 
 
EPIDEMIOLOGY  
Cervical spondylosis is the most frequent cause of spinal cord disturbance in patients 
older than 55 years. 
On the basis of radiological findings ,90% of men older than 50 years and 90% of 
women older than 60 years have evidence of degenerative changes in the cervical spine. 
 Both sex are affected equally. Cervical spodylosis usually starts earlier in men than 
women. 
 
LOCATION: 
             Generally the C5 & C6 roots are most commonly affected by cervical spondylosis as 
a result of increased mobility at the C5 - C6 & C6 – C7 levels. 
              Acute disc lesions are seen most often at the C7 level followed by C6 level. 
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AETIOLOGY 
1. Degenerative Causes 
There are primary and secondary. 
a) Primary – Senility 
 Genetic factors 
 Metabolic factors 
 Manual Labour 
b) Secondary – Osteo arthritis 
 Rheumatoid arthritis 
 Metastatic carcinoma 
 Lymphoma of spine 
 TB spine 
2. Trauma 
 Automobile accident with whiplash injury 
 Atheletic injury 
 Sudden jerk on the arms during falling down 
 Disc prolaps or previous injury 
3. Occupational cause 
4.    Hereditary factors 
 Congenital narrowing of the cervical spinal canal. 
 Segmental defets – Hemi vertebra, Fushed Vertebrae. 
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5.  Acquired narrowing of cervical spinal canal due to  
 Osteophytes 
 Ossified posterior longitudinal ligament. 
 Facet joint hypertrophy (results foraminal stenosis and compression of root of 
radicular artery). 
 Hypertrophied ligamentun flavum (compress the cord during extension). 
 
Pathophysiology 
 Intervertebral discs lose hydration and elasticity with age and these leads to cracks 
and fissures.  The surrounding ligaments also lose their elastic properties and develop 
traction spurs.  As the disc space narrows, the annulus bulges and facet override.  This 
change, in turn, increase motion at that spinal segment and further hastens the damage 
to the disc, annulus fissures and herniation may occur.  Acute disc herniation may 
complicate chronic spondylotic changes. 
 As the annulus bulges, the cross sectional area of the canal is narrowed.  This effect 
may be accentuated by hypertrophy of the facet joints (posterioly) and of the 
ligamentum flavum, which becomes thick with age.  Neck extension causes the 
ligaments to fold inward, reducing the unterioposterior (AP) diameter of the spinal 
canal. 
 As disc degeneration occurs, the uncinate process ovverrides and hypertrophies 
compromising the ventrolateral portion of the foramen.  Facet hypertrophy decreases 
the dorsolateral aspect of the foramen.  this change contributes to the radiculopathy 
that is associated with cervical spondylosis.  Marginal osteophytes begin to develop. 
 
PATHOLOGY 
 The early changes to be erosion and flaking of cartilaginous surface with advance of 
disease. Cleft appear within the cartilage at the right angles to the surface, these claft may 
penetrate to the subchondral bone producing cartilage fibrillation. Sometimes fragment of 
cartilage break off to create joint mice. This result is growth of blood vessels from the 
subchondral bone which is dense, smooth, glittering, to ivory. This is known as eburnation. 
The loss cartilage accounts for the thinning of joint space which is seen radiographically. 
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Osteophyte development from margin of articular cartilage may extend to ligament and 
capsular attachments. These are called “Bony spurs” of OA. These bony spurs accounts for 
nodules known as Heberden’s nodes. 
 
Common clinical syndromes associated with cervical spondylosis include the following:- 
1. HEAD ACHE 
          Head ache is a common symptom. It’s usually located in occipital region.  
2. CERVICAL PAIN 
 Chronic sub occipital head ache may be present. 
 Pain may radiate to the occipital, shoulder, scapula (or) arm. 
 The pain, which is worse when the patient is in certain position, can interfere with 
sleep. 
3. AUTONOMIC SYMPTOMS 
           Vertigo, flushing, tinnitus, visual blurring are present. These are mediated by 
sympathetic disturbance to the sinuvertebral nerves from stellate ganglion. 
4. CERVICAL RADICULOPATHY 
Compression of Cervical nerve roots leads to ischemic changes that cause sensory 
dysfunction (Radicular pain) and motor dysfunction (weakness). Radiculopathy most 
commonly occurs in persons aged 40-50yrs. An acute herniated disc or chronic spondylotic 
changes can cause cervical radiculopathy and myelopathy. The C6 root is the most commonly 
affected one because of the predominant degeneration of the C5-C6 interspace. The next 
common sites are at  C6-C7. There is also referred pain and tenderness along the medial 
border of the scapula. 
5. CERVICAL MYELOPATHY 
 It  may be precipitated by a large central disc herniation but is more commonly the 
result of spondylotic changes superimposed on a congenitally narrowed canal. Dorsomedial 
herniation of disc and the development of transverse bony bars or posterior osteophytes may 
results alone or in combination with pressure on the spinal cord or the anterior spinal artery 
which supplies the anterior 2/3 of the cord. 
It has an insidious onset, which typically becomes apparent in persons aged 50-60 years.  
 Upper motor neuron signs develop in the limbs with spasticity of the legs. 
 Sensory loss in the upper limbs is common. 
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 Tingling and numbness with progressive clumsiness. 
 Involvement of the sphincter is unusual at presentation. 
 
THE SITE OF SENSORY DISTURBANCES WITH INDIVIDUAL ROOT 
Nerve root  Dislevel Symptoms 
C3 C2-C3 Pain and numbness in  the back of the neck mastoid process, 
and pinna of ear. 
C4 C3-C4 Pain and numbness in the back of the neck, levator scapulae 
and anterior chest. 
C5 C4-C5 Pain in the neck,  Tip of the shoulder, anterior arm, numbness 
over middle of the body, deltoid muscle. 
C6 C5-C6 
Pain in the neck, shoulder, medial border of the scapula, lateral 
arm, dorsal forearm, numbness in tip of thumb or on dorsum of 
hand over first dorsal interosseus muscle. 
C7 C6-C7 
Pain in the neck, shoulder, medial border of scapula, lateral 
arm, dorsal forearm, sensory change in index and middle 
finger. 
C8 C7-T1 Pain in the neck, medial border of scapula,medial aspects of 
arm and forearm. Sensory change in the ring and little fingers.  
 
THE MOTOR SYMPTOMS AND SIGNS 
(INCLUDING REFLEXES) 
Nerve Root Disc level Weakness-Reflex change 
C3 C2-C3 Not readily detectable weakness or reflex change except by 
EMG. 
C4 C3-C4 Not readily detectable weakness or reflex change except by 
EMG. 
C5 C4-C5 Weakness of extension of arm and shoulder particularly 
above 90o,wasting of deltoid muscle ,no reflex change.  
C6 C5-C6 Weakness of biceps muscle, diminished triceps reflex. 
C7 C6-C7 Weakness of triceps muscle, diminished triceps reflex. 
C8 C7-T1 Weakness of triceps and small muscles of hand.No reflex 
change. 
 
PHYSICAL EXAMINATION 
1. Spurling sign 
Radicular pain is exacerbated by extension and lateral bending of the neck toward the 
side of the lesion. Which result in further foraminal compromise. 
2. Lhermitte’s sign 
The generalized electric shock sensation is associated with neck extension. 
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3. The elbow flexion test 
           Fully flex the elbow and observe for ulnar nerve distribution. 
4. Shoulder abduction test 
Relief of cervical radiculopathy by abduction. 
5. Phalynx wrist flexion test 
 Full passive flexion of the patients wrist for 30-60 seconds and looking for 
reproduction or worsening of worsening of finger dysthesiasis 
6. Adson’s test 
 Turns his head to the involved side, raises the chin and holds a deep inspiration and 
while the ipsilateral radial pulse is palpated with the arm slightly abducted from the side if 
pulse diminishes test positive for thoracic outlet syndrome. 
7. Roo’s test 
            The patients is asked to abduct the shoulder 900, flex the elbow 900 and open & close 
the hands slowly for 3 minutes. 
i) Hand pallor 
ii) Diminished pulse 
iii) Ulnar dysthesias 
If these are positive suggest thoracic outlet syndrome. 
Complications 
1. Pseudo arthrosis 
2. Graft displacement. 
3. Neurological injury 
PATHOLOGIES THAT MIMIC CERVICAL SPONDYLOSIS 
1. Hereditary spastic paralysis 
2. Amyotropic lateral sclerosis 
3. Intrinsic & Extrinsic neoplasia 
4. Multiple neoplasia 
5. Spinal infarction 
6. Thoracic outlet syndrome 
7. Vitamin B12 deficiency 
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INVESTIGATION: 
     1. Plain – x ray of cervical spine antero posterior and lateral views. 
 Intervertebral disc space narrowing 
 Osteophytic  changes 
 Altered  Lordosis 
 Degeneration in facet and vertebral joints. 
 Foraminal stenosis, central stenosis. 
 Sclerosis in the vertebrae. 
2. MRI -  (MAGNETIC RESONANCE IMAGING: 
To asses cervical canal diameter,to find out severity of the compression 
3. CT – SCAN (Computerised Tomography) 
 Confirms degenerative changes 
 May demonstrate posterior osteophytes and disc herniation. 
4. CT – MYELOGRAPHY: 
  Useful for localisation of cord compression 
5. EXAMINATION OF CSF 
  Very high level of protein. 
INSTRUCTION: 
 Do not getting look down to read (or do any other work). Bring the reading materials 
to the eye level. 
 All the neck movements can be performed with practice, by using trunk movements. 
 While lying on sides, head should be in neutral position. 
 Use low level pillow supporting the head and neck. Pillow line up to the shoulders 
level.  
PROGNOSIS: 
            Cervical spondylosis progresses slowly. By the using the pathological conditions of 
the spine, spinal cord and the nerve roots the spondylosis can be assessed. Improvement can 
be felt with some of the visible changes with drug treatment. In complicated cases 
improvement is not possible. Long history of suffering multiple disc lesion and in 
recompression of spinal cord may adversely affect the prognosis. 
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MATERIALS AND METHODS 
 The clinical study on Cegana vatham was carried out in the post graduate Sirappu 
Maruthuvam department of, Government Siddha Medical College, Palayamkottai.  In this 
study 40 patients (who satisfy the inclusion criteria and exclusion criteria) were treated as OP 
and IP patients. 
Selection of the patients 
Age 
 Between 20 years and 60 years 
Sex 
 Male and Female 
Clinical findings 
 The patients were selected on the basis of the following clinical findings. 
1. Pain, stiffness an restricted movements in the neck. 
2. Tingling sensation and numbness in the upper limbs. 
3. Radiating pain in the upper limbs 
4. Feeling of heaviness in the body and weakness of the limb 
5. Constipation 
6. Mental depression 
7. Burning sensation of eyes. 
The detailed history was taken from the patient about 
1. Occupation 
2. Social economic status 
3. Psychological condition 
 
PAIN ASSESSMENT  
UNIVERSAL PAIN ASSESSMENT SCALE  
0 1 2 3 4 5 6 7 8 9 10 
A.0 :  No Pain  
B. 1-3  :  Mild pain  
C.4-6 :  Moderate pain 
D.7-10 :  Severe pain  
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Reference: Clinical Manual for Nursing Practice. (National Institute of Heatlth Warren Grant 
Magnuson Clinical center 
 
GRADATION: 
Grade 1: Fit for all activities to do their work without support (Normal)  
Grade 2: Mild Pain and Mild restriction of Movements  
Grade 3: Moderate Pain and Moderate restriction of Movements  
Grade 4: Severe Pain and Severe restriction of Movement  
Diagnosis 
 The diagnosis was made by following siddha diagnostic methods.  Nilam, kaalam, 
poriyal aridhal, pulanal arithal, vinaadhal, mukkutra nilaigal, udal thathukal nilai and envagai 
thervugal and the diagnosis of cegana Vatham were obtained which correlated with modern 
diagnosis of cervical spondylosis by the x-ray findings. 
 
The x-ray findings 
Exclusion criteria 
 Cervical rib 
 Trauma 
 Spina bifida 
 Diabetes mellitus 
 Ankylosing spondylosis 
 Tuberculosis in spine 
 Cardiac disease 
 Pregnant women and lactating mothers 
 Neoplasms 
 Patients with any other serious systemic illness 
 Congenital anomalies of spine. 
Investigation 
 The following investigations were done in all selected patients in the laboratory of 
Government Siddha Medical College, Palayamkottai. 
Blood 
 Total WBC count 
 Differential WBC count 
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 Erythrocyte sedimentation rate 
 Hemoglobin estimation 
 Estimation of blood sugar 
 Estimation of blood urea 
 Estimation of serum cholestrol 
Urine 
 Albumin 
 Sugar 
 Deposit 
Radiological Investigations 
X-Ray cervical spine 
 AP-view 
 Lateral view 
 Oblique view (if needed) 
Treatment 
 Vellai ennai 10ml at morning with hot water was given on the first day of treatment. 
 All the patients were treated with the following medicine. 
1. VATHATHIRKU LEGHIYAM 
Kottaipakalavu (6.02gm) 
2. PANCHARKA THYLAM – 30ml 
As external application 
 Thokkanam and Yoga asanas were applied as the balancing therapy. 
 All the patients were advised to follow dietary regimen (or) Pathiyam. 
The Bio-chemical analyses were done in the Department of Bio-chemistry of Government 
Siddha Medical College, Palayamkottai. 
 
  
48 
 
RESULTS AND OBSERVATION 
  For the clinical study 40 patients were selected and treated in PG-III Sirappu 
Maruthuvam Department, Government Siddha Medical College and Hospital, Palayamkottai.  
Results were observed with respect to the following criteria. 
1. Age distribution 
2. Sex distribution 
3. Kaalam 
4. Thinai 
5. Paruva kaalam 
6. Etiological Factors 
7. Occupation 
8. Clinical Manifestations 
9. Duration of illness 
10. Disturbance in vadha 
11. Disturbance in pitha 
12. Disturbance in kabha 
13. Udal Thathukkal 
14. Envagai Thervugal 
15. Pulse reading (Naadi) 
16. Neikuri 
17. Provocative test 
18. Progress chart 
19. Patients treated only with trial drugs 
20. Trial drugs along with complementary therapy (Thokkanam) 
21. Trial drugs along with complementary therapy (Yoga asanas) 
22. Effect of Trial drug along with complements therapies. 
23. Comparison between effective of trial drug and trial drug with complementary 
therapies 
24. Effect of therapy 
  
 1. AGE DISTRIBUTION 
Table 1. Illustrates the age distribution
S.no Age 
1 16 – 20 
2 21 – 30 
3 31 – 40 
4 41 – 50 
5 51 – 60 
 Total 
                         
             
 
Inference: 
  Among the 40 patients, in the highest incidence was in the age between 51
incidence was  in the age between21
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No. Of patients  Percentage(%)
- 
1 
9 
10 
20 
40 
-30. 
 
0% 
2.5% 
22.5% 
25% 
50% 
100% 
 
-60, lowest 
 2. SEX DISTRIBUTION  
Table 2. Illustrates sex distributions in relative percentage.
S.no Sex 
1 Male  
2 Female 
3 Total  
 
                     
 
 
Inference: 
  Out  of 40 patients ,64% were females  and 36% were males.
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No. Of cases Percentage
Op Ip 
9 5 
16 10 
25 15 
 
 
35% 
65% 
100% 
 
 3.KAALAM 
Table 3.  Illustrates the kaalam
S.no Kaalam 
1 Vatha kaalam(1-
33yrs) 
2 Pitha kaalam(34-
66yrs) 
3 Kaba kaalam(67-
100yrs) 
 
                
 
Inference: 
Out of 40 patients, 
7.5% cases were  in  the vatha kaalam
92.5% cases were in the pitha kaalam.
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No. Of patients  Percentage(%)
3 
37 
- 
 
 
 
7.5% 
92.5% 
- 
 
 4. THINAI (THE HABITAT OF THE PATIENTS)
Table 4. Illustrates the thinai
S.no Thinai or Land 
1 Kurinji 
2 Mullai 
3 Marutham 
4 Neithal 
5 Paalai 
6 Total  
 
              
 
Inference:  
  Among the 40 patients, 2.5% were from kurinji,95% were from marutham, 2.5% were 
from neithal 
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No. Of patients  Percentage(%)
1 
- 
38 
1 
- 
40 
 
2.5% 
- 
95% 
2.5% 
- 
100% 
 
  
5. PARUVAKALAM 
Table 5. Illustrates the Paruvakalam
 
S.no Paruvakalam 
1 Kaarkalam Avani
(15 aug 
2 Koothirkaalam Ippasi
(15 oct 
3 Munpanikaalam Margazhi
(15 dec 
4 Pinpanikaalam Maasi
(15 feb 
5 Elaveenirkaalam Chitthirai
(15 apr 
6 Muthuvenirkaalam Aani
(15 jun
 
                 
                 
Inference: 
  Among 40 cases, 60% were admitted in munpanikaalam ,15% of patient were 
admitted in pinpanikaalam, 10% of patient admitted in elavenirkaalam,10% patient admitted 
in muthuvenirkaaalam, and 5% patient admitted in koothirkaalam
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Month No. Of patients  Percentage(%)
-puratasi 
– 14 oct) 
- 
-karthigai 
– 14 dec) 
2 
-thai 
– 14 feb) 
24 
-panguni 
– 14 apr) 
6 
-vaigasi 
– 14 jun) 
4 
-aadi 
– 14 aug) 
4 
 
 
- 
5% 
60% 
15% 
10% 
10% 
 
 6. DISTRIBUTION BASED ON ETIOLOGICAL FACTORS
Table 6. Illustrates etiological factors
S.no Precipitating factors 
1 Exposure to cold 
2 Senility 
3 Occupation 
4 Metabolic 
5 Total 
 
 
             
 
Influence 
  It was noted while taking the  history of the patients that ceganavatham was caused 
mainly (55%)due to the nature of the occupation .The  remaining were due to other factors
like to senility and exposure cold.
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No. Of patients  Percentage(%)
4 
14 
22 
- 
40 
 
 
10% 
35% 
55% 
- 
100% 
 
 
 7. OCCUPATION  
Table 7. Illustrates occupation
S.no Occupation 
1 Agricultural labours 
2 House wives 
3 Beedi worker 
4 Hotel worker 
5 Weight lifters 
6 Tailors 
7 Others 
 
 
Inference 
 Out of 40 cases, in this study the rate of incidence is higher in home maker (35%) 
which includes  Beediworkers (20%),agricultural labours and weight lifters (15%),tailors 
(10%),hotel workers (5%). 
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No. Of patients  Percentage(%)
6 
14 
8 
2 
6 
4 
40 
 
15% 
35% 
20% 
5% 
15% 
10% 
100% 
  
 8. CLINICAL MANIFESTATION
Table 8.  Illustrates the clinical manifestation
S.no Udal kattukal
1 Pain in nape of neck 
2 Stiffness in the neck 
3 Radiating pain in the upper limbs
4 Headache 
5 Giddiness 
6 Numbness in upper limb
7 Constipation 
8 Feeling of heaviness of the body
9 Burning sensation of the eyes
10 Weakness of the upper limbs
11 Mental depression 
                
                   
 
Inference: 
  Among the 40 cases, all of them had pain in the nape of neck  and 60% of patients had 
stiffness in neck  and 85% of patients had radiating pain in upper limb 57.5% of patients had 
numbness in the upper limb and 45% of pat
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  No. Of patients  Percentage(%)
40 100%
24 
 34 
6 
18 
 23 57.5%
22 
 11 27.5%
 6 
 16 
8 
ients had giddiness. 
 
 
60% 
85% 
15% 
45% 
 
55% 
 
15% 
40% 
20% 
 
  
9. DISTRIBUTION ACCORDING TO THE DURATION OF ILLNESS
Table 9. Illustrates Distribution according to the duration of illness
S.no Duration of illness 
(in months) 
1 0 – 1 
2 1 – 3 
3 3 – 6 
4 6 – 12 
5 12 – 24 
6 24 – 36 
 
             
 
Inference 
 From the present study it was studied that the disease Cegana vatham reflected its 
symptoms mostly over a period of 6
taking while 40% of the patients reported the data.
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No. Of patients  Percentage(%)
1 
8 
10 
16 
3 
2 
-12 months which was confirmed during the history 
 
 
 
2.5% 
20% 
25% 
40% 
7.5 
5 
 
 10. DISTURBANCE IN VATHAM
Table 10. Illustrates disturbance in vatham
S.no Vatham 
1 Piranan 
2 Abanan 
3 Vudhanan 
4 Viyanan 
5 Samanan 
6 Naagan 
7 Koorman 
8 Kirukaran 
9 Thevathathan 
10 Thananjayan  
           
 
                 
 
Inference 
 Among the 10 types of vatha, Samanan and viyanan were affected in all the cases 
(100%).  Abanan was noted to be deranged 
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No. Of patients  Percentage(%)
- 
22 
40 
- 
40 
- 
- 
- 
25 
- 
in 55% and Devathathan was abnormal in 62.5%
 
- 
55% 
100% 
- 
100% 
- 
- 
- 
62.5% 
- 
 
 . 
 11. DISTURBANCES IN PITHAM
Table 11. Illustrates disturbances in pitham
S.no   Pitham 
1 Anarpitham 
2 Ranjagapitham 
3 Sathagapitham 
4 Aalosagapitham 
5 Pirasagapitham 
             
                   
 
Inference 
 The five types of pitham were analyzed in all 40 cases, Sathaga pitham was altered in 
all cases (100%) evidenced as difficulty in handling their regular duties because of pain and 
stiffness in neck and upper limb.  Ranjaga pitham was affected in 7.5% patients denoting low 
haemoglobin count. 
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No. Of patients  Percentage(%)
8 
3 
40 
- 
- 
 
20% 
7.5% 
100% 
- 
- 
 
 12. DISTURBANCES IN KABAM
 
Table 12.  Illustrates  disturbances in kabam
S.no Kabam 
1 Avalambagam  
2 Kilethagam  
3 Pothagam  
4 Tharpagam  
5 Santhigam  
                      
 
                      
 
Inference 
 Santhigam was observed to be affected in all the cases.  Tharpagam was abnormal in 
35% of the cases. 
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No. Of patients  Percentage(%)
- 
- 
- 
14 
40 
 
- 
- 
- 
35% 
100% 
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13. INVOLVEMENT OF UDAL KATTUKAL 
Table 13. Illustrates the involvement of udal kattukal 
S.no Udal kattukal No. Of patients  Percentage(%) 
1 Saaram 40 100% 
2 Senneer 40 100% 
3 Oon 10 25% 
4 Kozhuppu 40 100% 
5 Enbu 40 100% 
6 Moolai 0 - 
7 Sukkilam / 
suronitham  
0 - 
 
 
 
 
 Inference 
 It was diagnosed during the study that among the seven thathus saram,senneer, 
kozhuppu, Enbu were affected in 100% of the cases,  and Oon had  25% cases were affected 
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14. CONDITION OF ENVAGAI THERVUGAL
Table 14. Illustrates the 
S.no Envagai thervugal 
1 Naa 
2 Niram 
3 Mozhi 
4 Vizhi 
5 Malam 
6 Moothiram 
7 Naadi(thontha naadi) 
8 Sparisam  
             
                
               
 
Inference 
 It was learnt during the study that thontha naadi was noted in all 40 cases, malam was 
affected in 55% of cases and  naa in 7.5% of cases.
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condition of envagai thervugal 
No. Of patients  Percentage(%)
3 
- 
- 
- 
22 
- 
40 
- 
 
 
7.5% 
- 
- 
- 
55% 
- 
100% 
- 
 
 15. NAADI 
Table 15. Illustrates the  pulse reading (naadi)
S.no Parameters 
1 Vatha pitham 
2 Pitha vatham 
3         Kaba vatham 
                     
 
                           
  
 
Inference 
 As mentioned above thontha naadi was noted in all cases and among them 
vatha pitha naadi and 30% were pitha vatha naadi .
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No. Of patients  Percentage(%)
28 
12 
- 
 
 
70% 
30% 
- 
                
70% were 
 16 NEIKURI 
Table 16. Illustrates the neikuri analysis
S.no Inference 
1 Spreading like snake 
2 Spreading like ring 
3 Stants like a pearl 
4 Others  
5 Total  
            
 
                  
 
Inference 
 In neikuri analysis 55% of the cases presented with vatha neer, 22.5% with kaba neer, 
17.5% with pitha neer, and the remaining 5% with other neer.
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No. Of patients  Percentage(%)
22 
7 
9 
2 
40 
 
 
55% 
17.5% 
22.5% 
5% 
100% 
 
 S.no Clinical features
1 Spurling test 
2 Axial compression test
3 Phalanx wrist flexion tet
4 Elbow flexion test 
5 Finger escape sign 
6 Tinels sign 
7 Adson test 
8 Roos test 
                   
 
Inference 
 Based on modern aspect, for the diagnostic purpose and to determine the differential 
diagnosis few provocative tests were done and noted in all 40 cases spurling test, axial 
compression sign were positive in all 
were negative in all cases. 
 
 
  
65 
Table17. Provocative tests 
 No. Of patients Percentage
40 100%
 40 100%
 20 
21 52.5%
30 
- 
- 
- 
cases (100%) and tinel’s sign, adson’s test. Roo’s test 
 
 
 
50% 
 
75% 
- 
- 
- 
 
 Table 18.  Progressive chart
 
S.no 
 
 
Clinical feature
1 Pain in neck 
2 Pain in shoulder 
3 Radiating pain in the right upper 
limb 
4 Radiating pain in the left upper 
limb 
5 Numbness 
6 Tenderness 
7 Restriction of movement(ROM)
8 Burning sensation 
9 Giddiness 
      
        
 
Inference 
  It was noted that, clinical manifestations like pain in the neck, restriction of 
movements and radiation of pain to other parts were remarkably reduced after treatment 
when compared to that of before treatment, Numbness and tenderness showed moderate 
reduction after treatment. 
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Before treatment After treatment
No.Of 
cases 
Percentage No.Of 
cases 
40 100% 1 
34 85% 2 
24 60% 2 
10 25% 1 
23 57.5% 2 
10 25% 0 
 12 30% 0 
1 2.5% 0 
18 45% 0 
 
percentage 
2.5% 
5% 
5% 
2.5% 
5% 
- 
- 
- 
- 
 
  
Table 19. Assessment of curative effects in patients treated only with trail drug
(internal and external medicines)
Symptoms Initial readings
No of patients
No pain 0 
Mild 4 
Moderate 8 
Severe 13 
              
 
                 
 
Inference 
 From the above study, it was inferred that severe pain that was noted in patients 
before treatment (52%) had a remarkable decline after treatment  (80%), similarly moderate 
and mild pain were also observed to have decreased after treatment.
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 Final readings
 percentage No of patients Percentage
- 20 
16% 4 
32% 1 
52% 0 
 
 
 
 
80% 
16% 
4% 
- 
 
 Table 20. Assessment of curative effects in cervical spondylosis patients treated with 
trail drugs along with complimentary therapy (Thokkanam)
Symptoms Initial readings
No of patients
No pain 0 
Mild 1 
Moderate 2 
Severe 5 
            
 
                 
 
Inference 
 Administration of trial drug along with complementary therapy reduced severe pain in 
almost all the cases, pain reduced in mild and moderate cases.
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 Final readings
 Percentage No of patients Percentage
- 7 
12.5% 1 
25% 0 
62.5% 0 
 
 
 
87.5% 
12.5% 
- 
- 
 
 Table 21. Assessment of curative effects in cervical spondylosis patien
trail drugs. Along with complementary therapy (Yoga asanas)
 
S.no symptoms 
 
patients
1 No pain 
2 Mild 
3 Moderate 
4 Severe 
             
 
             
 
Inference 
 Administration of trial drug along with complementary therapy reduced severe pain in 
almost all the cases. 
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ts treated with 
 
Initial readings Final readings
No of 
 
Percentage No of 
patients 
0 - 5 
1 14.3 1 
3 42.8 0 
3 42.8 1 
 
Percentage 
71.4 
14.3 
- 
14.3 
 
  
Table 22.  Effect of trail drug along with complementary therapies
S.no Effect of therapy 
1 Marked effect 
2 Moderate effect 
3 Mild effect 
4 No effect 
               
                  Table 22.  Effect of trail drug along with complementary therapies
         
               
 
Inference 
 Administration of trial drug along with complementary therapies had a good response 
80% moderate with 13.33% . 
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No. Of patients  Percentage(%)
12 
2 
0 
1 
 
 
80% 
13.3 
- 
6.6 
                                                                      
 
 Table 23. Comparison between 
complementary therapies 
 
S.no 
 
 
Effect of therapy
1 Good 
2 Moderate 
3 Mild 
4 No  
                        
 
Table 23. Comparison between effective of trail drug and trail drug with 
complementary therapies 
              
 
Inference 
 From the above data, it can be concluded that administration of trial drug along with
complementary therapies had comparatively more effect than administering trial drug alone.
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effective of trail drug and trail drug with 
 
Trail drug alone Trail drug with 
external therapy
No.Of 
cases 
percentage No.Of 
cases 
20 80% 12 
4 16% 2 
1 4% 0 
0 - 1 
 
Percentage 
80% 
13.3% 
- 
6.6% 
 
 
 
  
S.no Effect of therapy 
1 Marked effect 
2 Moderate effect 
3 Mild effect 
4 No effect 
 
                                                   Table 24. Effect of therapy
                
 
Inference 
 Thus from the analysis of the data collected during the course of treatment and at the 
end of treatment it is inferred that the 
complementary) had marked effect of 80% moderate effect of 20% and mild effect of 2.5% 
and 2.5% has no effect. 
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Table 24. Effect of therapy 
 
No. Of patients  Percentage(%)
32 
6 
1 
1 
  
overall effect of the therapy  (Internal, external and 
 
80% 
15% 
2.5% 
2.5% 
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S:N0 IP:NO NAME AGE/SEX DATE OF 
ADMISSION 
DATE OF 
DISCHARGE 
TREATED 
DAYS 
EFFECT OF 
THERAPY 
1.  63354 Aysha 53/F 25-06-2017 12-08-2017 48 Days Marked 
2.  63487 Chithambaravalli 50/F 25-06-2017 12-08-2017 48 Days Marked 
3.  64138 Ramachandran 58/M 27-07-2017 07-09-2017 35 Days Mild 
4.  109915 Kalyani 43/F 12-11-2017 23-01-2018 42 Days Marked 
5.  112931 Stephan 53/M 22-12-2017 07-02-2018 48 Days Marked 
6.  113035 Indiraganthi 52/F 22-12-2017 07-02-2018 48 Days Marked 
7.  1278 Marimuthu 33/M 04-01-2018 20-02-2018 48 Days Marked 
8.  1537 Muthukrishnan 57/M 04-01-2018 07-02-2018 35 Days Mild 
9.  6651 Subbu 53/F 19-01-2018 16-02-2018 28 Days Moderate 
10.  7755 Muthamilselvi 36/F 23-01-2018 12-03-2018 48 Days Marked 
11.  7962 Bhuvaneshwari 37/F 23-01-2018 12-03-2018 48 Days Marked 
12.  8276 Ganesan 38/M 24-01-2018 12-03-2018 48 Days Marked 
13.  9936 Thangaperumal 55/M 29-01-2018 05-03-2018 35 Days Marked 
14.  10079 Seethalaxshmi 47/F 01-02-2018 21-03-2018 48 Days Marked 
15.  11346 Lakshmi 58/F 02-02-2018 22-03-2018 48 Days Mild 
16.  12258 Nagarajan 49/M 05-02-2018 27-03-2018 48 Days Marked 
17.  12268 Jeya 40/F 05-02-2018 21-03-2018 42 Days Marked 
18.  12567 Nathina banu 38/F 06-02-2018 28-03-2018 48 Days Marked 
19.  28983 Pandaram 60/M 27-03-2018 24-04-2018 28 Days Mild 
20.  35315 Sudha 30/F 18-04-2018 05-06-2018 48 Days Marked 
21.  28633 Umamaheshwari 38/F 26-04-2018 08-05-2018 42 Days Marked 
22.  35447 Lakshmi 41/F 18-04-2018 05-06-2018 48 Days Marked 
23.  35450 Velu 53/M 18-04-2018 05-06-2018 48 Days Mild 
24.  74906 Selvi 45/F 18-04-2018 05-06-2018 48 Days Marked 
25.  75001 Thangam 52/F 19-04-2018 20-06-2018 48 Days Marked 
 
74 
 
 
S:N0 IP:NO NAME AGE/SEX DATE OF 
ADMISSION 
DATE OF 
DISCHARGE 
TREATED 
DAYS 
EFFECT OF 
THERAPY 
1.  2167 Pitchammal 60/F 01-08-2017 16-08-2017 16 Days Marked 
2.  3331 Esakiyammal 55/F 22-12-2017 06-01-2018 15 Days Marked 
3.  3361 Ramasamy 57/M 27-12-2017 13-02-2018 44 Days Marked 
4.  801 Kaliyapan 52/M 27-12-2017 15-01-2018 19 Days Marked 
5.  3369 Revathy 32/F 28-12-2017 19-01-2018 22 Days Marked 
6.  169 Valliyammal 48/F 24-01-2018 08-02-2018 16 Days Marked 
7.  170 Jamuna 58/F 24-01-2018 08-02-2018 16 Days  Mild 
8.  676 Lakshmi 55/F 24-01-2018 12-03-2018 20 Days Moderate 
9.  487 Ponsanthi 40/F 30-01-2018 23-02-2018 25 Days Marked 
10.  330 Annathai 59/F 08-02-2018 23-02-2018 16 Days Marked 
11.  329 Gnanaiya 60/M 08-02-2018 17-02-2018 20 Days Mild 
12.  3279 Sembagavalli 47/F 14-02-2018 29-03-2018 43 Days Marked 
13.  484 Muthu 60/M 22-02-2018 01-03-2018 17 Days No Effect 
14.  771 Pushpam 49/F 20-03-2018 04-04-2018 15 Days Marked 
15.  1022 Somu 60/M 16-04-2018 20-05-2018 16 Days Marked 
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BLOOD INVESTIGATION BEFORE AND AFTER TREATMENT – OP PATIENTS 
 
S.NO OP.NO TC DC HB ESR BLOOD SUGAR BLOOD  SERUM 
        N L E B M   F PP UREA CHOLESTEROL 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1. 63354 7800 7900 66 60 28 33 6 1     10.7 11.6 30 16 76 80   20 18 172 170 
2. 63487 9000 9100 60 62 37 36 3 2     8.9 10.8 30 20 96 102   17 17 160 165 
3. 64138 7200 7300 65 67 32 31 3 2     11.8 12 26 10 79 76   18 17 128 130 
4. 109915 7400 8000 60 61 38 37 2 2     11 11.2 28 16 113 115   23 20 140 138 
5. 112931 8800 9400 64 64 32 34 4 2     10.8 11.6 34 26 126 120   26 20 164 170 
6. 113035 8900 9100 67 66 30 33 3 1     11 13 38 25 80 82   34 30 130 134 
7. 1537 7500 8000 50 67 46 31 4 2     13 14 21 18 100 106   21 18 160 162 
8. 1726 7600 8200 50 61 44 37 6 2     11 12.6 22 18 81 90   24 20 137 140 
9. 6651 6600 7200 63 66 34 33 3 1     12.9 13 20 10 110 104   12 12 120 120 
10. 7755 8000 8400 60 64 36 34 4 2     12.8 14 34 12 75 76   40 26 144 148 
11. 7862 9400 9600 72 74 21 24 7 2     10.9 11.4 18 12 95 100   15 12 180 186 
12. 8276 7600 8100 57 64 40 34 3 2     12 12 20 12 110 108   24 22 140 152 
13. 9936 7400 7600 54 64 42 33 4 3     11.9 13 15 13 102 106   21 18 143 140 
14. 10079 8800 9000 67 68 30 30 3 2     10.9 12 30 16 94 100   23 18 158 160 
15. 11346 7600 8100 64 65 32 31 4 3     10 11.8 28 10 86 85   35 32 174 170 
16. 12258 6400 7100 57 61 36 37 7 2     10. 4 12 20 12 116 110   19 14 197 200 
17. 12268 9200 9500 67 66 28 32 5 2     11.4 12 15 10 103 100   15 12 187 190 
18. 12567 5600 6400 53 67 42 32 5 2     10.2 11 25 16 98 110   34 20 186 178 
19. 28633 8400 8500 63 64 35 34 2 1     8.6 10 34 18 98 104   17 15 160 166 
20. 28983 7800 8100 65 65 31 32 4 3     9 9.8 40 32 78 86   34 28 180 190 
21. 35315 7400 7800 65 66 31 33 4 1     11 11.5 32 18 110 108   31 30 200 210 
22. 35447 9000 9100 65 66 32 32 3 2     9.6 10 42 36 94 90   36 34 146 146 
23. 35450 8900 9100 62 64 36 35 2 1     7.5 8.5 41 37 100 108   18 16 150 150 
24. 74906 7500 7400 67 67 30 31 3 2     11.8 12 32 24 96 90   20 20 163 160 
25. 75002 9100 9400 64 64 32 34 4 2     9.6 11 40 30 102 100   30 20 178 172 
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BLOOD INVESTIGATION BEFORE AND AFTER TREATMENT – IP PATIENTS 
 
S.NO IP.NO TC 
DC HB ESR BLOOD SUGAR BLOOD  SERUM 
        N L E B M   F PP UREA CHOLESTEROL 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1. 2167 9000 9100 60 62 37 36 3 2     7.8 8.6 24 20 96 104   20 18 147 150 
2. 3279 8400 8500 65 66 32 32 3 2     9.8 10.8 28 16 70 76   18 18 165 165 
3. 3331 8900 9100 66 68 32 31 2 1     10.8 11 42 17 79 78   24 22 160 162 
4. 3361 7800 8100 64 65 32 32 4 3     7.4 8.4 38 25 89 90   21 20 150 154 
5. 3369 8100 8700 62 65 34 33 4 2     12.5 12.6 42 26 113 118   23 22 152 150 
6. 169 7600 7900 60 61 38 37 2 2     10.8 11.2 40 30 101 115   20 20 180 185 
7. 170 9100 9400 67 67 32 31 4 2     10.6 12 26 18 92 100   36 34 162 165 
8. 329 7400 7800 67 67 30 31 3 2     11 11.6 24 16 78 80   34 32 165 173 
9. 330 7800 7900 63 64 35 35 2 1     11.2 12 42 40 110 120   18 18 146 150 
10 484 8900 9000 60 64 38 34 2 2     10.2 10.4 38 30 116 118   22 20 158 156 
11 487 7500 7900 60 62 37 36 3 2     12 12.6 25 18 101 115   20 18 160 167 
12 676 9000 9100 67 66 30 33 3 1     12 13.2 48 36 80 86   34 32 180 182 
13 771 8900 9000 60 61 38 37 2 2     9 11 24 13 92 98   17 17 165 166 
14 801 9200 9400 63 67 35 32 2 1     9.8 10 32 24 120 118   20 20 130 132 
15 1022 7500 7900 60 62 37 36 3 2     12 13.2 42 30 74 80   35 34 145 149 
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URINE EXAMINATION BEFORE & AFTER TREATMENT – IN PATIENTS 
S.no 
 
OP.no Before treatment After treatment 
Albumin  Sugar Deposit Albumin  Sugar Deposit 
1.  63354 Nill Nill NAD Nill Nill NAD 
2.  63487 Nill Nill NAD Nill Nill NAD 
3.  64138 Nill Nill NAD Nill Nill NAD 
4.  109915 Nill Nill NAD Nill Nill NAD 
5.  112931 Nill Nill 2-3 pus cells Nill Nill 1-2 Pus cell 
6.  113035 Nill Nill NAD Nill Nill NAD 
7.  1537 Nill Nill NAD Nill Nill NAD 
8.  1726 Nill Nill NAD Nill Nill NAD 
9.  6651 Nill Nill NAD Nill Nill NAD 
10.  7755 Nill Nill NAD Nill Nill NAD 
11.  7862 Nill Nill NAD Nill Nill NAD 
12.  8276 Nill Nill 1-2 pus cells Nill Nill NAD 
13.  9936 Nill Nill NAD Nill Nill NAD 
14.  10079 Nill Nill NAD Nill Nill NAD 
15.  11346 Nill Nill NAD Nill Nill NAD 
16.  12258 Nill Nill NAD Nill Nill NAD 
17.  12268 Nill Nill NAD Nill Nill NAD 
18.  12567 Nill Nill NAD Nill Nill NAD 
19.  28633 Nill Nill NAD Nill Nill NAD 
20.  28983 Nill Nill NAD Nill Nill NAD 
21.  35315 Nill Nill 2-3 pus cell Nill Nill 1-2 Pus cells 
22.  35447 Nill Nill NAD Nill Nill NAD 
23.  35450 Nill Nill NAD Nill Nill NAD 
24.  74906 Nill Nill NAD Nill Nill NAD 
25.  75002 Nill Nill NAD Nill Nill NAD 
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URINE EXAMINATION BEFORE & AFTER TREATMENT – IN PATIENTS 
 
S.no 
 
Ip.no Before treatment After treatment 
Albumin  Sugar Deposit Albumin  Sugar Deposit 
1 2167 Nill Nill NAD Nill Nill NAD 
2 3279 Nill Nill NAD Nill Nill NAD 
3 3331 Nill Nill NAD Nill Nill NAD 
4 3361 Nill Nill NAD Nill Nill NAD 
5 3369 Nill Nill NAD Nill Nill NAD 
6 169 Nill Nill NAD Nill Nill NAD 
7 170 Nill Nill NAD Nill Nill NAD 
8 329 Nill Nill 2-3pus cell Nill Nill 1-2 pus cell 
9 330 Nill Nill NAD Nill Nill NAD 
10 484 Nill Nill NAD Nill Nill NAD 
11 487 Nill Nill NAD Nill Nill NAD 
12 676 Nill Nill NAD Nill Nill NAD 
13 771 Nill Nill NAD Nill Nill NAD 
14 801 Nill Nill NAD Nill Nill NAD 
15 1022 Nill Nill NAD Nill Nill NAD 
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DISCUSSION 
 Based on the clinical manifestations discussed in Yugi vaithiya chinthamani 800 forty 
cases were enrolled for the study.  Envagaithervugal the siddha diagnostic method was used 
to diagnose the disease and it was confirmed with the modern investigations.  After 
confirmation of the diagnosis the trial drug was administered along with the special therapies.  
Observations were noted and analysed.  They are discussed here under. 
Age distribution 
 The statistical study shows high incidence of Cegana vatham in the age group 
between 51-60 years as it is one of the degenerative disease and lowest incidence in the age 
between  
20-30. 
Most of the patients belong to pithakalam. 
 This information is bestowed by our siddhars as the wordings. 
 “Ou{<mi!Jl<hkil<!ubKke<eqz<!
! uqjvf<KhqVkquqbqz<!nh<HOlUl<!hiOv”/!
The target sites affected in cervical spondylosis are generally bones, muscles, nerves, 
hairs, blood, urine, fat which are the components of appu and prithiviboothas (Appu+ prithivi 
= kabam  responsible for destruction).  Hence they begin to degenerate above fifty. 
Sex distribution 
 There is a slight variation in the male, female ratio and it is noted obviously in the 
study. 
Thinai 
 About 95% of patients from maruthanilam.  It may be due to altered lifestyle, food 
habits etc. 
Seasonal distribution 
 Most of the patients came during, Munpani kaalam, Pinpani kaalam, Elavenil kaalam. 
Etiological factors 
 Majority of patients of the Ceganavatham was caused mainly (55%) due to the nature 
of occupation.  the remaining were due to other factor like senility and exposure to cold.. 
Occupational status 
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 The rate of incidence is higher in occupational group which includes home maker 
(35%) and Agricultural labour (15%) Beedi workers (20%), weight lifters (15%) 
Tailors(10%).  homemakers are mostly affected. 
Clinical Manifestations 
 Pain in the nape of the neck is present in all forty cases (100%), 85% of cases had 
radiating pain in upper limbs, 60% of cases had stiffness in the Neck.  Hence symptoms 
associated very well with the disease as proved by the statistical tests. 
Duration of illness 
 Most of the patient with the disease Cegana vatham reflected its symptoms over a 
period of 6-12 months which was confirmed during the history taking while 40% of the 
patients reported the data. 
Derangement in vatha 
 Viyanan and Samanan was affected in all 40 cases (100%). 
Disturbances in Pitha 
 Mostly Sathagapitham was affected in all 40 cases (100%). 
Disturbances in Kabha 
 Almost Santhigam was affected in all 40 cases (100%). 
Udal Thathukkal 
 In this study the patients was affected with seven thathus saram, senner, kozhuppu, 
enbu in 100% of cases, oon in 25%  cases was affected. 
 Envagai Thervugal 
 In this study thontha naadi was noted in all 40 cases,  malam was affected in 55% of 
cases and naa in 7.5% of cases. 
 In naadi 70% were vatha pitha naadi, 30% were pitha vatha naadi and remaining were 
kabavatha naadi. 
Investigation 
 Laboratory investigations were done in all the cases before and after treatment.  The 
significant variations occur in parameters like ESR and HB, while other parameters have 
insignificant variation. 
Pre clinical studies 
 The phytochemical study of  “Vathathirku leghiyam” had revealed the presence of 
calcium, ferrous iron, tannic acid, unsaturated compound, reducing sugar. 
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Pharmacological studies 
 The pharmacological studies done in “Vathathirku leghiyam” revealed the presence of 
actions such as 
1. Anti – inflammatory action 
2. Analgesic activity. 
Toxicity studies 
 Acute toxicity studies in rats for “Vathathirku leghiyam”   revealed that it has no 
toxicity effect. 
Treatment 
 The treatment was aimed to retain the deranged thoshas and providing relief from 
symptoms.  Before treatment the patients were advised to take vellai ennai 15ml with hot 
water during morning for first day of treatment. 
 From the second day onwards Internal medicine Vathathirku leghiyam 6.02gm two 
times a day after food and Pancharka thylam is given as external. 
 At the time of treatment the patients were advised to follow pathiyam and specifically 
advised to avoid foods which increase vadha. 
 Along with the course of treatment the complementary therapies like Thokkanam and 
Yoga asanas therapy were given additionally to some of the patients. 
 The outcome of this study is mainly assessed by reduction in pain in cervical joint.  
Increased range of reduction of restricted movements and improvement in quality of life 
universal pain assessment scale was also used to detect proper outcome.  No adverse effect 
was noted for both internal and external medicine along with the course of treatment. 
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SUMMARY 
 40 cases with Cegana vatham were diagnosed clinically based on yugi 800 and 
admitted in the inpatient ward and outpatient ward of post graduate department of sirappu 
maruthuvam, Government Siddha Medical College Hospital, palayamkottai and treated by 
the trial medicines. 
 Laboratory diagnosis of Ceganavatham was done by siddha diagnostic principles and 
endorsed by modern methods of investigations. 
 The various siddha aspects of examination of the disease were carried out and were 
recorded in the proforma. 
 The trial medicine chosen for both internal and external treatments were          
Vathathirku leghiyam 6.02gms/days in two  doses for forty eight days as per the 
severity of the diseases, Pancharka thylam (External) 
 Before starting the treatment careful detailed history was carried out and recorded for 
the forty selected cases. 
 During the period of treatment all the patients were put under pathiyam (A specific 
dietary regimen) 
 A periodical laboratory investigation was made for all the cases along with the 
radiological investigations. 
 The observations made during the clinical study shows that the main internal drug 
Vathathirku leghiyam  is clinically effective. 
 Though there was appreciable clinical improvement, there was not much remarkable 
radiographic changes. 
The action of external application Pancharka thylam with Thokkanam and Yoga 
asanas is also quite remarkable. 
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CONCLUSION 
 All 40 patients (25 OPD and 15 IP – 8 patients with trial medicines and Massage, 7 
with Yoga asanas along with trial medicines). were treated for this dissertation work with 
Vathathirku leghiyam 6.02gm/day in two doses a day and Pancharka thylam (externally) 
 In the pre clinical study pharmacological evaluation of the trial drug shows. 
 Significant analgesic effect 
 Significant Anti inflammatory effect (Internal medicine) 
In the preclinical study toxicity study of “Vathathirku leghiyam”  shows that the trial drug 
had no acute toxicity. 
The overall effects of the clinical trial drug are  
 Marked effect  - 80% 
 Moderate effect - 13% 
 Mild effect  - 0% 
 No effect  - 6.6% 
 This result of the clinical trial illustrates the marked effect of the drugs and 
complementary therapy. 
 The trial drug “Vathathirku leghiyam” and external “Pancharka thylam” is effective.  
No adverse effects were noticed during the treatment period.  So the trial medicine is safe and 
easily preparable medicine.  
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INGREDIENTS OF  VATHATHIRKKU LEGHIYAM 
Sathikai 
 
Kirambu 
 
Milagu 
 
Omam 
 
Inji 
 
Seeragam 
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Elam  
 
Poondu 
 
Nilapanai Kizhangu 
 
Milk 
 
Sathipathiri 
 
Thippili 
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INGREDIENTS OF  PANCHARKA THYLAM 
 
  
Veliparuthi 
 
Athandai 
 
Thagarai vithai 
 
Mookirattai 
 
Kostam 
 
Amukkara 
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Erukku charu 
 
Nochi 
 
Kasthuri Manjal 
 
Indhuppu 
 
Gingelly Oil 
 
Charanai ver 
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VATHATHIRKKU LEGHIYAM 
 
PANCHARKA THYLAM 
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TREATMENT 
TRIAL DRUGS: 
INTERNAL DRUG: VATHATHIRKKU LEGHIYAM 
REFERANCE: ATHMARATCHAMIRTHAM 
INGREDIENTS: 
Poondu (Allium sativum)                                 - 1 Padi (1440ml) 
Sathikai (Myristica fragrans)                           -  5 varagan (21gm) 
Sathipaththiri (Myristica fragrans)                       -  5 varagan (21gm) 
Kirambu (Syzygium aromaticum)                       -  5 varagan(21gm) 
Seeragam (Cuminum cyminum)                          -  5 varagan (21gm) 
Elam  (Elettaria cardamomum)                            -  5 varagan(21gm) 
Akkarakaram (Anacylus pyrethrum)                  -  5 varagan(21gm) 
Thippilli moolam (Piper longum)                        -  5 varagan(21gm) 
Chukku (Zingiber officinale)                               -  5 vargan(21gm) 
Milagu (Piper nigrum)                                        -  5 varagan(21gm) 
Thippili (Piper longum)                                      -  5 varagan(21gm) 
Omam (Trachyspermum ammi)                          -  5 varagan(21gm) 
Parangipattai (Smilax china)                               -  5 varagan(21gm) 
Nilapanaikizhangu (Curculigo orchioides )        -  5 varagan(21gm) 
Cow milk                                                            -  1 Padi(1440ml) 
Nei (Ghee)                                                           -  1 Padi(1440ml) 
Then(honey)                                                        -  1 Padi(1440ml) 
  
Dose    :  Kottaipakalavu (6.022)  
Duration  :  48 Days  
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EXTERNAL DRUG: PANCHARKA THYLAM 
REFERANCE:  Agathiyar mani ennum  vaithiya sinthamani venba-4000 
 
INGREDIENTS: 
 
Erukku ( Calotropis gigantea )                        -  5palam(175gm) 
Notchi ( Vitex negundo )                                -  5palam(175gm) 
Charanai ( Trianthema portulacastrum )         -  5palam(175gm) 
Athandai ( Capparis zeylanica )                      -  5palam(175gm) 
Amukkura ( Moringa oleifera )                    -  5palam(175gm) 
Murungai ( Moringa oleifera )                       -  5palam(175gm) 
Veliparuthi ( Pergularia daemia )                   -  5palam(175gm) 
Mukkirattai ( Boerhaavia diffusa )                -  5palam(175gm) 
Thaneer ( Water )                                          -    1 naazhi(1.34lt) 
Induppu ( Sodium chloride impure)              -  1palam(35gm) 
Thagaraivithai ( Cassia tora )                        -  1palam(35gm) 
Chukku                                               -  1palam(35gm) 
Elam                                                         -  1palam(35gm) 
Kirambu ( Syzygium aromaticum )              -  1palam(35gm) 
kottam ( Costus speciosus )                          -  1palam(35gm) 
Katturi manjal ( Curcuma aromatic )          -  1 palam(35gm) 
Gingelly oil ( Sesamum indicum )               -  4 padi(5.36litre) 
Goat”s milk                                                -  4 padi(5.36 litre) 
!
 !
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2/!h,{<M!;<<< !
 
Botanical Name               :  Allium sativum 
Synonyms        !!!!!!!!! ;!! zSel<?!gibl<?!out<Tt<tq?!out<jt!h,{<M/!
Family                             :  Liliaceae 
Part used                          :  Bulb 
Sju!!!!!!!!!!!!!!!! ;!! giIh<H!
uQvqbl<!!!!!!!!!!!!!!! ;!! ouh<hl<!
hqvqU!!!!!!!!!!!!!!!! ;!! giIh<H?!
Therapeutic action           :  dvlig<gq?!ngm<Muib<ugx<xq?!!
dmx<Oxx<xq?!Ogijpbgx<xq/!
Chemical constituents    :  Allin, ajoeje, vinyldithins, vitamin,protein, 
                                           saponin, phytoalexin, minerals. 
ohiKG{l<!;<<< !
!!!!!!!!!!!!!!#!se<eqobiM!uikf<!kjz!OfiU!kit<uzq!
!!!!!!!!!!!!!!!!le<equV!fQIg<Ogiju!ue<sQkl<!ne<eOl!"!
!!!!!!!!!!!!!!!!dt<tqt<tq!g{<hib<!djt&z!OvigLl<!Ohil<!
!!!!!!!!!!!!!!!!out<Tt<tq!ke<eiz<!ouV{<M!#!"!
3/!sikqg<gib<!;< << << < !
 
Botanical Name            :  Myristica fragrans 
Synonyms                       :  Gzg<gib<!
Family                             :  Myristicaceae 
Part used                              :  Seed  
Sju!!!!!!!!!!!!! ;!! KuIh<H?!giIh<H!
ke<jl!!!!!!!!!!!! ;!! ouh<hl<!
hqvqU!!!!!!!!!!!!!! ;!! giIh<H!
Therapeutic action!!!!! ;!! ngm<Muib<ugx<xq?!ouh<hL{<mig<gq?!dvlig<gq?!
Chemical constituents    :  Myristicin, sabinene, allylbenzene, propyllbenzene/!
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ohiKG{l<!;!<<< !
!!!!!!!!!!!!!!#!kiK!fm<ml<!Ohkq!sVuisq!bR<sqv!Ofib<!
!!!!!!!!!!!!!!!!YKSui!sr<gisl<!dm<gqv{q!.!OuOki!
!!!!!!!!!!!!!!!!czg<gib<!uVl<hq{qOhil<!Wx<x!lbz<!hqk<kr<!
!!!!!!!!!!!!!!!!!Gzg<gi!bVf<KuIg<Gg<!%X!#/!
4/!sikqhk<kqvq< << !
 
Botanical Name          :  Myristica fragrans 
Family                         :  Myristicaceae 
Synonyms!!!!!!!!!;!!! \ikqh<hk<kqvq?!uSuisq!
Part used                     :  Aril 
Sju!!!!!!!!!!!!;!! giIh<H?!KuIh<H!
uQvqbl<!!!!!!!!!!!!;!! ouh<hl<!
hqvqU!!!!!!!!!!!!!;!! giIh<H!
Therapeutic action  !!;!! ngm<Muib<ugx<xq?!ouh<hL{<mig<gq?!dxg<gL{<mig<gq!
Chemical constituents ;!Myristicin, sabinene, allylbenzene, propyllbenzene/!
ohiKG{l<!;<<< !
!!!!!!!!!!!!sikqkVl<!hk<kqvqg<Gk<!kihs<!Svf<k{qBl<!
!!!!!!!!!!!!YKgqe<x!hqk<kl<!dbVr<gie<!.!kiKuqVk<kq!
!!!!!!!!!!!!B{<mir<!gqvg{qObi!Omikg<!gpqs<szXl<!
!!!!!!!!!!!!h{<mir<!GjxOb!hgI/!
)n/G*!
5/!gqvil<H!;<<< !
 
Botanical Name          : Syzygium aromaticum 
Family                        : Myrtaceae 
Part used                     :  Flower bud 
Sju!!!!!!!!!!!!;!giIh<H!
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uQvqbl<!!!!!!!!!!!!!;!ouh<hl<!
hqvqU!!!!!!!!!!!!!!;!giIh<H!
Therapeutic actions!!!!;!ngm<Muib<ugx<xq?!hsqk<kQK~{<c/!
Chemical constituents : Eugenol, eugenitin,  eugenin, kaempferol. 
!
ohiKG{l<!;<<< !
!!!!!!!!!!!#!hqk<k!lbg<gl<!OhkqObiM!uif<kqb,l<Ohil<!
!!!!!!!!!!!!!Sk<kquqvk<!kgMh<Hs<!Okie<XOli!#!/!
.!ngk<kqbI!G{uigml<!
6/!sQvgl<Q <Q <Q <!
 
Botanical Name           : Cuminum cyminum 
Synonyms               ;!! njs?!sQvq?!dhGl<hhQsl<?!fx<sQvq?!Kk<ksil<hzl<?!!
!!!!!!!!!!!!!!!!!!!! hqvk<kq.uqgi?!hqk<kfisqeq?!OhiseGOmivq?!Olk<kqbl</!
Family                      :  Apiaceae 
Part used                     :  Fruit  
Sju!!!!!!!!!! ;!! giIh<H?!-eqh<H!
uQvqbl<!!!!!!!!!!!;!! km<hl<!
hqvqU!!!!!!!!!!!!;!! -eqh<H!
Therapeutic action    !;!! ngm<Muib<ugx<xq?!ouh<hL{<mig<gq?!hsqk<kQK~{<c?!KuIh<hq!
Chemical constituents :   Limonene, 1,8 cineole, linalool, linalyl acetate/!
ohiKG{l<!;<<< !
!!!!!!!!!!!!!!!hqk<kolE!lf<kqvqjbh<!hqe<eh<!hMk<kqbue<!
!!!!!!!!!!!!!!!sk<KVju!Bf<Kxf<K!sikqk<K!.!lk<koeEl<!
!!!!!!!!!!!!!!!visjeB!lQoue<X!f{<jhh<!hzh<hMk<kq!
!!!!!!!!!!!!!!!OhiseG!mivqosBl<!OhiI/!
)!Okve<!ou{<hi*!
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7/Wzl<!;<<< !
 
Botanical Name           :   Elettaria cardamomum 
Synonyms                   ;!!! NR<sq?!Ogivr<gl<?!Kc!
Family                         : Zingiberaceae 
Part used                      : Seed 
Sju!!!!!!!!!!!!!;!!! giIh<H!
uQvqbl<!!!!!!!!!!!!;!!! ouh<hl<!
hqvqU!!!!!!!!!!!! ;!! giIh<H!
Therapeutic actions      ;!! ouh<hL{<mig<gq?!ngm<Muib<ugx<xq?!hsqk<kQk<K~{<c/!
Chemical constituents  :  Limonene terpinolene alpha terpinyl acetate,  
                                         Myrcene, Protocatechuic acid, 1,8 cineole. 
ohiKG{l<!;<<< !
 
lzuik!OliM!ubqx<Xg<!ogikqh<H!
sz&xz<!uibqeqh<H!kigl<!.!szOhkq!
OuIg<Gf<!kjzOfib<!lqG'm<js!Jblqju!
Ohig<G!R<sqx<!Oxzl<!Hgz<!
Wzk<kqeiz<!uikl<!G{liGl</!
)n/G*!
8/!ng<gvgivl<< << << <!
 
Botanical Name           :  Anacyclus pyrethrum 
Synonyms                   :!! ng<gvigivl<!?!ng<gqvigivl</!
Family                         :  Asteraceae 
Part used                      :  Rhizome 
Sju!!!!!!!!!!!!!;!! giIh<H!
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uQvqbl<!!!!!!!!!!!;!!! ouh<hl<!
hqvqU!!!!!!!!!!! ;!! giIh<H!
Therapeutic action!!!;!! ouh<hL{<mig<gq?!dlqp<fQIh<ohVg<gq?!!
Chemical constituents :   Pyrethrin 
ohiKG{l<!;<<< !
!!!!!!!!!!!!!!ng<gv!givl<!nke<OhI!djvk<kg<giz<!
!!!!!!!!!!!!!!dg<gqvgiz<!nk<Okiml<!YMr<gi{<!.!Lg<gqblib<g<!
!!!!!!!!!!!!!!ogi{<miz<!szl<DXl<!ogil<hjeOb!"!kigSvl<!
!!!!!!!!!!!!!!g{<miz<!hbf<OkiMr<!gi{</!
)n/G*!
 ng<gvgivk<kiz<?!hbr<gvlie!gizqe<Gx<xl<!)!uikOkiml<*!OhiGl</!
!
9/kqh<hqzq!&zl<!;< << << < !
 
Botanical Name             :  Piper longum 
Synonyms!!!!!!!!!!;!! nl<hqec?!gqvf<kqOuI?!gqvf<kqgl<?ke<le<?!
!!!!!!!!!!!!!!!!!!!! ke<&zl<?!kqh<hqzqgm<jm?!fXg<GOuI?!OlicOuI/!
Family  !!!!!!!!!!!!:  Piperaceae!!
Part used                         :  Root 
Sju!!!!!!!!!!!!!!;!! giIh<H!
uQvqbl<!!!!!!!!!!!!!;!! ouh<hl<!
hqvqU!!!!!!!!!!!!!!!;!! giIh<H!
Therapeutic action!!!!!;!! hsqk<kQk<K~{<c!
Chemical constituents    :  Coumaperine, piperolactam, demethoxycurcumin, 
                                           aphanamol, piperidine. 
 !
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:/!Sg<G!;<<< !
 Name                            :  Zingiber officinale 
Synonyms!!!!!!!!!;!! nVg<ge<?!S{<c?!osi{<c?!fuSX?figvl<?!
!!!!!!!!!!!!!!!!!!!!!ostuI{l<?!uqmLcb!nlqIkl<?!gMhk<kqvl<!
Family                          :  Zingiberaceae 
Part used                      :  Rhizome 
Sju!!!!!!!!!!!!;!! giIh<H!
uQvqbl<!!!!!!!!! ;!! ouh<hl<!
hqvqU!!!!!!!!!!!!;!! giIh<H!
Therapeutic actions!!;!! ouh<hL{<mig<gq?!ngm<Muib<ugx<xq?!hsqk<kQk<K~{<c/!
Chemical constituents    :  Isovanillin, Glycol monopalimitate, b- gingino, 
                                            Beta - sitosterol palmitate, adenine, malemide 5 - oxime. 
ohiKG{l<!;<<< !
!!!!!!!!!!!!uikh<!hq{qubq!X~kx<!osuquib<!
!!!!!!!!!!!!!!!!!!uzqkjz!uzqGjz!uzqbqV!uqpqfQI!
!!!!!!!!!!!!sQkk<!okiMuvq!Ohkqh<!hzOvi!
!!!!!!!!!!!!!!!!!!sqglzq!Lglg!Lglqc!ghliI!
!!!!!!!!!!!!sQks<!svl<uqvq!Ohks<!SvOfib<!
!!!!!!!!!!!!!!!!!okxqhMoleolipq!GuIHuq!keqOz!
!!!!!!!!!!!!=Kg<!GkUlq!kQKg<!Gkui!
!!!!!!!!!!!!!!!!!okEl<uqkq!bqjzfu!SXG{!LeOu/!
)Ok/G*!
 Sg<gqeiz<!uik!hq{q!kQVl</!
 !
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21/!!lqtG!;!
 
Botanical Name          :  Piper Nigrum 
Synonyms     !!!!!! ;!! gzqje?!Ogitgl<?!kqvr<gt<?!sVlhf<kl<?!
!!!!!!!!!!!!!!!!!!!!!ut<tqsl<?!lisl</!
Family                        :  Piperaceae 
Part used!!!!!!!!!!;!! uqjk!
Sju!!!!!!!!!!!!;!! jgh<H?!giIh<H!
uQvqbl<!!!!!!!!!!!!;!! ouh<hl<!
hqvqU!!!!!!!!!!!!!;!! giIh<H!
Therapeutic actions!!!;!! uiklmg<gq?!uQg<gr<gjvs<sq?!fs<svq?!Ljxouh<hgx<xq/!
Chemical constituents   :  Piperine, Superoxide anions, Nitric oxide. 
                                           Dipiperamides D & E, Piptigrine, Wisanine. 
!
ohiKG{l<!;<<< !
!!!!!!!!!!!!!ntjuBxig<givl<!njmf<kqVg<Gl<!uik!
!!!!!!!!!!!!!uqjtjuobz<!zilXg<Gl<!olb<Ob!.!lqtgqe<gib<!
!!!!!!!!!!!!!g{<muIg<Gl<!-e<hlil<!givqjgOb!"!sQp<&zr<!
!!!!!!!!!!!!!ogi{<muIg<G!fe<lVf<kir<!%X/!
)n/G*!
 lqtG!uik!uqjtUgt<!wz<zil<!Ohig<Gl</!
!
22/!kqh<hqzq!;<<< !
 
Botanical Name           :  Piper longum 
Synonyms    !!!!!!!;!! NIgkq?!d{<svl<?!dzjufisq?!gile<Gmivq?!
!!!!!!!!!!!!!!!!!!!!!svl<?sic?!Ktuq?!g{l<?!gzqeq?!nl<H?!NkqlVf<K/!
Family                          :  Piperaceae  
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Part used!!!!!!!!!!;!! Fruit 
Sju!!!!!!!!!!! !;!! -eqh<H!
uQvqbl<!!!!!!!!!!!!;!! km<hl<!
hqvqU!!!!!!!!!!!!!;!! -eqh<H!
Therapeutic actions!!!;!! ouh<hL{<mig<gq?!ngm<Muib<ugx<xq/!
Chemical constituents   :  Coumaperine, piperolactam, 
                                          demethoxycurcumin, aphanamol, piperidine. 
ohiKG{l<!;<<< !
!!!!!!!!!!-Vlz<!Ge<ll<!-jvh<H!gbh<hq{q!
!!!!!!!!!!=jt!hi{<M!sf<bisl<!nOvisgl<!
!!!!!!!!!!ohiVlz<!Djk!sqvh<hq{q!&Is<jsOfib<!
!!!!!!!!!!h,vqg<!GR<sz!Okiml<!hQzqgLl<!
!!!!!!!!!!uVl!zh<ohVg<!OgiM!lOgikvl<!
!!!!!!!!!!ohVlijzh<Hvq!Olgh<!hqmgLl<!
!!!!!!!!!!OhVf<!kqh<hqzqh<!Ohvr<Gjvg<gOu/!
 kqh<hqzq!uikl<!kQIg<Gl</!
!
23/!!Yll<<<<!
 
Botanical Name          : Trachyspermum ammi 
Synonyms!!!!!!!!;!! nsl<kigl<?!nsl<ki!Yll<!
Family                        :  Apiaceae 
Part used!!!!!!!!!!;!! Seed!!!!!!!!!
Therapeutic action!!!;!!! hsqk<kQk<K~{<c?!ngm<Muib<ugx<xq!
Chemical constituents ;!! Thymol, p-cymene 
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24/!hxr<gqh<hm<jm< < << < << < < !
 
Botanical Name       :   Smilax china 
Synonyms!!!!!!!;!! lK <^lqgl<?!lK <^lQgq?!sQeh<hm<jm?!hxr<gqs<sg<jg!
Family                     :   Liliaceae 
Part used                  :   Root 
Sju!!!!!!!!!!!;!! -eqh<H!
uQvqbl<!!!!!!!!!!;!!! km<hl<!
hqvqU!!!!!!!!!!!;!!! -eqh<H!
Therapeutic action!!;!!! dmx<Oxx<xq?!Olgh<hq{quqzg<gq?!
!!!!!!!!!!!!!!!!!!!! gill<ohVg<gq?!K~b<jlbig<gq!
Chemical constituents  :   Carotene, cryptoxanthin, neo-b-carotene 
!
ohiKG{l<!;<<< !
!!!!!!!!!!!!!!kigl<!hzuikf<!kiKfm<ml<!H{<hqtju!
!!!!!!!!!!!!!!Olgr<!gcgqvf<kq!uQp<&zf<!.!OkgLme<!
!!!!!!!!!!!!!!Gm<jm!hgf<kOlx<!ogit<ulel<!Ohil<hxr<gqh<!
!!!!!!!!!!!!!!hm<jmbqje!Bs<svqk<Kh<!hiI/!
)Ok/G*!
 hxr<gqh<hm<jm!hz!uikr<gjtBl<!Ohig<Gl</!
!
25/!fqzh<hjegqpr<G< << << < !
 
Botanical Name           :  Curculigo orchioides 
Synonyms!!!!!!!!!;!! uivigq?!kiz&zq?!kqvtivl<?!kqvgk<kiV!kqv{vise<!!
!!!!!!!!!!!!!!!!!!!! sgqbl<?!kjzk<kiK?!fqzuqPlq?!Ofbl<?!Gxk<kq?!!
ssqbl<?!sqk<kq/!
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Family                         :  Hypoxidaceae 
Part used                      :  Rhizome 
Sju!!!!!!!!!! ;!! -eqh<H!
uQvqbl<!!!!!!!!!!!!;!! km<hl<!
hqvqU!!!!!!!!!!!!!;!! -eqh<H!
Therapeutic action!!!;!! dvlig<gq?!ngm<Muib<ugx<xq?!KuIh<hq?!!
!!!!!!!!!!!!!!!!!!!!!!sqXfQI!ohVg<gq?!!uxm<sqbgx<xq!
Chemical constituents  : Phenyl glycosides, orcinal glycoside, corchioside A 
ohiKG{l<!;<<< !
!!!!!!!!!!!!!!!!Olg!uez<k{qBl<!ou{<Gm<mf<!kie<uqzGl<!
!!!!!!!!!!!!!!!!Ohig!lqgULXl<!ohix<ogicOb!"!.!Ohigik!
!!!!!!!!!!!!!!!!$jzOl!gr<gOtiM!Ke<EgVl<!Ht<tqBl<OhiR<!
!!!!!!!!!!!!!!!!siz!fqzh<hjeg<Gk<!kie</!
26/!hiz<<<<!
Synonyms : hbl<?!gQvl<?!Sjk?!hbS?!hiG?!nLK?!Kk<kl<?!siX/!
ohiKG{l<!;!
!!!!!!!!!“hizI!gqpuI!hpR<Svk<OkiI!H{<{itq!
!!!!!!!!!!!$jzbI!Olgk<OkiI!KIhzk<OkiI!WZlquI!
!!!!!!!!!!!wz<ziIg<G!liGl<!-jtk<kuIg<GR<!sikglib<!
!!!!!!!!!!!fz<zib<!hSuqe<hiz<!fim<M#/!
16.!ofb<;< << !
English Name:Ghee 
ohiKg<G{l<;/< << << < !
!!!!!!!!!!!kigLp!jzgm<gl<!uif<kq!hqk<kl<!uiBhqv!
!!!!!!!!!!!Olgl<!ubqx<oxvqU!uqg<gzpz<.ligisr<!
!!!!!!!!!!!Ge<ll<!uxm<sq!Gmx<Hvm<m!z <^kqgm<gR<!
!!!!!!!!!!!osie<&zl<!Ohig<gfqjxk<!Kh<H/!
!
!
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28/!Oke<;<<< !
ohiKg<G{l<;< << << < !
NBTm!Em<c{l!Ovisq!bgg<ghL!
Olb!upgl<!utv<k<kqMr<gi{<.Kib!!
lkqb!olEuke!likvOs!fiTl<!
Hkqb!fXf<Okeix<!Hgz</!
Sju;!-eqh<H!!
osb<jg;<<< !dt<tipx<xq,!lzlqtg<gq,!Kuv<h<hq,!npgzgx<xq,!Ogijpbgx<xq,!hsqk<kQk<K~{<c,!
dvlig<gq,!K~g<gL{<mig<gq/!!
 
EXTERNAL DRUG – PANCHARKA THYLAM 
2/!wVg<G!;<<< !
 
Botanical Name : Calotropis gigantea 
Family : Asclepiadaceae 
Part used : Leaf 
Sju!;!giIh<H!
uQvqbl<!;!ouh<hl<!
hqvqU!;!giIh<H!
Therapeutic actions : Anti inflammatory, Analgesic. 
Chemical constituents : Caoutchouc, asclepin, gigastin, mudarine. 
ohiKG{l<!;<<< !
!!!!!!!!!!#!uzq$jz?!uiBuqm!lf<kl<!.!lzhf<kl<!
!!!!!!!!!!!wz<zi!lgZ?!olVg<gqjzjbg<!g{<miz<!#/!
.!ngk<kqbI!G{uigml<!
 !
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3/!ofis<sq!;<<< !
 
Botanical Name : Vitex negundo 
Family : Verbenaceae 
Part used : Leaf 
Sju!;!jgh<H?!giIh<H!
uQvqbl<!;!ouh<hl<!
hqvqU!;!giIh<H!
Therapeutic actions : Vermifuge, Alterative 
Chemical constituents!;!Vitegnoside, 7,8 dimethyl herbacetin. 
ohiKG{l<!;<<< !
!!!!!!!!!!//…////////////……!gvofis<sqx<!hm<jmbK!
!!!!!!!!!!!Kt<T!se<eq!uiklgx<Xl<!/…………!
.!ngk<kqbI!G{uigml<!
4/!sivj{!;!
 
Botanical Name : Trianthema portulacastrum 
Family : Aizoaceae 
Part used : Root 
Sju!;!jgh<H!
uQvqbl<!;!ouh<hl<!
hqvqU!;!giIh<H!
Chemical constituents : Trianthenol, 3-acetylaluritolic acid, p-methoxybenzoic acid. 
5/!Nk{<jm<<< !;!
Botanical Name: Capparis zeylanica 
Family : Capparaceae 
Part used : Root 
Sju!;!sqXjgh<H!
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uQvqbl<!;!ouh<hl<!
hqvqU!;!giIh<H!
Therapeutic actions : Sedative, Stomachic 
Chemical constituents: alpha & beta amyrin, n-tricontane!
ohiKG{l<<<<!;!
!!!!!!!!!!#!……!uik!gMh<hgZ!liOk!N!oki{<jmg<Gh<!
!!!!!!!!!!!!!!!Ohikh<!hzhq{q!Ohil<//////!#!
.ngk<kqbI!G{uigml<!
6/!nSugf<kq!;<<< !
 
Botanical Name : Withania somnifera  
Family : Solanaceae 
Part used : Rhizome 
Sju!;!jgh<H!
uQvqbl<!;!ouh<hl<!
hqvqU!;!giIh<H!
Therapeutic actions : Sedative, Tonic, Deobstruent 
Chemical constituents : Isopelletierine, anaferine, saponins, sitoindosides 
ohiKG{l<!;<<< !
!!!!!!!!!!!!!!!!!!#!ogiR<f<!KuIh<hir<!ogicbgbl<!$jzbvq!
!!!!!!!!!!!!!!!!!!!!!lqR<Sgvh<!hie<hi{<M!oum<hkm<H!.!uqR<sq!#!!
.!ngk<kqbI!G{uigml<!
7/!LVr<jg!;<<< !
 
Botanical Name : Moringa oleifera 
Family : Moringaceae 
Part used : Bark 
Sju!;!jgh<H?!KuIh<H?!-eqh<H/!
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uQvqbl<!;!km<hl<!
hqvqU!;!giIh<H!
Therapeutic actions : Antispasmodic, Stimulant, Diuretic 
Chemical constituents!;!Hexacosane, Flavanoids, Quercetin 
!
ohiKG{l<!;<<< !
!!!!!!!!!!!sqg<GVg<G!bh<hqR<sk<!kqs<Svk<kqx<!GR<sfqg<Gl<!
!!!!!!!!!!!ng<GVg<G!vh<hl<!nOvisqgm<GR<!.!Sg<gqzk<kqe<!
!!!!!!!!!!!ogis<js!BxuVf<kqg<!%Xukx<G!lilkjeh<!
!!!!!!!!!!!hs<js!BxuVf<kqh<!hiI!#!/!
.!OkjvbI!G{uigml<!
8/!Ouzqh<hVk<kq!;< << << < !
 
Botanical Name : Pergularia daemia 
Family : Asclepiadaceae 
Part used : Leaf 
Sju!;!jgh<H!
uQvqbl<!;!ouh<hl<!
hqvqU!;!giIh<H!
Therapeutic actions : Anthelmintic, Emetic, Expectorant 
Chemical constituents!;!Terpenoids, alpha-amyrin, beta-sitosterol 
ohiKG{l<!;<<< !
!!!!!!!!!!!#!…//…!g{<cg<Gl<!uikr<!gMR<se<eq!OkimLl<Ohil<!
!!!!!!!!!!!!!d{<cg<Gl<!uisjebil<!YK!#/!
.!ngk<kqbI!G{uigml<!
 !
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9/!&g<gqvm<jm!;< << << < !
Botanical Name : Boerhaevia diffusa 
Family : Nyctaginaceae 
Part used : Leaf 
Sju!;!jgh<H!
uQvqbl<!;!ouh<hl<!
hqvqU!;!giIh<H!
Therapeutic actions : Refrigerant, Laxative, Diuretic 
Chemical constituents : Beta-sitosterol,  Beta- D- glucose 
ohiKG{l<!;<<< !
!!!!!!!!!!!!!#!&g<gqvm<jmbquqjz!LjxB{!uikOfi!
!!!!!!!!!!!!!!!!big<jgbqx<!ohm<c!bvoue<!umr<GOl!#!/!
.!Okve<!ou{<hi!
:/!-f<Kh<H!;< << << < !
Chemical Name : Sodium chloride impure 
Sju!;!duIh<H! !
Therapeutic actions : Carminative, Stimulant, Laxative 
Chemical constituents :  Berberine 
ohiKG{l<!;<<< !
!!!!!!!!!!!!!!nm<mGe<l!lf<kl<!nsqIgvR<$v!sQkhqk<kl<!
!!!!!!!!!!!!!!Km<m!jubl<!fich<H{<!Okimr<gt<!!.!ogm<mlzl<!
!!!!!!!!!!!!!!gm<Muqm!uqf<jkbg<!gilqbOfib<!
!!!!!!!!!!!!!!ue<gvh<hie<!uqm<M!uqm!uqf<Kh<jh!uqt<!#/!
 !
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21/!kgjv!uqjk!;!
 
Botanical Name : Cassia tora 
Family : Fabaceae 
Part used : Seeds 
Sju!;!jgh<H?!duIh<H!
uQvqbl<!;!ouh<hl<!
hqvqU!;!giIh<H!
Therapeutic actions : Febrifuge, Laxative 
Chemical constituents!;!Anthroquinones, Glycosides 
ohiKG{l<!;<<< !
!!!!!!!!!!!!!#u{<M!gcBmOe!ue<gMu!El<hzuil<!
!!!!!!!!!!!!!!h{<M!fjlh<HjmBl<!h{<ckIgt<!.!g{<mjvg<gib<!
!!!!!!!!!!!!!!hqk<k!neZl<!ohVk<k!kgjvuqjkg<!
!!!!!!!!!!!!!!gqk<kjvBt<!fqz<zi!kqjs!#!/!
.!ngk<kqbI!G{uigml<!
22/!Sg<G!;<<< !
 Name           :  Zingiber officinale 
Synonyms!!!!;!! nVg<ge<?!S{<c?!osi{<c?!fuSX?figvl<?!
!!!!!!!!!!!!!!!!ostuI{l<?!uqmLcb!nlqIkl<?!gMhk<kqvl<!
Family              :  Zingiberaceae 
Part used           :  Rhizome 
Sju!!!!!! !;!! giIh<H!
uQvqbl<!!!!!!!;!! ouh<hl<!
hqvqU!!!!!!!!;!! giIh<H!
Therapeutic actions!!!;!ouh<hL{<mig<gq?!ngm<Muib<ugx<xq?!hsqk<kQk<K~{<c/!
Chemical constituents : Isovanillin, Glycol monopalimitate, b- gingino,                                            
Beta - sitosterol palmitate, adenine, malemide 5 - oxime. 
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ohiKG{l<!;<<< !
!!!!!!!!!!!!uikh<!hq{qubq!X~kx<!osuquib<!
!!!!!!!!!!!!!!!!!!uzqkjz!uzqGjz!uzqbqV!uqpqfQI!
!!!!!!!!!!!!sQkk<!okiMuvq!Ohkqh<!hzOvi!
!!!!!!!!!!!!!!!!!!sqglzq!Lglg!Lglqc!ghliI!
!!!!!!!!!!!!sQks<!svl<uqvq!Ohks<!SvOfib<!
!!!!!!!!!!!!!!!!!okxqhMoleolipq!GuIHuq!keqOz!
!!!!!!!!!!!!=Kg<!GkUlq!kQKg<!Gkui!
!!!!!!!!!!!!!!!!!okEl<uqkq!bqjzfu!SXG{!LeOu/!
)Ok/G*!
!
23/Wzl<!;<<< !
Botanical Name           :  Elettaria cardamomum 
Synonyms                   !;!!NR<sq?!Ogivr<gl<?!Kc!
Family                         : Zingiberaceae 
Part used                      : Seed 
Sju!!!!!!!!!!!!!!!;!!giIh<H!
uQvqbl<!!!!!!!!!!!!!!!;!!ouh<hl<!
hqvqU!!!!!!!!!!!!!!!!!;!giIh<H!
Therapeutic actions      ;!ouh<hL{<mig<gq?!ngm<Muib<ugx<xq?!hsqk<kQk<K~{<c/!
Chemical constituents  : Limonene terpinolene alpha terpinyl acetate,  
                                        Myrcene, Protocatechuic acid, 1,8 cineole. 
ohiKG{l<!;<<< !
lzuik!OliM!ubqx<Xg<!ogikqh<H!
sz&xz<!uibqeqh<H!kigl<!.!szOhkq!
OuIg<Gf<!kjzOfib<!lqG'm<js!Jblqju!
Ohig<G!R<sqx<!Oxzl<!Hgz<!
Wzk<kqeiz<!uikl<!G{liGl</!!!!!!!!)n/G*!
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24/!gqvil<H!;<<< !
 
Botanical Name : Syzygium aromaticum 
Family : Myrtaceae 
Part used :  Flower bud 
Sju!;!giIh<H!
uQvqbl<!;!ouh<hl<!
hqvqU!;!giIh<H!
Therapeutic actions : Anti-spasmodic, Carminative, Stomachi 
Chemical constituents!;!Essential oil mainly contain eugenol & eugenol acetate, 
                                          beta-caryophyllene 
ohiKG{l<!;<<< !
!!!!!!!!!!!#!hqk<k!lbg<gl<!OhkqObiM!uif<kqb,l<Ohil<!
!!!!!!!!!!!!!Sk<kquqvk<!kgMh<Hs<!Okie<XOli!#!/!
.!ngk<kqbI!G{uigml<!
25/!Ogim<ml<!;< << << < !
Botanical Name : Costus speciosus 
Family : Costaceae 
Part used : Root 
Sju!;!jgh<H?!uqXuqXh<H!
uQvqbl<!;!ouh<hl<!
hqvqU!;!giIh<H!
Therapeutic actions : Tonic, Stimulant, Diaphoretic 
Chemical constituents : Tetracosanoic acid, succinicacid, beta sitosterol 
ohiKG{l<!;!<<< !
!!!!!!!!!!!!#!fim<cZX!oum<jm!fMg<gl<!wEOfib<gt<!
!!!!!!!!!!!!!Ogim<moles<!osie<eiz<!GjzBr<gi{<!.!%m<cx<!
!!!!!!!!!!!!!SvOkimf<!oki{<jmOfib<!Okiziz<!hqk<kl<!
!!!!!!!!!!!!!hvOksl<!OhiOb!hxf<K!#!/!!!!!!!!!!.!ngk<kqbI!G{uigml</!
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26/!g^<K~vq!lR<st<!;< < << < << < < !
Botanical Name : Curcuma aromatica 
Family : Zingiberaceae 
Part used : Rhizome 
Sju!;!jgh<H!
uQvqbl<!;!ouh<hl<!
hqvqU!;!giIh<H!
Therapeutic actions : Carminative, Stimulant 
Chemical constituents!;!Curcumol, tetramethylpyrazine, neocurdione 
ohiKG{l<!;<<< !
!!!!!!!!!!!!!!!!H{<[r<!gvh<hiEl<!Ohigig<!gqVlqgTl<!
!!!!!!!!!!!!!!!!f{<[lf<!kig<gqeqB!fislib<!.!u{<{lzIk<!
!!!!!!!!!!!!!!!!okik<Ok!xtglqe<Oe!Sg<gqzLl<!HkqBlir<!
!!!!!!!!!!!!!!!!g^<K~vq!lR<sTg<Gg<!gi{</!
.!ngk<kqbI!G{uigml</!
27/!fz<oz{<o{b<!;< < << < << < < !!
wt<<<<!
 wt<tqz<!-Vf<K!fz<oz{<o{b<!kbivqg<gh<hMgqxK/!
 Botanical Name : Sesamum indicium 
Family : Pedaliaceae 
Part used : Seed 
Sju!;!-eqh<H!
ke<jl!;!ouh<hl<!
hqvqU!;!-eqh<H!
Therapeutic actions : Demulcent, Nutritive, Laxative 
Chemical constituents!;!2-o-beta-D-glucopyranosyl, 3,4 dihydroxy-8-octadane 
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ohiKG{l<!;<<< !
!!!!!!!!!!!!!!#!g{<[g<G!ytqjbBl<!dmZg<G!ue<jlBl<!kVl<!
!!!!!!!!!!!!!!!!!GVkqh<!ohVg<jg!d{<miGl<!#!/!
!.!ngk<kqbI!G{uigml</!
28/!out<tim<Mh<hiz<!;< < < << < < << < < < !
!!!!!!!!!“sQklkq!siIm<!sqOz]<llXl<!H{<{iXl<!
!!!!!!!!!!uik!sqOz]lLh<Ohi!lib<f<K/!
out<tim<Mh<! hizqeiz<! uik! hqk<k! okif<kl<! ?! Suisgisl<?! sQkikqsivl<?! ghOki]l<?!
uqv{l<?!uikk<kqZ{<migqb!uQg<gl<!Lkzqbe!kQVl</!
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ANNEXURES -I!
TRIAL DRUGS: 
INTERNAL DRUG: VATHATHIRKU LEGHIYAM (Internal) Ref:(Athmaratchamirtham 
Pg 308 ) 
PANCHARKA THYLAM (External) 
Ref:(Agathiar mani ennum vathiya sithamani venba  4000 Pg 99) 
Ingredients 
VATHATHIRKU LEGHIYAM (internal) 
Sl. 
No  
DRUGS BOTANCAL NAME PART 
USED  
AMOUNT 
1 Poondu Allium sativum  Bulb 1 Padi (1440 ml) 
2 Chathipaththiri Myristica fragrans  Aril 5 varagan (21 grm) 
3 Sathikkai  Myristica fragrans Seed 5 varagan (21 grm) 
4 Seeragam Cuminum cyminum Fruit 5 varagan (21 grm) 
5 Kirambu Syzygium aromaticum Flower 
bud 5 varagan (21 grm 
6 Elam Elettaria carda momum Seed 5 varagan (21 grm) 
7 Akkarakaram Anacyclus Pyrethrum Rhizome 5 varagan (21 grm) 
8 Thipilimoolam Piper longum Root 5 varagan (21 grm) 
9 Chukku Zingiber officinale Rhizome 5 varagan (21 grm) 
10 Milagu Piper nigrum  Seed 5 varagan (21 grm) 
11 Thippili Piper longum  Fruit 5 varagan (21 grm) 
12 Omam  Carum copiticum Seed 5 varagan (21 grm) 
13 Parangipattai Smilax China Root 5 varagan (21 grm) 
14 Nilapanaikizhangu Curculigo orchioides  Rhizome 5 varagan (21 grm 
15 Cow Milk     1Padi (1440 ml) 
16 Nei (Ghee)   1Padi (1440 ml) 
17 Then (Honey)   1 Padi (1440 ml) 
  
Dose: Kottaipakalavu (6.022 gm) 
Adjuvant: Milk  
Duration: 40 days  
 
Source of raw drugs: 
  The required raw drugs are purchased from authorized centers and standardized 
before preparing medicines .The raw drugs will be authenticated and then they are purified 
and the medicines are prepared in Gunapadam laboratory of Government Siddha Medical 
College, Palayamkottai. 
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PREPARATION: 
 Boil the Grartic in Cow’s Milk and stir well add the above raw drugs to the above 
boiled milk finally add the Honey & stir well till reaches is consistency  
DRUG STORAGE: 
The trial drug VATHATHIRKU LEGHIYAM is stored in a clean and dry air tight 
container and it is dispensed to the patients in packets. 
EXTERNAL DRUG: 
PANCHARKA THYLAM (External) 
Ref:(Agathiar mani ennum vathiya sithamani venba  4000 Pg 99) 
Ingredients 
Sl. 
No  
DRUGS BOTANCAL NAME PART 
USED  
AMOUNT 
I Erukkam Samoola 
Sarru 
Calotropis gigantea Whole 
Plant  
1Nazhi – 1.34 litre 
 
II Amukkura Withania somnifera Rhizome  5 Palam (175 gm) 
 Murungai Moringa oleifera Bark  5 Palam (175 gm) 
 Veliparuthi Pergularia daemia Leaf  5 Palam (175 gm) 
 Charanai Trianthema Portulacastrum Root 5 Palam (175 gm) 
 Athandai Capparis zeylanica Root  5 Palam (175 gm) 
 Notchi Vitex negundo Leaf  5 Palam (175 gm) 
 Mukkirattai Boerhaavia disffusa Leaf 5 Palam (175 gm) 
 Thanner (water )   1 Nazhi (1.34 litre) 
III Induppu Sodium Chloride impura  1 Palam (35 gm) 
 Thagarai Vithai Cassia tora Seed 1 Palam (35 gm) 
 Kirambu Syzygium aromaticum Fruit  1 Palam (35 gm) 
 Chukku Zingiber offcinale Rhizome 1 Palam (35 gm) 
 Elakkai Elettaria Caradamomum Fruit 1 Palam (35 gm) 
 Kottam Costus specious Root 1 Palam (35 gm) 
 Kathuri Manjal Curcuma aromatic Rhizome 1 Palam (35 gm) 
 Gingely oil Sesamum indicum 
 
5.36 liter 
 Goat’s milks  
 
5.36 liter 
 
METHOD OF PREPARATION  : 
 Add water to no : II ingredients  and make kudineer  
 Grind no : III ingredients and make into Karkam mix colotropis juice to the kudineer 
and  add karkam also. Add gingely oil and white goats’s milk, mix well and boil the oil 
finally filter the oil and keep if for use.   
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DRUG STORAGE:  
The trial drug is stored in a clean dry air tight container and it is given to the patients 
in disposable pet bottles.  
 
INDICATIONS: 
It is indicated externally for Vatha diseases of Joint Pain  
 
DISPENSING : 
 The Leghiyam  are dispensed in airtight packets – Each packet contains 84gms  
 The oil is dispensed in a dry air tight bottles-for their required amount 
 For Outpatient one packet is given for seven days onces. (to be taken thrice daily) 
 For Inpatient every day the medicine packets will be dispensed in person. 
!
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ANNEXURES -II 
QUALITATIVE AND QUANTITATIVE ANALYSIS 
BIO-CHEMICAL ANALYSIS OF VATHATHIRKU LEGHIYAM  
(IN POWDER FORM) 
Preparation of the extract:   
  5gms of the drug was weighed accurately and placed in a 250ml clean beaker.  Then 
50ml of distilled water is added and dissolved well.  Then it is boiled well for about 10 
minutes.  It is cooled and filtered in a 100ml volumetric flask and then it is made  to 100ml 
with distilled water.  This fluid is taken for analysis. 
QUALITATIVE ANALYSIS 
S.NO EXPERIMENT OBSERVATION INFERENCE 
1.  
TEST FOR CALCIUM 
2ml of the above prepared extract is taken in a 
clean test tube to this add 2ml of 4% ammonium 
oxalate solution 
No white 
precipitate is 
formed 
Abesence of    
calcium 
2. 
TEST FOR SULPHATE 
2ml of the extract is added to 5% barrium chloride 
solution. 
A white 
precipitate is 
formed 
Indicates the 
presence of 
sulphate 
3.  
TEST FOR CHLORIDE 
The extract is treated with silver nitrate solution 
A white 
precipitate is 
formed 
Indicates the 
presence of 
chloride 
4. 
TEST FOR CARBONATE 
The substance is treated with concentrated HCL. 
No brisk 
effervescence  is 
formed 
Absence of 
carbonate 
5. 
 
TEST FOR STARCH 
The extract is added with weak iodine solution 
No Blue colour is 
formed 
Absence of starch 
6.  
TEST FOR FERRIC IRON 
The extract is acidified with glacial acetic acid 
and potassium ferro cyanide. 
No blue colour is 
formed 
Absence of ferric 
iron 
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7. 
TEST OF FERROUS IRON  
The extract is treated with concentrated nitric acid 
and ammonium thiocyanide solution 
Blood red colour 
is formed 
Indicates the 
presence of 
ferrous iron 
8.  
TEST FOR PHOSPHATE 
The extract is treated with ammonium molybdate 
and concentrated nitric acid 
No yellow 
precipitate is 
formed 
Absence of 
phosphate 
9.  
TEST FOR ALBUMIN 
The extract is treated with esbach’s reagent 
No Yellow 
precipitate is 
formed 
Absence of 
Albumin 
10.  
TEST FOR TANNIC ACID 
The extract is treated with ferric chloride. 
No blue black 
precipitate is 
formed 
Absence of tannic 
acid 
11.  
TEST FOR UNSATURATION 
Potassium permanganate solution is added to the 
extract 
It gets 
decolourised. 
 
Indicates the 
presence of 
unsaturated 
compound 
12.  
TEST FOR THE REDUCING SUGAR 
5ml of Benedict’s qualitative solution is taken in a 
test tube and allowed to boil for 2 minutes and 
add 8 to10 drops of the extract and again boil it 
for 2 minutes. 
Colour change 
occurs. 
Indicates the 
presence of 
Reducing sugar 
13.  
TEST FOR AMINO ACID 
One or two drops of the extract is placed on a 
filter paper and dried well. After drying, 1% 
ninnhydrin is sprayed over the same and dried it 
well. 
Violet colour is 
formed 
Indicates the 
presence of 
Amino acid 
14. 
TEST FOR ZINC 
The extract is treated with Potassium 
ferrocyanide. 
No white 
precipitate is 
formed 
Absence of Zinc. 
 
Inference:   The given sample of “Vathathirku leghiyam” contains sulphate, 
chloride,ferrous iron,  unsaturated compound, reducing sugar, amino acid. 
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PHARMACOLOGICAL ANALYSIS 
EFFECT OF VATHATHIRKU LEGHIYAM WITH HONEY/GHEE ON ACETIC 
ACID INDUCED WRITHING IN MICE1 
1. Kaneria MS, Naik SR, Kohli RK. Anti-inflammatory,antiarthritic and analgesic 
activity of a herbal formulation. Indian J.Experimental Biol. 2007; 45: 279. 
 
       Acetic acid induced writhing method was adopted for evaluation of analgesic activity. 
Writhing is defined as a stretch, tension to one side, extension of hind legs, contraction of the 
abdomen so that the abdomen of mice touches the floor, turning of trunk (twist). Any 
writhing is considered as a positive response. 
 
MATERIAL AND METHODS 
ANIMALS: 
          Healthy Swiss albino rats of either sex weighing 20-25g were used in this study. All the 
animals were obtained from Animal house of the KMCH College of Pharmacy, Coimbatore. 
The animals were housed comfortably in a group of six in a single clean plastic cage with a 
metal frame lid on its top. They were housed under standard environmental conditions of 
temperature (24±1°C) and relative humidity of 30-70 %. A 12:12 h light dark cycle was 
followed. All animals had free access to water and standard pelletized laboratory animal diet 
ad libitum. All the experimental procedures and protocols used in this study were reviewed 
and approved via the Approval No. ----------------------------- by the Institutional Animal 
Ethical Committee (IAEC) of KMCH College of Pharmacy, Coimbatore 
(685/PO/Re/S/2002/CPSCEA Dated 21st August 2002 constituted in accordance with the 
guidelines of the CPCSEA, Government of India. 
DRUGS: 
         Acetic acid (Sigma Chemical Co. Bangalore, India) and Indomethacin  were purchased 
from (Ranbaxy, India). All drugs were dissolved in saline. The different doses of 
VATHATHIRKU LEGHIYAM were prepared WITH HONEY/GHEE.The control group received 
vehicle as control. All drugs were prepared just before use. 
 PREPARATION OF ACETIC ACID: 
         A solution of acetic acid (1% v/v) in distilled water was prepared. 
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DOSAGE SCHEDULE: 
The required dose for mice/rat will be calculated by using the standard dose calculation 
procedure from recommended clinical dose. 
 
CONVERSION FORMULA: 
Human dose is 6000 mg /kg day 
Total clinical dose (a) x conversion factor (b) 0.018 = (c) per 30 gm of mice 
6000 mg x 2(a) x 0.018 (b) = 108 (c) /30 gm of mice 
108/1000x30 = 3.24 mg  
Experimental Doses Calculated as per the standard procedures are 
 
 
S.No 
 
Groups 
 
Dose /kg, weight 
 
Volume of administration 
 
1 Vehicle Control -- 0.5 ml 
 
2 Therapeutic Dose 3.24 mg /kg 
 
0.5 ml 
3 Middle  Dose   16.2mg/kg 0.5 ml 
4 High Dose 81mg/kg 0.5 ml 
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EXPERIMENTAL PROCEUDRE: 
 
        GROUP 1 – CONTROL (IP injection of 0.1 ml 1% acetic acid) 
       GROUP 2 -- IP injection of 0.1 ml 1% acetic acid + Indomethacin (5mg/kg, i.p) 
       GROUP 3 -- 0.1 ml 1% acetic acid (ip) + VATHATHIRKU LEGHIYAM WITH   
HONEY/GHEE  3.24MG /KG(PO)                        
                                      
       GROUP 4 -- 0.1 ml 1% acetic acid (ip) + VATHATHIRKU LEGHIYAM WITH  
HONEY/GHEE  16.2mg/Kg(Po) 
 
      GROUP 5 -- 0.1 ml 1% acetic acid (ip) + VATHATHIRKU LEGHIYAM WITH  
HONEY/GHEE   81mg/kg(po) 
PROCEDURE: 
            Wister albino mice of either sex were divided into five different groups each 
containing Six animals, the animals were marked individually. Food was withdrawn 12 hours 
prior to drug administration till completion of experiment. The animals were weighed and 
numbered appropriately. The test and standard drugs were given orally. After 60 minutes 
writhing was induced by intra-peritoneal injection of 1% acetic acid in volume of 0.1 ml/10g 
body weight. The writhing episodes were recorded for 30 minutes; stretching movements 
consisting of arching of the back, elongation of body and extension of hind limbs were 
counted. Anti-nociceptive  activity was expressed as the percentage inhibition of abdominal 
constrictions using the ratio:  
             (Control mean – Treated mean) × 100/Control mean 
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EFFECT OF VATHATHIRKU LEGHIYAM WITH HONEY/GHEE ON ACETIC 
ACID INDUCED WRITHING IN MICE1 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by one 
way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, ***P < 0.05 
calculate by comparing treated group with CONTROL group.         
 
GROUP 
 
No of Writhing (30min) 
 
Inhibition (%) 
 
 
CONTROL 
 
 
45.33±4.807 
 
---- 
 
Indomethacin (5mg/kg, i.p) 
 
 
22.67±1.764 
 
49.98 % 
 
VATHATHIRKULEGHIYAM 
0.028mg/kg(po) 
 
 
42.67±1.764 
 
5.86 % 
 
VATHATHIRKULEGHIYAM 
0.014mg/kg(po) 
 
 
31±1.528 
 
31.61 % 
 
VATHATHIRKULEGHIYAM 
0.28mg/kg(po) 
 
 
31.33±1.764 
 
30.88 % 
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EFFECT OF VATHATHIRKU LEGHIYAM WITH HONEY/GHEE ON HOT PLATE 
METHOD IN MICE1 
 
1. Turner RA. Screening methods in pharmacology. In: Turner, R., Hebborn, P. (eds.). 
Academic press, New York. 1965; 100.  
 
            The paws of mice and rats are very sensitive to heat at temperatures which are not                 
damaging the skin. The responses are jumping, withdrawal of the paws and licking of the 
paws. 
 MATERIAL AND METHODS 
ANIMALS: 
          Healthy Swiss albino rats of either sex weighing 20-25g were used in this study. All the 
animals were obtained from Animal house of the KMCH College of Pharmacy, Coimbatore. 
The animals were housed comfortably in a group of six in a single clean plastic cage with a 
metal frame lid on its top. They were housed under standard environmental conditions of 
temperature (24±1°C) and relative humidity of 30-70 %. A 12:12 h light dark cycle was 
followed. All animals had free access to water and standard pelletized laboratory animal diet 
ad libitum. All the experimental procedures and protocols used in this study were reviewed 
and approved via the Approval No. ----------------------------- by the Institutional Animal 
Ethical Committee (IAEC) of KMCH College of Pharmacy, Coimbatore 
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(685/PO/Re/S/2002/CPSCEA Dated 21st August 2002 constituted in accordance with the 
guidelines of the CPCSEA, Government of India. 
      The hot plate, which is commercially available, consists of a electrically heated surface. 
The temperature is controlled for 55° to 56 °C. This can be a copper plate or a heated glass 
surface. The animals are placed on the hot plate and the time until either licking or jumping 
occurs is recorded by a stop-watch. 
 
 
 
 
 
 
 
EXPERIMENTAL PROCEUDRE: 
 
        GROUP 1 – CONTROL  
       GROUP 2 – Pentazocine (10mg/kg, I.P) 
       GROUP 3 -- VATHATHIRKU LEGHIYAM WITH HONEY/GHEE  
                                   3.24 mg /kg(po)           
              
       GROUP 4 – VATHATHIRKU LEGHIYAM WITH HONEY/GHEE     
                                      16.2mg/kg(po) 
 
      GROUP 5 -- VATHATHIRKU LEGHIYAM WITH HONEY/GHEE     
                                      81mg/kg(po) 
 
PROCEUDRE: 
  Mice were screened by placing them on a hot plate maintained at 55±1ºC and 
recording the reaction time in seconds for forepaw licking or jumping. Only mice which 
reacted within 15sec and which did not show large variation when tested on four separate 
occasions, each 15min apart, were taken for the test. The time for forepaw licking or jumping 
on the heated plate of the analgesiometer maintains at 55ºC was taken as the reaction time. 
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Prior to treatment, the reaction time of each mouse (licking of the forepaws or jumping 
response) was done at 0- and 10-min interval. The average of the two readings was obtained 
as the initial reaction time (Tb). The reaction time (Ta) following the administration of the ---
------------, Pentazocine and distilled water was measured at 0.5, 1, 2, and 3h after latency 
period of 30min. 
 
The following calculation was:  
 
          Percentage analgesic activity = Ta-Tb/Tb × 100 
 
 
 
 
 
EFFECT OF VATHATHIRKU LEGHIYAM WITH HONEY/GHEE ON HOT PLATE 
METHOD IN MICE:- 
 
GROUP 
 
Reaction time in seconds at time (minutes) (mean ± sem) (mean ± sem) 
 
O mints 60 mints 90 mints 120 mints 180 mints 
 
CONTROL 
 
3.497±0.1114 
 
4.59±0.165 
 
4.75±0.083 
 
4.87±0.049 
 
4.37±0.098 
 
 
STANDARD 
 
3.413±0.1598 5.77±0.039** 
 
7.077±0.13*** 
 
7.83±0.061*** 
 
6.92±0.22*** 
 
 
V  L + LOW DOSE 
 
3.42±0.1804 
 
7.627±0.15*** 
 
7.65±0.17*** 
 
8.87±0.043*** 
 
7.37±0.11*** 
 
 
V L  + MIDDLE DOSE   
 
3.613±0.06888 
 
7.37±0.23*** 
 
8.59±0.168*** 
 
7.82±0.118*** 
 
8.66±0.14*** 
 
 
V L+ HIGH DOSE 
 
3.453±0.1642 
 
6.5±0.115*** 
 
7.13±0.072*** 
 
7.48±0.18*** 
 
7.50±0.27*** 
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated 
by one way ANOVA  followed by dunnett’s ***P< 0.001, **P < 0.01,*P < 0.05 
calculated by comparing treated group with CONTROL group. 
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EFFECT OF VATHATHIRKU LEGHIYAM WITH HONEY/GHEE ON 
CARRAGEENAN-INDUCED LOCALISED INFLAMMATORY PAIN IN RATS 
SUMMARY 
  The study plan was developed based on the guidelines of Vogel1 and also it has 
reference to Chao Ma and Jun-Ming Zhang2 and Walker et al. 3, Winter CA, Risley EA, Nuss 
GW. Carrageenin induced edema in hind paw of the rat as an assay for anti-inflammatory 
drugs. Proc Soc Exp Biol Med. 1962;111:544–7. 
Objective 
To study the anti-inflammatory effect of VATHATHIRKU LEGHIYAM were prepared WITH 
HONEY/GHEE in the rat model of Carrageenan-induced localized inflammation.  
Methods: 
Test System 
Species : Rat   
Strain : Albino Wister 
Age : 6-8 weeks at the time of dosing 
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Total no. of Rats : 24 
Sex : Male 
Weight                   :    150 gm 
 The animals were housed in polypropylene cages with stainless steel top grills having 
facilities for holding pellet food and drinking water in bottle with stainless steel sipper tube. 
Each cage contained 6 rats. All rats had free access to potable water and standard pelleted 
laboratory animal diet ad libitum. Paddy husk was used as bedding material. The animals 
were divided into 5 groups (6 rats/group). Localized inflammatory pain was induced in all 
groups of animals by intraplantar injection of carrageenan (50 µl of 3% suspension).  
 
 
 One day before the experiment, three basal readings of hind paw in each rat were 
recorded. Group 1 received vehicle orally, Group 2 received a standard drug Diclofenac 
sodium (10 mg/kg i.p), whereas groups 3,4and 5 received VATHATHIRKU LEGHIYAM. The 
doses of VATHATHIRKU LEGHIYAM were prepared WITH HONEY/GHEE, whereas Diclofenac 
sodium was dissolved in normal saline. After 30 min, the rats were challenged with 
subcutaneous injection of 0.1 ml of 1% w/v solution of carrageenan into the sub plantar 
region of left paw. The paw was marked with ink at the level of lateral malleolus and 
immersed in mercury up to the mark. The paw volume was measured at 0, 1, 2, 3, 4, 5 and 6th 
hr after carrageenin injection using Digital Plethysmometer. The difference between initial 
and subsequent reading gave the actual edema volume.  
DOSAGE SCHEDULE: 
  The required dose for mice/rat will be calculated by using the standard dose 
calculation procedure from recommended clinical dose. 
 
CONVERSION FORMULA: 
Human dose is 6000 mg /kg day 
Total clinical dose (a) x conversion factor (b) 0.018 = (c) per 150 gm of Rat 
6000 mg x 2(a) x 0.018 (b) = 108 (c) /150 gm of Rat 
108/1000x150 = 16.2 mg  
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Experimental Doses Calculated as per the standard procedures are 
 
S.No 
 
Groups 
 
Dose /kg, weight 
 
Volume of administration 
 
1 Vehicle Control -- 
1 ml 
 
2 Therapeutic Dose 
16.2 mg /kg 
 
1 ml 
3 Middle  Dose 81mg/kg 
1 ml 
 
4 High Dose 405mg/kg 1 ml 
EXPERIMENTAL DESIGN: 
Group-I:   Served as a negative control (0.1ml of 1% carrageenin) 
Group-II: Served as standard received Diclofenac sodium (10mg/kg, i.p) + 
                  (0.1ml of 1% carrageenin) 
Group-III: Received VATHATHIRKU LEGHIYAM were prepared WITH HONEY/GHEE  
        (16.2 mg /kg) + (0.1ml of 1% carrageenin) 
Group IV: Received VATHATHIRKU LEGHIYAM were prepared WITH HONEY/GHEE  
                   (81 mg/kg ) + (0.1ml of 1% carrageenin) 
Group V: Received VATHATHIRKU LEGHIYAM were prepared WITH HONEY/GHEE  
                   (405 mg/kg ) + (0.1ml of 1% carrageenin) 
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TABLE: EFFECT OF VATHATHIRKU LEGHIYAM WITH HONEY/GHEE ON Carrageenin -
INDUCED PAW EDEMA IN RATS (BODY WEIGHT in gms) 
 
Group 
 
Only 
Carrageenin 
Carrageenin + 
STD 
Carrageenin + 
L.D 
Carrageenin 
+ M.D 
Carrageenin 
+ H.D 
 
INITIAL 
BODY 
WEIGHT 
156.7±1.333 
 
142.3±28.48 
 
161±4.973 
 
166.3±2.813 
 
151.5±3.191 
 
 
Values are expressed as the mean ± S.D. Statistical significance (p) calculated by one 
way ANOVA  followed by dunnett’s. ns- not significant **P< 0.05 calculated by comparing 
treated group with control group. 
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TABLE: EFFECT OF VATHATHIRKU LEGHIYAM WITH HONEY/GHEE ON Carrageenin -
INDUCED PAW EDEMA IN RATS 
 
Values are expressed as the mean ± S.D. Statistical significance (p) calculated by one way 
ANOVA  followed by dunnett’s. ns- not significant **P< 0.05 calculated by comparing 
treated group with control group. 
 
 
 
 
Group 
Mean paw 
volume before 
Carrageenin 
injection 
Paw Volume after induction with   Carrageenin 
Increase in paw volume (ml) after   Carrageenin   injection (mean ± SEM)/Percent   
inhibition of edema 
0 min 30 min 1h 2h 3h 4h 5h 6h 
 
Control 
 
4.105± 
0.1627 
 
7.425± 
0.1594 
 
7.483± 
0.1429 
 
8.348± 
0.2079 
 
8.39± 
0.1014 
 
7.86± 
0.0801 
 
8.283± 
0.2986 
 
7.913± 
0.2277 
 
Standard 
 
4.085± 
0.1617 
 
7.033± 
0.1053 
 
7.813± 
0.1993 
 
7.79± 
0.249 
 
7.958± 
0.2091 
 
7.788± 
0.1251 
 
6.033± 
0.1574 
 
5.663± 
0.2765 
 
LD 
 
3.698± 
0.258 
6.973± 
0.1963 
 
 
7.648± 
0.1579 
8.153± 
0.2022 
 
8.105± 
0.1269 
 
 
7.448± 
0.2509 
 
6.638± 
0.3813 
 
6.1± 
0.2967 
 
MD 
 
4.283± 
0.09437 
 
7.068± 
0.1006 
 
7.488± 
0.2231 
 
7.8± 
0.1545 
 
8.16± 
0.1066 
 
7.75± 
0.03764 
 
6.235± 
0.1546 
 
5.49± 
0.1828 
HD 4.028± 
0.2623 
7.108± 
0.3236 
7.66± 
0.3129 
 
6.893± 
0.3936** 
 
7.335± 
0.2522** 
 
6.94± 
0.1685 
 
6.17± 
0.1339 
 
5.003± 
0.2594 
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FIG: EFFECT OF VATHATHIRKU LEGHIYAM WITH HONEY/GHEE ON CARRAGEENIN-
INDUCED PAW EDEMA IN RATS 
 
                 
           GROUP – I ONLY CARRAGEENIN                              GROUP –II CARRAGEENIN + STD                 
               
              GROUP –III CARRAGEENIN + L.D                  GROUP –IV CARRAGEENIN +MD                     
  
GROUP –V CARRAGEENIN + H D 
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ACUTE TOXICITY STUDY IN FEMALE WISTER RATS TO EVALUATE 
TOXICITY PROFILE OF VATHATHIRKU LEGHIYAM WITH HONEY/GHEE 
 
Table 1. Test substance details 
Name of the test substance 
 
VATHATHIRKU LEGHIYAM  
With Honey/Ghee 
Colour of the test substance -Light brown 
Nature of the test substance Powder 
 
Table 2. Experimental protocol 
Name of the study Acute toxicity 
Guideline followed OECD 423 method-acute toxic class method 
Animals Healthy young adult female wister rats, 
nulliparous, non-pregnant 
Body weight 150-200 g 
Sex                       female 
Administration of dose and volume 6000 mg/kg in 200g body weight, single 
dose in 1 ml 
Number of groups and animals 
5 groups and 3 animals in each group 
1000,2000,3000,5000and 6000mg/kg 
Route of administration Oral Cavage (po) 
Vechicle Honey/Ghee 
 
Table3. Housing and feeding conditions 
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Room temperature 22°C  ±  3°C 
Humidity 40-60% 
Light 12 h : 12h (light : dark cycle) 
Feed 
Standard laboratory animal food pellets 
with water ad libitum 
Table 4. Study period and observation parameters 
Initial once observation First 30 minutes and periodically 24 h 
Special attention First 1-4 h after drug administration 
Long term observation Upto 14 days 
Direct observation parameters 
Tremors, convulsions, salivation, diarrhea, 
lethargy, sleep and coma. 
Additional observation parameters 
Skin and fur, eyes and mucous membrane, 
respiratory, circulatory, autonomic and 
central nervous systems, somato motor 
activity and behavior pattern etc. 
  
The time of death, if any, is recorded. (Complete observations: annexure I). After 
administration of the drug, food is withheld for a further 1-2 hours. 
Study procedure 
Acute oral toxicity was performed as per organization for economic co-operation for 
development (OECD) guideline 423 method. The VATHATHIRKU LEGHIYAM With 
Honey/Ghee was administered in a single dose by tuberculin syringe. Animals are fasted 3 h 
prior to dosing (food was withheld for 3 h but not water). Following the period of fasting 
animals was weighed and test substance was administered orally at a dose of 
1000,2000,3000,5000 and 6000mg/kg. After the VATHATHIRKU LEGHIYAM With 
Honey/Ghee administration, food was withheld 2 h in mice. Animals are observed 
individually after at least once during the first 30 minutes, periodically during the first 24 hrs, 
with special attention given during the first 4 hrs, and daily thereafter, for a total of 14 days.  
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REPORT 
Toxicological evaluation of VATHATHIRKU LEGHIYAM with Honey/Ghee 
Table:5 Effect of VATHATHIRKU LEGHIYAM  With Honey/Ghee on acute 
toxicity test in female rats. 
 
RESULT: 
  From acute toxicity study it was observed that the administration of 
VATHATHIRKU LEGHIYAM with Honey/Ghee to Female Wister rats did 
not induce drug-related toxicity and mortality in the animals up to 6000mg/kg in 
200g female Wister rats. So No-Observed-Adverse-Effect- Level (NOAEL) of  
S.N 
 
 
Response 
Head Body Tail 
Before After Before After Before After 
1 Alertness Normal Normal Normal Normal Normal Normal 
2 Grooming Absent Absent Absent Absent Absent Absent 
3 Touch response Absent Absent Absent Absent Absent Absent 
4 Torch response Normal Normal Normal Normal Normal Normal 
5 Pain response Normal Normal Normal Normal Normal Normal 
6 Tremors Absent Absent Absent Absent Absent Absent 
7 Convulsion Absent Absent Absent Absent Absent Absent 
8 Righting reflux Normal Normal Normal Normal Normal Normal 
9 Gripping strength Normal Normal Normal Normal Normal Normal 
10 Pinna reflux Present Present Present Present Present Present 
11 Corneal reflux Present Present Present Present Present Present 
12 Writhing Absent Absent Absent Absent Absent Absent 
13 Pupils Normal Normal Normal Normal Normal Normal 
14 Urination Normal Normal Normal Normal Normal Normal 
15 Salivation Normal Normal Normal Normal Normal Normal 
16 Skin colour Normal Normal Normal Normal Normal Normal 
17 Lacrimation Normal Normal Normal Normal Normal Normal 
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VATHATHIRKU LEGHIYAM  with Honey/Ghee is 6000 mg/kg equal to 
human dose 
DISCUSSION 
VATHATHIRKU LEGHIYAM with Honey/Ghee was administered 
single time at the doses of 1000,2000,3000,5000 and 6000mg/kg to female Wister 
rats and observed for consecutive 14 days after administration. Doses were 
selected based on the pilot study and literature review. All animals were 
observed daily once for any abnormal clinical signs. Weekly body weight and 
food consumption were recorded. No mortality was observed during the entire 
period of the study. Data obtained in this study indicated no significance 
physical and behavioral signs of any toxicity due to administration of 
VATHATHIRKU LEGHIYAM with Honey/Ghee at the doses of 
1000,2000,3000,5000 and 6000mg/kg to female Wister rats  
At the 14th day, all animals were observed for functional and behavioral 
examination. In functional and behavioral examination, home cage activity, 
hand held activity were observed. Home cage activities like Body position, 
Respiration, Clonic involuntary movement, Tonic involuntary movement, 
Palpebral closure, Approach response, Touch response, Pinna reflex, Sound 
responses, Tail pinch response were observed. Handheld activities like 
Reactivity, Handling, Palpebral closure, Lacrimation, Salivation, Piloercetion, 
Papillary reflex, abdominal tone, Limb tone were observed. Functional and 
behavioral examination was normal in all treated groups. Food consumption of 
all treated animals was found normal as compared to normal group. 
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SUMMARY & CONCLUSION: 
Summary: 
The present study was conducted to know single dose toxicity of 
VATHATHIRKU LEGHIYAM with Honey/Ghee on female Wister rats. The 
study was conducted using 15 female Wister rats. The female animals were 
selected for study of 8- 12 weeks old with weight range of within ± 20 % of 
mean body weight at the time of randomization. The groups were numbered as 
group I, II, III, IV and V and dose with 1000,2000,3000,5000 and 6000mg/kg of 
VATHATHIRKU LEGHIYAM with Honey/Ghee. The drug was 
administered by oral route single time and observed for 14 days. Daily the 
animals were observed for clinical signs and mortality.  
There were no physical and behavioral changes observed in Female 
Wister rats during 14 days. Mortality was not observed in any treatment groups. 
Conclusion: 
The study shows that VATHATHIRKU LEGHIYAM with 
Honey/Ghee did not produce any toxic effect at dose of 1000,2000,3000,5000 and 
6000mg/kg to rats. So No-Observed-Adverse-Effect-Level (NOAEL) of 
VATHATHIRKU LEGHIYAM with Honey/Ghee is 6000 mg/kg. 
7.0 ABBREVIATIONS 
No.   Number 
Mg  Milligram 
Kg   Kilogram 
LD50  Lethal Dose 50 
p.o  peros 
ML  Milliliter 
%   percentage 
R&D   Research and Development 
g%   Gram percentage 
g  Gram 
NOAEL  No-Observed-Adverse-Effect-Level 
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MLD   Minimum Lethal Dose 
MTD   Maximum Tolerated Dose 
OECD Organisation of Economic Co-operation and Development 
CPCSEA  Committee for the Purpose of Control and Supervision of 
Experiments on Animals 
 
 
8.0 REFERENCES: 
 
1. OECD. Guideline for Testing of Chemicals 423, Acute oral toxicity (acute toxic 
class method). December 2001. 
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SUB-ACUTE TOXICITY STUDY IN WISTER RATS TO EVALUATE 
TOXICITY PROFILE OF VATHATHIRKU LEGHIYAM WITH 
HONEY/GHEE  
Objective 
 The objective of this study is to evaluate the toxic effects, if any, as a result of the 
repeated once daily oral administration of VATHATHIRKU LEGHIYAM WITH 
HONEY/GHEE to Wister Albino rats for a minimum period of 28 consecutive days. 
This study will provide information on any major toxic effects, target organs and a 
rationale for concluding the No-Observed-Adverse-Effect-Level (NOAEL) and/or No 
Observed Effect Level (NOEL) / LOEL (Low Observed Effect Level) and risk 
assessment in humans. 
1. Test Guidelines  
This study plan is prepared as per the following guidelines: 
Schedule – Y, Amendment version 2005, Drugs and Cosmetics Rules, 1945. 
OECD – 407 – Repeated dose 28-day Oral Toxicity Study in Rodents, Adopted 3 
October, 2008. 
1.1. Test System Details 
Species : Rat 
Strain  : Wister Albino  
Source    : Sree Venkateshwara Enterprises Pvt Ltd, Bangalore  
Age : 6-8 weeks  
Sex : Male / Female (nulliparous and non-pregnant) 
Body weight   : 160.0to 180.0 g 
1.2.  Acclimatization 
Animals will be allowed to acclimatize to the experimental room conditions for five 
days prior to the commencement of dosing. During the acclimatization period, the 
animals will be observed daily for any apparent adverse clinical signs. Prior to 
assignment to the study and commencement of treatment, a detailed physical health 
examination will be performed on all animals by a veterinarian and animals with any 
evidence of ill health or poor physical condition will not selected for the study. 
137 
 
1.3. Randomization and Grouping 
On the starting day of dosing, the animals will be weighed and health examination 
will be performed by veterinarian. Animals will be randomly allocated to different 
groups according to their body weight by using MS-Excel sheet as described in the 
randomization SOP. Animals will be divided into four groups (vehicle control, low, 
intermediate, and high dose). At the initiation of the treatment, the body weight 
variation between the groups did not exceed ±20% of the mean weight of each sex. 
1.4. Animal Identification 
In each cage, animals will be identified with numbers by marking at the base of the 
ear. The cages will be identified with an attached colored cage label showing study 
number, study code, group number, sex, dose, strain, species, cage number, route of 
administration and animal number. 
2. Animal Husbandry 
2.1. Animal Welfare and approval 
The study was approved by the IAEC (SLS) and Committee for the Purpose of 
Control and Supervision of Experiments on Animals (CPCSEA registration number: 
Abc14).Their recommendations regarding animal care and handling will be followed. 
2.2. Environmental Conditions 
The temperature of the experimental room will be maintained at 22±30C and the 
relative humidity between 30-70 %. The photoperiod will be 12 hours light and 12 
hours dark cycles  
2.3. Housing Conditions 
Two animals will be housed in autoclaved polypropylene rat cages (Size in mm=L x 
W x H: 430 x 290 x 160) using paddy husk as the bedding material. Each cage will be 
fitted with a top grill having provision for keeping rodent pellet feed and an 
autoclaved polypropylene water bottle with stainless steel drinking nozzle. Cages will 
be placed on 3-tier racks and cage rotation will be performed every week. Cages will 
be changed at least twice a week. The cages and water bottles will be cleaned and 
autoclave sterilized. 
2.4. Sanitation 
Each day, the floor of the animal room will be swept and mopped. Cages and bedding 
material will be changed once in three days and water bottles will be changed daily. 
All the experimental procedures will be done in a clean environment. 
2.5. Feed 
The experimental animals will be provided with irradiated rodent pellet feed ad 
libitum supplied from Sai feeds Pvt ltd, Chennai . Feed will be withheld for four hours 
prior to blood collection and necropsy. 
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2.6. Drinking Water 
Animals will be provided with filtered drinking water ad libitum  passed through 
water filter system (Aquaguard™) in autoclaved polypropylene bottles. Water bottles 
will be changed daily. Microbial analysis of water will be carried out once monthly 
and the report is maintained in the study file. 
3. Personnel Safety 
All personnel handling animals undergo regular medical examination. Protective clothing 
like apron, face mask, head cap, and gloves will be used to maintain hygienic conditions. 
4. Materials and Methods  
4.1. Preparation of Dose formulation 
The dose formulation will be prepared under aseptic conditions as per SLS, SOP.  
4.2. Route of Administration and Justification 
Administration will be by oral gavage, as it is one of the possible routes of exposure. 
4.3. Frequency and Duration of Administration  
Once daily for 28 consecutive days 
4.4. Dosing Procedure 
The test item will be administered in once daily by oral gavage using a suitable 
intubation cannula fitted with a graduated syringe. The scheme of dosing and 
sacrifice time points are presented in the below below Table. 
4.5. Experimental Procedures 
All experimental procedures will be performed in accordance with the Study plan 
and Standard Operating Procedures (SOPs) of SLS. 
4.6 DOSAGE SCHEDULE: 
The required dose for mice/rat will be calculated by using the standard dose calculation 
procedure from recommended clinical dose. 
CONVERSION FORMULA: 
Human dose is 6000 mg /kg day 
Total clinical dose (a) x conversion factor (b) 0.018 = (c) per 150 gm of Rat 
6000 mg x 2(a) x 0.018 (b) = 108 (c) /150 gm of Rat 
108/1000x150 = 16.2 mg  
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Experimental Doses Calculated as per the standard procedures are 
 
S.No 
 
Groups 
 
Dose /kg, weight 
 
Volume of administration 
 
1 Vehicle Control -- 1 ml 
 
2 Therapeutic Dose 16.2 mg /kg 
 
1 ml 
3 Middle  Dose 81mg/kg 1 ml 
 
4 High Dose 405mg/kg 1 ml 
 
 
Experimental Design 
 
 
 
Group 
No. Group 
Dose                          
(mg/kg  
b.wt /day) 
No. of Animals 
Male Female 
G1 Vehicle control HONEY/GHEE 5 5 
G2 Low dose of  VATHATHIRKU 
LEGHIYAM WITH HONEY/GHEE 
               
16.2m g /kg 
 
5 5 
G3 Intermediate dose VATHATHIRKU 
LEGHIYAM WITH HONEY/GHEE   
81mg/kg 5 5 
G4 High dose  VATHATHIRKU 
LEGHIYAM WITH HONEY/GHEE   
405mg/kg 5 5 
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5. Observations 
Animals will be observed daily throughout the treatment period at regular intervals. 
During the treatment period, animals will be observed twice daily for any clinical signs of 
toxicity, morbidity and mortality. All the surviving animals will be sacrificed at the end of 
scheduled period and subjected to gross necropsy and histopathological evaluations. 
5.1.Clinical Signs 
All the animals will be subjected to cage-side (home-cage) observations twice a day 
for any clinical signs of toxicity, preferably at the same time each day and considering 
the peak period of anticipated effect. In addition to home cage observations, a detailed 
clinical examination will be performed once prior to dosing and weekly thereafter 
during treatment period.  
5.2. Morbidity/ Mortality 
All animals will be examined twice a day for mortality and signs of morbidity.  
5.3. Body Weights 
Body weights will be recorded at the beginning of acclimatization, before 
randomization, there after at weekly intervals and at the time of necropsy. 
5.4. Feed Consumption 
Feed consumption will be calculated on a weekly basis throughout the study period. 
5.5. Hematology and Clinical Biochemistry  
Hematology and clinical biochemistry tests will be performed with terminally 
collected blood samples on day-29 from all animals. Animals will be deprived of feed 
overnight and blood samples will be collected by tapping the ear for visibility of the 
vein site and inserted the needle into the marginal ear vein and collected the blood 
into micro centrifuge tube. Approximately 0.5 ml of blood will be collected in vials 
containing 1% EDTA (20µl) as an anticoagulant for hematological analysis. 
Approximately 2 ml blood will be collected from each animal in micro centrifuge 
tubes containing 15µl of heparin (19 units) and the plasma will be separated by 
centrifugation at 4000 rpm for ten minutes at 4oC. The plasma will be stored at -20 oC 
± 2 and used for all clinical chemistry analysis. 
5.6. Hematology 
Erythrocyte count (RBC), Total Leucocyte count (WBC), Hemoglobin (Hb), 
Hematocrit (HCT), Mean Corpuscular Volume (MCV), Mean Corpuscular 
Hemoglobin (MCH), Mean Corpuscular Hemoglobin Concentration (MCHC) and 
Platelet (PLTC). 
141 
 
5.7. Clinical Biochemistry  
Glucose, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), 
Alkaline phosphatase (ALP), Total protein, Albumin, Creatinine, Urea, Cholesterol, 
Triglycerides, Sodium, Potassium, Calcium, and  Chloride. 
5.8 Pathology 
All animals will be euthanized by CO2 asphyxiation and subjected to necropsy under 
the supervision of the veterinary pathologist. Different tissues/organs of thoracic, 
abdominal and cranial cavities will be examined for any gross pathological changes. 
Tissues from vehicle control and high dose groups will be subjected to detailed 
histopathological analysis (Ovaries/ testes,  kidneys, liver, lungs). The organs will be 
fixed using Bouin’s (reproductive organs) and 10% neutral buffered formalin 
(kidneys, liver, spleen, lungs).Processing of tissue will be done by spin tissue 
processer, embedding of the tissue by tissue embedder. The tissues will be initially 
trimmed to 10-20µ thickness and later 3-6µ to obtain thinner tissue sections by using 
rotary microtome. Haematoxylin and Eosin staining will be performed for all tissues. 
5.8. Organ Weights 
Absolute weights of adrenal glands, brain, ovaries/testes, epididymis/uterus, heart, 
kidneys, liver, spleen and lungs will be recorded for all the animals after trimming 
adherent tissue immediately after dissection from the animal. Paired organs will be 
weighed together. Relative weights of these organs against fasting animal body 
weights will be calculated and reported. 
6. Data Compilation  
Data will be summarised in a tabular form showing the number of animals, experimental 
design, dose groups, dose volume and concentrations, test item and vehicle control 
details. All findings like clinical signs, mortality and morbidity data, time of death, body 
weights, feed consumption, clinical signs, and necropsy and pathology observations will 
be recorded and given in the final report. One original copy of the final report is issued to 
the sponsor.  
7. Statistical Analysis 
All the parameters of treated groups of both sex, viz. body weight, feed consumption, 
organ weights (absolute and relative), biochemical parameters, and hematology 
parameters will be analyzed using SPSS software, version 16.0 by using one-way 
ANOVA test with multiple comparison (vehicle controls treated groups) in the study 
report, and p value < 0.05 is considered as statistically significant.  
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MATERIALS AND METHODS 
         ESTIMATION OF HEMATOLOGICAL PARAMETERS: 1 
Collection of blood for hematological studies 
After the treatment period the animals were anaesthetized by ketamine hydrochloride and the 
blood was collected from Retro-orbital sinus by using capillary into a centrifugation tube which 
contains EDTA for haematological parameters The haematological parameters like RBC, WBC 
and Hb percentage, Differential cell count, MCV, MCHC, Hematocrit, MCH, platelet count were 
estimated by the following procedures. 
1. ENUMERATION OF RED BLOOD CELLS: 1    Ramnic 2007) 
Reagents : RBC diluting fluid 
       Procedure: 
         Using a red blood cell pipette of haemocytometer, well mixed blood was drawn up to 0.5 mark and RBC 
diluting fluid was taken up to mark II. The fluid blood mixture was shaken and transferred onto the counting 
chamber. The cells were allowed to settle to the bottom of the chamber for 2 min. See the fluid does not get 
dried. Using 45X or high power objective the RBC’s were counted uniformly in the larger corner squares.   
The cells were expressed as number of cells x1012/l 
2. ENUMERATION OF WBC: 2    John 1972) 
      Reagents: 
 Turk’s fluid: Turk’s fluid was prepared by mixing 2ml of acetic acid with 100 ml of distilled 
water. To this 10 drop of aqueous methylene blue 3 %    w/v) was added. This solution haemolysis the 
red cells due to acidity so that counting of white cells becomes easy. 
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Procedure:     
              Using a white blood cell pipette of haemocytometer, well mixed blood was drawn up to 0.5 mark and 
WBC diluting fluid was taken up to mark II. The fluid blood mixture was shaken and transferred onto the 
counting chamber. The cells were allowed to settle to the bottom of the chamber for 2 min. See the fluid does 
not get dried. 
 Using 10X or low power objective the WBC’s were counted uniformly in the larger corner squares.  
 The cells were expressed as number of cells/10mm. 
3. DIFFERENTIAL LEUCOCYTE COUNT: 3      John 1972) 
Reagent: 
              Leishmann’s stain: 150mg of powdered leishmann’s stain was dissolved in 133ml of acetone free 
methanol. 
Procedure: 
 A blood film stained with leishmann’s stain was examined under oil immersion and the different types 
of WBCs were identified. The percentage distribution of these cells was then determined. Smears were made 
from anticoagulant blood specimens and stained with leishmann’s stain. The slides were preserved for counting 
the number of lymphocytes and neutrophils, per 100 cells were noted.  
 From the different Leukocyte count and WBC count, absolute lymphocyte and neutrophil count were 
calculated. 
                                 Number of neutrophils  
 Absolute neutrophil count =   _______________________________   x  TWBC 
                             100  
                                                                  Number of lymphocytes  
 Absolute lymphocyte count =   _______________________________ x TWBC 
                             100 
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DETERMINATION OF BIOCHEMICAL PARAMETERS: 
 
For assessment of biochemical parameters, blood samples were collected from the animals by puncturing 
the retro-orbital plexus and centrifuged. The serum collected after centrifugation was analyzed for various 
biochemical parameters like SGOT, SGPT, ALP,TC.TG,HDL All of the above biochemical parameters were 
estimated using semi autoanalyzer (Photometer 5010 V5+, Germany) with enzymatic kits procured from Piramal 
Healthcare limited, Lab Diagnostic Division, Mumbai, India. 
1. Total Cholesterol (TC)  
 Principle 
Determination of cholesterol is done after enzymatic hydrolysis and oxidation. The colorimetric indicator is 
quinoneimine, which is generated from 4-aminoantipyrine and phenol by hydrogen peroxide under the catalytic 
action of peroxidase (trinder’s reaction). 
Cholesterol ester + H2O       CHE       Cholesterol + Fatty acid 
Cholesterol + O2          CHO      Cholesterol-3-one +H2O2 
2H2O2  + 4- Amino antipyrine + Phenol      POD          Quinonelimine + 4 H2O2 
Method  
 CHOD-PAP: Enzymatic photometric test 
Table 6: Reagents 
Goods buffer (pH 6.7) 50 mmol/ l 
Phenol 5 mmol/l 
4-aminoantipyrine 0.3 mmol/l 
Cholesterol estrase >  200 U/l 
Cholesterol oxidase >  100 U/l 
Peroxidase 3 KU/l 
Standard (5.2 mmol/l) 
 
Assay procedure 
a. 1 ml (1000 µl) of reagent-1 is taken in a 5 ml test tube. 
b.  Added 0.01 ml (10 µl) of serum. 
c. Mixed well and incubated at 37◦C   for 5 min. 
d. Read the test sample. 
NORMAL RANGE: < 200 mg/dl in serum.      
1. Deeg R, Ziegenhorn J, Kinetic enzymatic method for automated determination of total cholesterol in 
serum, Clin. Chem., 1983, 29:1798-802. 
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2. Triglycerides 
Principle 
Determination of triglycerides (TG) alters enzymatic splitting with lipoprotein lipase. Indicator is 
quinoneimine which is generated from 4-aminoantipyrine and 4- chlorophenol by hydrogen peroxidase under 
the catalytic action of peroxidase. 
Triglycerides              LPL           Glycerol + fatty acid 
Glycerol + ATP              GK            Glycerol-3-phosphate+ ADP 
Glycerol-3-phosphate +O2         GPO         Dihydroxyaceton phosphate + H2O2 
2H2O2  + 4- Amino antipyrine + 4- chlorophenol         POD     Quinonelimine + HCL + 4H2O2 
Method 
 Colorimetric enzymatic test using glycerol-3-phosphate-oxidase (GPO). 
Reagents 
Components and concentrations in the test Goods buffer pH 7.2, 50 mmol/ l 
Table 7: Reagents 
4-chloroPhenol 4 mmol/l 
ATP 2 mmol/l 
Mg2+ 15 mmol/l 
Glycerokinase > 0.4 Kµ/l 
Peroxidase > 2 Kµ/l 
Lipoprotein lipase > 4 Kµ/l 
4-aminoantipyrine 0.5 mmol/l 
Glcerol-3-phosphate- oxidase > 1.5Kµ/l 
Standard (2.3 mmol/l) 
 
Assay procedure 
a.  1 ml (1000 µl) of reagent-1 is taken in a 5 ml test tube. 
b. Added 0.01 ml (10 µl) of serum. 
c. Mixed well and incubated at 37◦C for 15 min. 
d. Read the test sample. 
 Normal Range: < 200 mg/dl in serum. 
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1. Cole T.G, Klotzsch S.G, Mcnarmara J, Measurement of triglyceride concentration, In Rifai N, Warnick 
G.R, Dominiczak M.H, Handbook of lipoprotein testing, Washington:AACC, Press, 1997, 115-26. 
3. HDL Cholestrol 
 Principle  
Chylomicrons, VLDL and LDL are precipitated by adding phosphotungstic acid and magnesium ions to the 
sample. Centrifugation leaves only the HDL in the supernatant. The cholesterol content in it is determined 
enzymatically. 
Method 
Phosphotungstic acid precipitation method. 
Table 8: Reagents 
Phosphotungstic acid 0.55 mmol/l 
Magnesium chloride 25 mmol/l 
Assay procedure 
A.  Preparation of supernatant for the HDL-CHL estimation 
    Added 200 µl of serum to the 500 µl of HDL-Cholesterol precipitating reagent (from HDL kit) in 1.5 ml 
centrifuge tube and mixed well. Centrifuged the above solution at 4000 rpm for 10 min. 
B. Preparation of test sample for the estimation of HDL-Cholesterol 
a. Taken 1000 µl of reagent-1 (from cholesterol kit) in a 5 ml test tube. 
b. Added, 100 µl of supernatant from above centrifuged solution 
c. Mixed well and incubated at 37◦C for 15 min. 
d. Read the test sample.  
Normal Range: > 60 mg/dl in serum. 
1. Friedewald W.T, Levy R.T, Frederickson D.S, Estimation of VLDL and LDL cholesterol, Clin. Chem., 
1972, 18:499-502. 
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4. ESTIMATION OF SERUM GLUTAMATE PYRUVATE TRANSAMINASES 
(SGPT/ ALT) 
1. Determination of aspartate aminotransferase (AST) 
      Aspartate aminotransferase, also known as Glutamate Oxaloacetate Transaminase 
(GOT) catalyses the transamination of L-aspartate and α keto glutarate to form oxaloacetate 
and L- glutamate. Oxaloacetate formed is coupled with 2,4- Dinitrophenyl hydrazine to form 
hydrazone, a brown coloured complex in alkaline medium which can be measured 
colorimetrically. 
Reagents  
  Buffered aspartate  (pH 7.4); 2,4- DNPH reagent;  4N sodium hydroxide;  working 
pyruvate standard; solution I (prepared by diluting 1 ml of reagent 3 to 10 ml with purified 
water). 
Procedure  
 Rietman and Frankle method was adopted for the estimation of SGOT. (Reitmann S, 
Frankel S, 1957. A colorimetric method for the determination of serum oxaloacetic and 
glutamic pyruvate transminases. American Journal of Clinical Pathology.28: 56-63.The 
reaction systems used for this study included blank, standard, test (for each serum sample) 
and control (for each serum sample). 0.25 ml of buffered aspartate was added into all the test 
tubes. Then 0.05 ml of serum was added to the test group tubes and 0.05 ml of working 
pyruvate standard into the standard tubes. After proper mixing, all the tubes were kept for 
incubation at 37oC for 60 min, after which 0.25 ml each of 2,4- DNPH reagent was added 
into all the tubes. Then, 0.05 ml of distilled water and 0.05 ml of each serum sample was 
added to the blank and the serum control tubes respectively. The mixture was allowed to 
stand at room temperature for 20 min. After incubation, 2.5 ml of solution I was added to all 
test tubes. Mixed properly and optical density was measured in a spectrophotometer at 505 
nm within 15 min. 
The enzyme activity was calculated as:-  
AST (GOT) activity in IU/L) = [(Absorbance of test - Absorbance of control)/ (Absorbance 
of standard - Absorbance of blank)] x concentration of the standard         
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2.  Determination of alanine aminotransferase (ALT) 
 Alanine aminotransferase, also known as Glutathione Peroxidase (GPT) catalyses the 
transamination of L-alanine and α keto glutarate to form pyruvate and L- Glutamate. 
Pyruvate so formed is coupled with 2,4 – Dinitrophenyl hydrazine to form a corresponding 
hydrazone, a brown coloured complex in alkaline medium which can be measured 
colorimetrically. 
Reagents 
  Buffered alanine (pH 7.4), 2,4–DNPH, 4N sodium hydroxide, working pyruvate 
standard, solution I (prepared by diluting 1 ml of reagent 3 to 10 ml with purified water). 
Procedure  
 Rietman and Frankle method was dopted for the estimation of SGPT. The reaction 
systems used for this study included blank, standard, test (for each serum sample) and control 
(for each serum sample). 0.25 ml of buffered alanine was added into all the test tubes. This 
was followed by the addition of 0.05 ml of serum into the test group tubes and 0.05 ml of 
working pyruvate standard into the standard tubes. After proper mixing, all the tubes were 
kept for incubation at 37oC for 60 minutes, after which 0.25 ml each of 2,4- DNPH reagent 
was added into all the tubes. Then, 0.05 ml of distilled water and 0.05 ml of each serum 
sample was added to the blank and the serum control tubes respectively. The mixture was 
allowed to stand at room temperature for 20 min. After incubation, 2.5 ml of solution I was 
added to all test tubes. Mixed properly and optical density was read against purified water in 
a spectrophotometer at 505 nm within 15 min. 
The enzyme activity was calculated as:- ALT (GPT) activity in IU/L) = [(Absorbance of test - 
Absorbance of control)/ (Absorbance of standard - Absorbance of blank)] x concentration of 
the standard.        
3. Determination of alkaline phosphatase (ALP) 
  Alkaline phoshatase from serum converts phenyl phosphate to inorganic phosphate 
and phenol at pH 10.0. Phenol so formed reacts in alkaline medium with 4-aminoantipyrine 
in presence of the oxidising agent potassium ferricyanide and forms an orange-red coloured 
complex, which can be measured spectrometrically. The color intensity is proportional to the 
enzyme activity. 
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Reagents: 
Buffered substrate 
Chromogen Reagent 
Phenol Standard, 10 mg% 
Procedure: 
  ALP was determined using the method of Kind (Kind PRM, King EJ, 1972. In-vitro 
determination of serum alkaline phosphatase. Journal of Clinical Pathology 7: 321-22\). The 
working solution was prepared by reconstituting one vial of buffered substrate with 2.2 ml of 
water. 0.5 ml of working buffered substrate and 1.5 ml of purified water was dispensed to 
blank, standard, control and test. Mixed well and incubated at 370C for 3 min. 0.05 ml each of 
serum and phenol standard were added to test and standard test tubes respectively. Mixed 
well and incubated for 15 min at 370C. Thereafter, 1 ml of chromogen reagent was added to 
all the test tubes. Then, added 0.05 ml of serum to control. Mixed well after addition of each 
reagent and the O.D of blank, standard, control and test were read against purified water at 
510 nm. 
  Serum alkaline phosphatase activity in KA units was calculated as follows  
[(O.D. Test-O.D. Control) / (O.D. Standard- O.D. Blank)] x 10 
 
4. Determination of bilirubin  
  In toxic liver, bilirubin levels are elevated. Hyperbilirubinemia can result from 
impaired hepatic uptake of unconjugated bilirubin, such a situation can occur in generalized 
liver cell injury, certain drugs (e.g Rifampin and probenecid) interfere with the rat uptake of 
bilirubin by the liver cell and may produce a mild unconjugated hyperbilirubinemia. Bilirubin 
level rises in diseases of hepatocytes, obstruction to bilirubin excretion into duodenum, in 
haemolysis and defects of hepatic uptake and conjugation of Bilirubin pigment such as 
Gilbert’s disease.  
Elevation of total serum bilirubin may occur due to:  
1.Excessive haemolysis or destruction of the red blood cells.Eg:Haemolytic disease of the 
new born. 
2.Liver diseases.Eg.Hepatitis and cirrhosis. 
3.Obstruction of the biliary tract.Eg.Gall stones. 
The method is based on the reaction of Sulfonilic acid with sodium nitrite to form 
azobilirubin which has maximum absorbance at 546nm in the aqueous solution. The intensity 
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of the color Produced is directly proportional to the amount of direct or total bilurubin 
concentration present in the sample. 
Reagents 
1. Diazo A-(Reagent-R1) :Ready to use 
2. Diazo B-(Reagent-R2):Ready to use 
3. Bilirubin Activater :Ready to use 
Procedure 
  Kind & King’s method was followed for the estimation of Bilirubin. Five hundred µl 
of working reagent was added to 50 µl of rat serum & incubated for 5 min at 37°C. 
Absorbance was measured AT 546 NM in semi auto analyzer against the standard. 
  The Bilirubin content was calculated using the following equation: 
  Total bilirubin (mg/dt) = Abs of the sample blank x 15. 
  Direct Bilirubin(mg/dt) = Abs of sample blank x 10. 
5. ESTIMATION OF UREA 
Urea is the nitrogen-containing end product of protein catabolism. States associated 
with elevated levels of urea in blood are referred to as hyper uremia or azotemia.  
Method 
  Estimation of urea was done by Urease-GLDH: enzymatic UV test.  
Principle 
Urea + 2H2O     Urease       2NH4 + 2HCO3 
2- Oxoglutarate +NH4+ +NADH      GLDH      L- Glutamate +NAD+ + H2O                                         
Table 14. Reagents 
R 1 
TRIS pH 7.8 120  mmol/l 
2-Oxoglutarate 7 mmol/l 
ADP 0.6 mmol/l 
Urease ≥ 6 KU/l 
GLDH ≥ 1 KU/l 
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Procedure 
a. Take 1000 µl of reagent-1 and 250 µl of reagent-2 in 5 ml test tube. 
b. To this, add 10 µl of serum. 
c. Mix well and immediately read the test sample at 340 nm Hg 334 nm Hg 365 nm 
optical path 1 cm against reagent blank (2-point kinetic). 
d. And note down the value. 
Normal range: 10 – 50 mg/dl. 
6. ESTIMATION OF URIC ACID 
Uric acid and its salts are end products of the purine  metabolism. In gout the most 
common complication of  hyperuricemia, ie. Increased serum levels of uric acid lead to 
formation of  monosodium urate crystal around the joints. 
Method  
Enzymatic photometric test using  TOOS (N ethyl- N (hydroxyl -3- sulfopropyl)-m- toluidin) 
Principle  
Uric acid + H2O + O2       uricase         Allantoin +CO2 +H2O2 
TOOS + 4 aminoantipyrine + 2H2O2      POD       Indamine + 3H2O 
Table 15.reagents 
R1 Phosphate buffer pH 7.0 100mmol/l 
TOOS 1mmol/l 
Ascorbate oxidase ≥1 KU/l 
R2 Phosphate buffer pH 7.0 100mmol/l 
4- amino antipyrine 0.3mmol/l 
K4 (Fe( CN)6) 10µmol/l 
Peroxidase ≥1KU/l 
Uricase ≥50U/l 
R 2 NADH 0.25 mmol 
R 3 Standard 40 mg/dl 
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Procedure 
a. Take 800µl of  reagents -1 in a2ml centrifuge tube. 
b. To this add 20µl of serum. 
c. Mix well and incubate at 30°c for 5 minutes. 
d. Then add 200µl of reagent2 
e. Mix well incubate for 5min at 37°c 
f. Measure the not down the values. 
Normal range: 1.9-8.2mg/dl 
7. ESTIMATION OF CREATININE:  
Principle: 
Creatinine forms a coloured complex with picrate in alkaline medium.  
The rate of formation of the complex is measured.  
Reagents: 
Reagent 1    Standard Creatinine (2mg/100ml) 
Reagent 2    Picric acid solution. 
Reagent 3     sodium hydroxide solution  
Procedure: 
 Take 500 µl of reagent -2 and 500 µl of reagent -3 in a 5ml test tube. To this add 100 
µl of serum. Mix well and immediately read the test sample at Hg 492 nm 1cm light path and 
note down the values.  
Normal range is 0.6 -1.1 mg/dl. 
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TABLE: 1   EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF VATHATHIRKU LEGHIYAM WITH 
HONEY/GHEE ON BODY WEIGHT IN Gram (PHYSICAL PARAMETER) 
EFFECT OF SUB ACUTE DOSES (28 DAY) 0F VATHATHIRKU LEGHIYAM WITH HONEY/GHEE 
ON BODY WEIGHT IN Gram (PHYSICAL PARAMETER). 
GPs Control Low Dose Middle Dose High Dose 
 
Male Female Male Female Male Female Male Female 
1stwk 
137.3±3.
528 
139.3±2.
404 
146.7±2.9
06 
141.3±1.7
64 
132±2.30
9 
135.3±2.4
04 
145.3±1.7
64 
142.3±2.7
28 
2ndwk 142.7±2.
906 
143.7±2.
603 
150.7±1.7
64 
150±4.16
3 
138±2.64
6 
139.7±2.1
86 153±1.732 
148±2.88
7 
3rdwk 
151.7± 
3.844 
152±4 
 
154± 
3.055 
156.7± 
1.764 
146.7± 
1.453 
147.3± 
2.963 
157±1.528 
 
154.3± 
2.728 
 
4thwk 162± 
2.082 
 
162.7± 
3.528 
 
163.3± 
3.48 
 
166.3± 
0.8819 
 
157.7± 
0.8819 
 
158.7± 
2.603 
 
166±2.082 
 
 
162± 
2.646 
 
 
Values are expressed as the mean ± S.D 
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2nd WK BODY WEIGHT
M F M F M F M F
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3rd WK BODY WEIGHT
M F M F M F M F
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4th WK BODY WEIGHT
M F M F M F M F
0
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  EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF VATHATHIRKU LEGHIYAM WITH 
HONEY/GHEE  ON FOOD INTAKE In Gram  
Effect Of Sub Acute Doses (28 Days) 0f VATHATHIRKU LEGHIYAM WITH HONEY/GHEE ON FOOD INTAKE 
IN Gram 
Groups Control Low Dose Middle Dose High Dose 
 
DAY Male Female Male Female Male Female Male Female 
Day 1 
34 28 15 10 18 60 12 24 
DAY2 
38 62 56 31 28 80 8 58 
DAY3 
38 30 44 52 66 32 34 14 
Day 4 
56 18 34 24 18 22 42 22 
DAY5 
34 10 18 6 44 58 38 26 
Day 6 
60 12 58 68 32 38 58 64 
DAY7 
50 14 61 88 58 34 62 74 
DAY8 
32 44 18 40 26 64 58 62 
Day 9 
80 56 22 60 48 56 56 64 
DAY10 
74 62 45 56 64 74 24 58 
Day 11 
44 54 68 58 30 62 70 56 
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DAY12 
54 60 38 62 56 64 62 48 
DAY13 
72 56 38 44 57 74 54 78 
Day 14 
38 19 54 50 16 74 72 56 
DAY15 
48 36 64 71 82 56 56 28 
Day 16 
56 78 54 42 56 80 56 77 
DAY17 
56 78 64 58 44 56 56 74 
DAY18 
45 52 34 56 72 64 62 54 
Day 19 
50 48 62 56 88 64 64 58 
DAY20 
16 35 20 75 35 56 72 34 
DAY21 
34 56 64 68 56 64 45 62 
Day 22 
56 34 18 58 64 78 56 42 
DAY23 
46 28 64 56 67 58 18 34 
DAY24 
54 42 34 78 46 64 30 68 
Day 25 
40 80 55 44 88 80 34 64 
DAY26 
64 42 56 64 52 46 58 56 
DAY27 
68 45 32 38 56 80 56 58 
DAY28 
88 36 58 34 24 74 62 61 
 
Values are expressed as the mean ± S.D 
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EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF VATHATHIRKU LEGHIYAM WITH 
HONEY/GHEE  ON WATER INTAKE IN ml 
Effect Of Sub Acute Doses (28 Day) 0f VATHATHIRKU LEGHIYAM WITH HONEY/GHEE on Water Intake in ml 
Groups Control Low Dose Middle Dose High Dose 
 
DAY Male Female Male Female Male Female Male Female 
Day 1 
70 75 85 140 70 100 50 70 
DAY2 
105 60 85 60 50 85 140 105 
DAY3 
130 60 85 60 70 150 165 130 
Day 4 
70 90 40 55 80 100 90 70 
DAY5 
130 210 60 70 130 70 75 60 
Day 6 
50 70 90 50 65 60 70 85 
DAY7 
70 80 50 130 60 70 90 55 
DAY8 
130 60 50 70 75 50 70 55 
Day 9 
110 40 80 55 130 20 130 85 
DAY10 
65 130 40 130 70 50 60 70 
Day 11 
80 60 55 70 60 60 70 30 
DAY12 
70 60 75 40 45 80 60 40 
DAY13 
50 60 40 65 55 50 30 60 
Day 14 
40 40 65 60 85 65 20 70 
DAY15 
60 65 20 60 65 80 60 70 
Day 16 
45 60 50 65 30 70 60 40 
DAY17 
80 60 40 70 30 60 20 55 
DAY18 
60 80 65 60 40 90 170 140 
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Day 19 
70 115 125 120 20 95 185 140 
DAY20 
70 90 95 50 65 60 75 50 
DAY21 
70 60 85 130 90 50 95 85 
Day 22 
140 40 60 105 70 60 90 60 
DAY23 
60 95 60 65 80 95 70 50 
DAY24 
110 90 75 60 70 50 60 70 
Day 25 
130 60 125 110 85 60 70 60 
DAY26 
70 110 90 60 50 70 110 40 
DAY27 
70 90 50 70 40 110 60 140 
DAY28 
65 50 110 60 85 75 60 125 
 
Values are expressed as the mean ± S.D 
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EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF VATHATHIRKU LEGHIYAM 
WITH HONEY/GHEE ON ORGAN WEIGHT in gm 
 
 
Values arae expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by dunnett’s (n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groups with control group.  
GROUP CONTROL 
 
Low Dose 
 
Middle Dose 
 
High Dose 
LIVER  WEIGHT 7.472±0.356 6.59±0.415ns 7.678±0.788ns 6.721±0.241ns 
KIDNEY 
WEIGHT 
L 
0.704±0.0114 0.574±0.019** 0.596±0.00145* 
0.515±0.0018**
* 
R 
0.666±0.0180 0.607±0.0354 0.560±0.0078** 
0.493±0.0043**
* 
HEART 
WEIGHT 0.745±0.0565 0.715±0.0343 0.660±0.0190 0.79±0.0517 
LUNGS  
WEIGHT 1.728±0.122ns 1.33±0.0596ns 1.663±0.1328ns 1.627±0.03301ns 
TESTIS WEIGH 2.357±0.0161
5 2.281±0.07202 1.739±0.1249* 1.89±0.179 
 0.6793±0.059
4 0.605±0.04431 0.5553±0.06623 0.5967±0.03567 
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0F VATHATHIRKU LEGHIYAM WITH HONEY/GHEE 
ON HAEMATOLOGICAL PARAMETERS 
Effect Of Sub Acute Doses (28 Day) 0f Vathathirku Leghiyam With Honey/Ghee On Haematological 
Parameters 
Groups Control Low Dose Middle Dose High Dose 
Rbc (X103/µl)  
 5.33±0.8585 6.403±0.289 5.96±0.2173 6.213±0.3619 
Wbc(X106/µl)  
 11.17±0.8762 11.87±0.8212 13.73±0.636 13.3±0.3606 
 
Hb (g/dl) 
 
16.4±1.29 
 
16.37±1.707 
 
13.5±0.3055 
 
14.37±0.977 
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by one 
way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, ***P < 0.05 
calculate by comparing treated group with CONTROL group.         
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0F VATHATHIRKU LEGHIYAM WITH 
HONEY/GHEE ON BIOCHEMICAL PARAMETER (LIVER PROFILE) 
Groups Control Low Dose Middle Dose High Dose 
Total 
Bilirubin(mg/dl) 
 
0.625±0.125 
 
 
0.865±0.195 
 
 
0.79±0.06 
 
 
1.015±0.055 
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated 
by one way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, 
***P < 0.05 calculate by comparing treated group with CONTROL group.         
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0F VATHATHIRKU LEGHIYAM WITH 
HONEY/GHEE ON BIOCHEMICAL PARAMETER (LIVER PROFILE) 
Groups Control Low Dose Middle Dose High Dose 
 
SGOT (U/L) 
 
85.95±9.25 
 
133.2±37.95 
 
77.9±14.9 
 
81.35±3.05 
 
SGPT (U/L) 69.79±15.72 
 
45.4±3.8 
 
48.15±21.85 
 
38.15±3.95 
 
ALP (U/L) 308.2±24.55 
 
321.8±15.75 
 
247.8±10.55 
 
267.3±1.9 
 
 
Values are expressed as the mean ± S.D; Statistical significance (p) calculated 
by one way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, 
***P < 0.05 calculate by comparing treated group with CONTROL group.         
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0F VATHATHIRKU LEGHIYAM WITH HONEY/GHEE 
ON BIOCHEMICAL PARAMETER (KIDNEY PROFILE) 
Groups Control Low Dose Middle Dose High Dose 
Urea (mg/dl) 26.03±1.01 
 
33.45±0.25 
 
39.08±1.18 
 
26.74±1.13 
 
Uric acid 
(mg/dl) 
1.615±0.135 
 
1.2±0.04 
 
1.31±0.07 
 
1.64±0.1 
 
Creatinine 
(mg/dl) 
0.33±0.05 
 
0.275±0.005 
 
0.23±0.02 
 
0.29±0.09 
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by one 
way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, ***P < 0.05 
calculate by comparing treated group with CONTROL group.         
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0F VATHATHIRKU LEGHIYAM WITH HONEY/GHEE 
ON BIOCHEMICAL PARAMETER (LIPID PROFILE) 
Groups Control Low Dose Middle Dose High Dose 
Total cholesterol 
(mg/dl) 
34.3±3.6 
 
44.85±0.75 
 
44.95±8.05 
 
41.2±1.1 
 
Triglycerides 
(mg/dl) 
101.3±5 
 
71.55±4.85 
 
68.28±2.48 
 
80.4±3.8 
 
HDL-
Cholesterol 
(mg/dl) 
10.12±0.185 
 
6.625±1.945 
 
6.65±2.05 
 
3.9±0.7 
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by one 
way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, ***P < 0.05 
calculate by comparing treated group with CONTROL group.         
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RESULTS: 
CLINICAL SIGNS: 
All animals in this study were free of toxic clinical signs throughout the 
dosing   period of 28 days. 
 Mortality: 
All animals in control and in all the treated dose groups survived 
throughout the dosing period of 28 days. 
 Body weight: 
Results of body weight determination of animals Table-1 from control 
and different dose groups exhibited comparable body weight gain throughout 
the dosing period of 28 days. 
Food consumption: 
During dosing and the post-dosing recovery period, the quantity of food 
consumed by animals from different dose groups was found to be comparable 
with that by control animals. 
Organ Weight: 
Group Mean Relative Organ Weights (% of body weight) are recorded in 
Table No.4 Comparison of organ weights of treated animals with respective 
control animals on day 29 was found to be comparable similarly. 
Hematological investigations: 
The results of hematological investigations (Table 4) conducted on day 
29 revealed following significant changes in the values of different parameters 
investigated when compared with those of respective controls; however, the 
increase or decrease in the values obtained was within normal biological and 
laboratory limits or the effect was not dose dependent. 
Biochemical Investigations: 
Results of Biochemical investigations conducted on days 29 and recorded 
in Table 2 revealed the following significant changes in the values of hepatic 
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serum enzymes studied. When compared with those of respective control. 
However, the increase or decrease in the values obtained was within normal 
biological and laboratory limits. 
Histopathology: 
In histopathological examination, revealed normal architecture in 
comparison with control and treated animal. 
 DISCUSSION: 
1)  All the animals from control and all the treated dose groups up to 500 mg/kg 
survived throughout the dosing period of 28 days. 
2)  No signs of toxicity were observed in animals from different dose groups 
during the dosing period of 28 days. 
3)  Animals from all the treated dose groups exhibited comparable body weight 
gain with that of controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be 
comparable throughout the dosing period of 28 days 
5)   Haematological analysis conducted at the end of the dosing period on day 
29, revealed no abnormalities attributable to the treatment. 
6) Biochemical analysis conducted at the end of the dosing period on day 29 no 
abnormalities attributable to the treatment. 
7) Organ weight data of animals sacrificed at the end of the dosing period was 
found to be comparable with that of respective controls. 
8) Histopathological examination revealed normal architecture in comparison 
with control and treated animal. 
 SUMMARY AND CONCLUSION:  
In conclusion VATHATHIRKU LEGHIYAM WITH HONEY/GHEE 
can be considered safe, as it did not cause either any lethality or adverse 
changes with general behavior of rats and also there were no observable 
detrimental effects (100 to 300 mg/kg body weight) over a period of 28 days. 
176 
 
Our results have demonstrated that the VATHATHIRKU LEGHIYAM 
WITH HONEY/GHEE is relatively safe when administered orally in rats. 
 
9.0 ABBRVIATION 
No.   Number 
Mg  Milligram 
Kg   Kilogram 
LD50  Lethal Dose 50 
p.o.  peros 
mL  Milliliter 
%   percentage 
R&D   Research and Development 
EDTA  Ethylene Diamine Tetra Acetic Acid 
M   Male 
g%   Gram percentage 
g  Gram 
NOAEL  No-Observed-Adverse-Effect-Level 
MLD   Minimum Lethal Dose 
MTD   Maximum Tolerated Dose 
OECD Organisation of Economic Co-operation and Development 
CPCSEA  Committee for the Purpose of Control and Supervision of  
Experiments on Animals 
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HISTOPATHOLOGY   -  TOXICITY STUDY 
SPECIMEN     : A) Liver.    Group –    : Vathathirkku leghiyam. 
                                                       
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MICROSCOPIC APPEARANCE:  
    Section from liver shows lobular architecture with interface hepatitis. Individual 
Hepatocytes shows reactive atypia. Portal triad shows no significant pathology. Central vein 
and Sinusoids show dilatation. 
10x shows mild alterd architecture 40x shows central vein congestion (2) 
40x shows central vein congestion 40x shows reactive atypia 
40x shows interface hepatitis and kuffer cell 40X shows mild periportal inflammation 
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SPECIMEN    :  B) spleen. 
Group – :  Vathathirkku leghiyam 
               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MICROSCOPIC APPEARANCE:  
                     Section studied from spleen shows normal white pulp and red pulp. Red pulp 
shows pigment laden macrophages and congested vessels. White pulp shows lymphocytic 
infiltrates forming germinal centre. The pencillar artery shows normal morphology. 
Megakaryocytes 
10x shows normal spleen with megakaryocytes 10x shows spleen with normal red and                  
white pulp 
40x shows megakaryocytes 
40x shows normal white pulp with megakaryocytes 
40x showws white pulp and red pulp 
179 
 
    SPECIMEN  :  C)  Kidney. 
Group – :  Vathathirkku leghiyam 
               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MICROSCOPIC APPEARANCE: 
 
 Section from kidney shows both cortex and medulla. Glomeruli and tubules shows no 
significant pathology. Interstitium shows no significant pathology. Blood vessels show 
congestion. There is no evidence of toxic changes. 
10x shows both cortex and medulla 10x shows normal kidney 
40 shows tubules 
40x shows focal segmental glomerulo nephritis with 
blood vessels congestion 
40x shows glomeruli and tubules 40x shows normal tubules 
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SPECIMEN  :  D) Testis 
Group – :  Vathathirkku leghiyam 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MICROSCOPIC APPEARANCE:  
           Section from testes with seminiferous tubules showing maturation arrest with lacking 
of spermatogenesis.  
10 shows normal spermatogenesis 40x shows normal seminiferous tubules 
40x shows normal spermatogenesis with 
normal maturation (2) 
40x shows normal spermatogenesis with normal 
maturation 
40x 
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ANNEXURE –V 
ASSESSMENT FORMS 
 
FORM I  : Screening and Selection Proforma 
FORM I A  : History Proforma on Enrollment 
FORM II  : Clinical assessment on enrollment 
FORM II A  : Clinical assessment during and after trial 
FORM III  : Laboratory Investigation on enrollment and conclusion  
  of trial 
FORM IV  : Consent Form 
FORM IV B  : Withdrawal form 
FORM IV C  : Patient information sheet 
FORM IV D  : Dietary Advice form 
FORM IV E  : Adverse Reaction form 
FORM IV F  : Discharge proforma 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “VATHATHIRKU LEGHIYAM” INTERNAL & “PANCHARKA 
THYLAM” EXTERNAL IN “CEGANAVATHAM” (CERVICAL SPONDYLOSIS). 
 
FORM I – SCREENING & SELECTION PROFORMA 
1. OP / IP NO    : ___________ 
2. NAME   : ___________ 
3. RELIGION    : H / C / M / O 
4. AGE / GENDER  : ___________ 
5. OCCUPATION  : ___________ 
6. INCOME   : ___________ 
7. CONTACT NO  : ___________ 
8. INCLUSION CRITERIA :  
INCLUSION CRITERIA: 
Age : Between 20 years and 60 years  
Sex : Male and female 
. Pain, stiffness and restricted movements in the neck. 
• Tingling sensation, numbness in the upper limbs. 
• Radiating pain in the upper limbs. 
• Feeling of heaviness in the body and weakness of the limb 
• Constipation 
• Mental depression 
• Burning sensation of eyes. 
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EXCLUSION CRITERIA: 
 Cervical rib 
 Trauma 
 Spina bifida 
 Diabetes mellitus 
 Ankylosing spondylosis 
 Tuberculosis in spine 
 Cardiac disease 
 Pregnancy and lactation 
 Neoplasms 
 Patients with any other serious systemic illness 
 Congenital anomalies of spine. 
 
ADMITTED TO TRIAL: 
    YES  NO 
If Yes Serial Number : 
 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “VATHATHIRKU LEGHIYAM” INTERNAL & “PANCHARKA 
THYLAM” EXTERNAL IN “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
 
FORM I A – HISTORY PROFORMA 
1. SL.NO     : ___________ 
2. OP / IP NO     : ___________ 
3. NAME    : ___________ 
4. RELIGION     : H / C / M / O 
5. AGE / GENDER   : ___________ 
6. OCCUPATION   : ___________ 
7. INCOME    : ___________ 
8. CONTACT NUMBER  : ___________ 
9. MARITAL STATUS   : Married / Unmarried 
10. COMPLAINTS & DURATION : 
 
11. PERSONAL HISTORY: 
PERSONAL HABITS YES NO IF YES SPECIFY DURATION 
Smoking    
Tobacco Chewing    
Alcohol    
Narcotic Drug Addiction    
12. DRUG HISTORY: 
 Whether the Patient has underwent any allopathic Treatment  
1. Yes    2. No. 
 If yes specify the nature of the drug and treatment duration _____ 
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13. FAMILY HISTORY: 
 Whether this problem runs in family? 
1. Yes  2. No 
If yes, mention the relationship of affected person(s) 
1. ___________ 
2. ___________ 
14. DIETARY HABITS : 
 
   1. Pure vegetarian 
   2. Non-Vegetarian 
 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “VATHATHIRKU LEGHIYAM” INTERNAL & “PANCHARKA 
THYLAM” EXTERNAL IN “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
 
FORM II AND II-A  CLINICAL ASSESSMENT ON ENROLLMENT AND ON 
VISITS 
 
1. OP / IP No     :  
2. BED No    :  
3. SL. NO    : 
4. NAME    : 
5. AGE     : 
6. GENDER    : 
7. OCCUPATION   : 
8. SOCIAL STATUS   : 
9. DATE OF ADMISSION  : 
10. DATE OF DISCHARGE  : 
11. POSTAL ADDRESS   : 
12. COMPLAINTS & DURATION : 
13. HISTORY OF PRESENT ILLNESS : 
14. PAST HISTORY   : 
15. FAMILY HISTORY   : 
 
16. MENSTRUAL HISTORY (If Applicable): 
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17. HABITS: 
1. Smoker    : 
2. Alcoholic    : 
3. Tobbaco chewer   :  
4. Betel nut chewer   : 
5. Non-Vegetarian   : 
6. Drug addiction   : 
18. GENERAL EXAMINATION: 
1. Body weight (Kg)   : 
2. Height (Cm)   :  
3. Body Temperature (F)  :  
4. Blood Pressure (mmHg)  : 
5. Pulse Rate (/min)   : 
6. Heart Rate (/min)   : 
7. Respiratory Rate (/min)  :  
8. Pallor    :  
9. Jaundice    : 
10. Clubbing    : 
11. Cyanosis    : 
12. Pedal Oedema   :  
13. Lymphadenopathy  :  
14. Jugular venous pulsation  : 
19. CLINICAL EXAMINATION: 
I. INSPECTION: 
1. Attitude    : 
2. Muscular spasm   : 
3. Muscle wasting – Proximal :  
4. Muscle wasting – Distal  : 
5. Minor Joint Swelling  : 
6. Major Joint Swelling  : 
7. Nodules    : 
8. Deformity    : 
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II. PALPATION: 
1. Swelling    : 
2. Tenderness   :  
3. Joint Stiffness   : 
4. Muscle wasting   : 
5. Local heat    : 
6. Local Lymphadenopathy  : 
7. Pitting Oedema   : 
8. Nodules    : 
 
III. MOVEMENTS: 
Restriction of joint movements 
1. Neck              :            Full            Partial    
2. Shoulder  : 
3. Elbow joint  : 
4. Knee joint  : 
5. Ankle joint  : 
6. Hip joint  : 
7. Minor joints  : 
 
IV. PAIN: 
1. Onset :   Sudden : Gradual : 
2. Early morning stiffness :  Present  : absent  : 
3. Nature of pain:  Mild  : Moderate :     Severe: 
4. Aggravating factor –Movements  : 
5. Relieving factor – rest   : 
6. Stiffness     : 
7. Tenderness    :  
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V. CLINICAL ASSESSMENT :  
1. Arthritis of three or more Joints  : 
2. Arthritis of hand joints   : 
3. Morning Stiffness    : 
4. Fever     : 
5. Anorexia     : 
6. Anaemia     : 
7. Spindle appearance of fingers  : 
8. Restricted movements   : 
9. Rheumatoid Nodules   : 
10. Numbness     : 
20. EXAMINATION OF OTHER SYSTEMS:  
1. CVS    : 
2. RS     : 
3. CNS    : 
4. ABDOMEN   : 
5. GENITO – URINARY  : 
 
EXAMINATION – SIDDHA ASPECTS 
1. NILAM: 
 1. Kurinji 2. Mullai 3. Marutham 4. Neithal 5. Paalai 
2. KAALAM: 
 1. Kaar Kaalam 2. Koothir Kaalam 3. Munpani Kaalam 
 4. Pinpani Kaalam 5. Elavenir Kaalam 6. Mudhuvenir Kaalam 
3. YAAKKAI:  
 1. Vatham   2. Pitham   3. Kabam 
 4. Vathapitham  5. Pithavatham  6. Kabavatham 
 7. Vathakabam  8. Pithakabam   9. Kabapitham 
4. GUNAM:  
 1. Sathuvam   2. Rasatham   3. Thamasam 
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5. KANMENDHIRIUM / KANMAVIDAYAM 
 1. Kai   : 
 2. Kaal   : 
 3. Vaai   : 
 4. Eruvaai  : 
5. Karuvaai  : 
6. UYIR THATHUKKAL: 
I. VATHAM: 
1. Piraanan  : 
2. Abaanan  : 
3. Viyaanan  : 
4. Uthaanan  : 
5. Samaanan  : 
6. Naagan  : 
7. Koorman  : 
8. Kirukaran  : 
9. Devathathan : 
10. Dhananjeyan : 
II. PITHAM : 
1. Analagam  : 
2. Ranjagam  : 
3. Saathagam  : 
4. Aalosagam : 
5. Praasagam  : 
III. KABAM: 
1. Avalambagam : 
2. Kilethagam : 
3. Pothagam  : 
4. Tharpagam : 
5. Santhigam  : 
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7. UDAL THAATHUKKAL: 
1. Saaram  : 
2. Senneer  : 
3. Oon  : 
4. Kozhuppu  : 
5. Enbu  : 
6. Moolai  : 
7. Sukkilam / Suronitham: 
8. ENVAGAI THERVUGAL: 
1. Naadi  : 
2. Sparisam  : 
3. Naa  :  
4. Niram  : 
5. Mozhi  : 
6. Vizhi  : 
7. Malam :  
i. Niram:  ii. Thanmai: iii. Irugal: iv.Ilagal: 
8. Moothiram : 
 
I. NEERKURI: 
 a. Niram : 
 b. Manam : 
 c. Edai  : 
 d. Nurai : 
 e. Enjal : 
II. NEIKURI: 
 Vatha Neer  :  Pittha Neer   :    Kaba Neer : 
   
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “VATHATHIRKU LEGHIYAM” INTERNAL & “PANCHARKA 
THYLAM” EXTERNAL IN “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
 
FORM III – LABORATORY INVESTIGATION 
1. BLOOD: 
1. TC   : (Cells / Cumm) 
2. DC (%)  : N : L : M : E : 
3. ESR (mm)  : ½ hr : 1 hr : 
4. Hb   : 
5. Blood Sugar : a) Fasting : b) Post Prandial : 
6. Renal function tests: 
Blood Urea:  Serum creatinine: 
7. Lipid profile : 
HDL:   LDL:  VLDL: 
Total Cholesterol : TGL : 
8. Liver Function tests: 
Serum Bilirubin :  Total  Direct  Indirect 
SPECIFIC INVESTIGATIONS 
 RA factor   : 
 ASO titre   : 
 C-Reactive Protein  : 
 SGOT    : 
SGPT    : 
 Serum albumin & globulin : 
 Total protein   : 
II. URINE: 
1. Albumin   : 
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2. Sugar   : 
3. Epithelial cells  : 
4. Pus cells   : 
5. Red blood cells  : 
6. Casts / Crystals  : 
III. MOTION: 
1. Ova   : 
2. Cyst   : 
3. Occult blood  : 
4. Pus cells   : 
IV. X-RAY FINDINGS 
 
 
 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “VATHATHIRKU LEGHIYAM” INTERNAL & “PANCHARKA 
THYLAM” EXTERNAL IN “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
    
FORM IV A – CONSENT FORM 
 
CERTIFICATE BY INVESTIGATOR 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the patient. 
Signature ______________ 
Date      ______________ 
Name    ______________ 
CONSENT BY PATIENT 
 I have been informed to my satisfaction, by the attending physician, the purpose of the 
clinical trial, and the nature of drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my body functions. 
 I am aware of my right to opt out of the trial at any time during the course of the trial 
without having to give the reasons for doing so. 
 I exercising my free power of choice, hereby give my consent to be included as a 
subject in the clinical trial of “VATHATHIRKU LEGHIYAM” (Internal drug) and 
“PANCHARKA THYLAM” (External drug) for the treatment of “CEGANA VATHAM” 
(CERVICAL SPONDYLOSIS)”. 
 
Place :        Signature  :  
Date :         Name  : 
        Witness Signature: 
        Name  :  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “VATHATHIRKU LEGHIYAM” INTERNAL & “PANCHARKA 
THYLAM” EXTERNAL IN “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
FORM IV B WITHDRAWAL FORM 
1. SL.NO    : ___________ 
2. OP / IP NO    : ___________ 
3. NAME   : ___________ 
4. RELIGION    : H / C / M / O 
5. AGE / GENDER  : ___________ 
6. OCCUPATION  : ___________ 
7. SOCIAL STATUS  : ___________ 
8. CONTACT NO  : ___________ 
9. DATE OF TRIAL COMMENCEMENT  : ___________ 
10. DATE OF WITHDRAWAL FROM TRIAL : ___________ 
11. REASONS FOR WITHDRAWAL   : ___________ 
 Long absence at reporting   :  Yes / No 
 Irregular treatment    :  Yes / No 
 Shift of locality    :  Yes / No 
 Increase in severity of symptoms  :  Yes / No 
 Development of severe adverse drug reactions:  Yes / No 
 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III (SIRAPPU MARUTHUVAM) 
 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “VATHATHIRKU LEGHIYAM” INTERNAL & “PANCHARKA 
THYLAM” EXTERNAL IN “CEGANA VATHAM” (CERVICAL SPONDYLOSIS). 
FORM IV C – DRUG COMPLIANCE FORM 
Name of the Drug : VATHATHIRKU LEGHIYAM 
Drugs issued  : (Mg / Gram) 
Drugs returned : (Mg / Gram) 
 
S. NO DATE DRUG TAKEN TIME 
MORNING / TIME EVENING / TIME 
Day 1    
Day 2    
Day 3    
Day 4     
Day 5    
Day 6    
Day 7    
Day 13    
Day 14    
Day 15    
Day 16    
Day 17    
Day 18    
Day 19    
Day 25    
Day 26    
198 
 
Day 27    
Day 28    
Day 29    
Day 30    
Day 31    
Day 37    
Day 38    
Day 39    
Day 40    
Day 41    
Day 42    
Day 43    
Day 44    
Day 45    
Day 46    
Day 47    
Day 48     
 
 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD  
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